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The feasibility of FTIR-based spectroscopy as a tool to measure cellular response to 
therapeutics was investigated. Fourier transform mid-infrared spectroscopy has 
been used in conjunction with multivariate analysis (MVA) to assess the chemistry 
of many clinically relevant biological materials; however, the technique has not yet 
found its place in a clinical setting.  One issue that has held the technique back is 
due to the spectral distortions caused by resonant Mie scattering (RMieS), which 
affects the ability to confidently assign molecular assignments to the spectral 
signals from biomaterials.  In the light of recently improved understanding of 
RMieS, resulting in a novel correction algorithm, the analytical robustness of 
corrected FTIR spectra was validated against multi-discipline methods to 
characterise a set of renal cell lines which were selected for their difference in 
morphology. 
After validation of the FTIR methodology by discriminating different cell lines, the 
second stage of analyses tested the sensitivity of FTIR technique by determining if 
discrete chemical differences could be highlighted within a cell population of the 
same origin. The renal carcinoma cell line 2245R contains a sub-population to 
contain a sub-population of cells displaying ‘stem-cell like’ properties. These stem-
like cells, however, are difficult to isolate and characterise by conventional ‘-omic’ 
means.  
Finally, cellular response to chemotherapeutics was investigated using the 
established renal cell lines CAKI-2 and A-498. For the model, 5-fluorouracil (5FU), 
an established chemotherapeutic agent with known mechanisms of action was used.  
Novel gold-based therapeutic compounds were also assessed in parallel to 
determine their efficacy against renal cell carcinoma. The novel compounds 
displayed initial activity, as the FTIR evidence suggested compounds were able to 
enter the cells in the first instance, evoking a cellular response. The long-term 
performance, tracked with standard proliferation assays and FTIR spectroscopy in 
the renal cancer cell model, however, was poor. Rather than dismissing the 
compounds as in-active, the compounds may simply be more effective in cancer 
cell types of a different nature. The FTIR-based evidence provided the means to 
suggest such a conclusion.  
Overall, the initial results suggest that the combination of FTIR and MVA, in the 
presence of the novel RMieS-EMSC algorithm can detect differences in cellular 
response to chemotherapeutics. The results were also in-line with complimentary 
biological-based techniques, demonstrating the powerful potential of the technique 
as a promising drug screening tool.  
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1.1│The Major Classes of Biological Macromolecules 
Molecules, such as water, inorganic ions and a large array of small organic  
molecules such as sugars and fatty acids can be taken up by cells. By a series of 
chemical reactions cells have the ability to alter and manufacture many small 
organic molecules. These small organic molecules are pre-cursors to 
macromolecule synthesis and cells must manufacture large organic molecules via 
their polymerisation. There are four main classes: proteins, nucleic acids, 
carbohydrates and lipids [1].   
 
1.1.1│Proteins 
Proteins are the most abundant and functionally versatile of the four biological 
macromolecules in the cell.  Proteins are comprised of amino acid sub-units, which 
are linked together by strong covalent peptide bonds. These linkages many be 
arranged in a linear polypeptide chain (Eq. 1) [1].   
 
 
(1) 
 
 
The peptide bonds link amino acid residues within proteins. This sequence of 
covalently linked amino acids is known as the primary (1˚) structure of a protein 
(Fig. 1.1). 
 
Protein secondary (2˚) structure primarily concerns the polypeptide backbone rather 
than the side chains. Polar side chains are generally arranged on the outside and 
hydrophobic ones on the inside in a water-soluble protein. The backbone has 
hydrogen groups (C=O, N-H) capable of hydrogen bonding which, unless satisfied 
with actual bond formation, would lead to a destabilised protein structure. As the 
polypeptide backbone crosses back and forth, folding the molecule into a compact 
shape the backbone is exposed to the hydrophobic protein interior. The non-polar 
side groups of the amino acids in the protein interior are not capable of hydrogen 
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bonding, therefore hydrogen bonding occurs with groups on the same, or and 
adjacent polypeptide backbone. The two main classes of structure which satisfy this 
arrangement are the  helix (Fig.1.1 2˚(i)), where the backbone is arranged in a 
spiral-like coil, and the  sheet (Fig.1.1 2˚(ii)), where polypeptide backbones are 
extended, side by side. The helix and sheet structures are connected with connecting 
loops known as random coils (Fig.1.1 2˚(iii)) that do not fall into the previous 
defined categories. Their structure is associated with side chain interactions and 
may not necessarily satisfy the hydrogen bonding potentials of the polypeptide 
backbone, therefore such sections are mostly found at the protein exterior in contact 
with water [1].  
 
Protein tertiary structure describes the arrangement of various secondary structure 
polypeptides that are folded up into the compact structure of a globular protein 
(Fig.1.1 3˚), defining the protein molecule. Hydrogen bonding and ionic interactions 
between side chains influence the folded structure while hydrophobic force is an 
essential contributor that drives the protein folding.  Individual protein molecules in 
a structure are called subunits.  Quaternary structure ((Fig.1.1 4˚) describes the 
arrangement of subunits into a singular functional complex [1].   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 │Diagrammatic illustration of the meaning of the four descriptions of protein 
structure; primary (1˚), secondary (2˚), tertiary (3˚) and quaternary (4˚). For secondary 
structure i-iii denotes alpha helix, beta sheet and random coil respectively [1].   
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Each type of protein usually has a unique function associated with its particular 
composition and feature. Roles include biological catalysis, contributing to 
organism structure, participating in cell signalling, recognition and immunity.  
 
1.1.2 │ Nucleic acids 
Nucleic acids consist of two closely related forms; deoxyribonucleic acid (DNA) 
and ribonucleic acid (RNA). Their function involves the storage and conversion of 
genetic information into proteins. They are comprised of a sugar-phosphate 
backbone and a series of base pairs which are the informational coding part of the 
nucleic acid structure. The term nucleic acid was derived from the fact that DNA 
was first isolated from cell nuclei, and is acidic due to the phosphate groups [1]. 
DNA is double stranded, comprised of two polynucleotide molecules paired 
together by hydrogen-bonded complimentary base pairing (Fig. 1.2) [2]. The base 
pairs in DNA are adenine to thymine and guanine to cytosine (In RNA, thymine is 
substituted for uracil).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2│ The Watson and Crick hydrogen-bonded base pairs of DNA, where S-P denotes the 
sugar-phosphate backbone. Two hydrogen bonds are formed between adenine and thymine, 
which is situated on the opposite strand. Three hydrogen bonds are formed between guanine and 
cytosine, which is also on the opposite strand.  
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The sugar-phosphate backbone is comprised of a series of 2’-deoxyribose molecules 
(or ribose in RNA) linked together by phosphodiesters (Fig. 1.3). When attached to 
ribose or deoxyribose, the bases are termed nuleosides and are associated as 
guanosine, thymidine, adenosine and cytidine [1]. 
 
 
 
 
 
 
 
 
 
 
 
1.1.3 │ Lipids 
Lipids are the main components of membranes in all cells and can also serve as 
energy storage molecules. Lipids are neutral fats derived from fatty acids, which 
have the structure RCOOH, where R is a long hydrocarbon chain [1].  
 
 
 
 
 
 
 
 
 
Figure 1.4 │membrane lipid arrangement in the lipid bilayer 
Figure 1.3│The sugar-phosphate backbone of DNA: A polymer with an alternating sequence of 
sugar-phosphate. The deoxyribose sugar is joined at both the 3'-hydroxyl and 5'-hydroxyl 
groups to phosphate groups in ester links, known as phosphodiester bonds.  
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Membrane lipids are amphipathic compounds comprising of a polar, hydrophilic 
head group and a non-polar, hydrophobic tail. These lipids arrange themselves in a 
lipid bilayer and are the basic structure of all biological membranes. The lipid 
bilayer is more complex than described in Figure 1.4 as integral proteins, peripheral 
proteins and some carbohydrate attachments also form part of the membrane 
structure. Cell membranes play major roles, aside from retaining the cell contents. 
They transport substances in and out of the cell, they transmit signal from the 
outside of the cell to the inside, maintain cell shape and are key for cell to cell 
interactions [1].  
 
1.1.4 │ Carbohydrates 
Carbohydrate molecules are the main source of energy for most living organisms. 
When polymerised, they can function as structural supports, protective coatings and 
long term energy storage molecules. Glucose, the central ingredient for metabolism 
activity, is stored in the cell in the form of glycogen and converted during 
glycogenolysis to glucose molecules when required (Eq. 2). Glycogen is catabolised 
via interaction with inorganic phosphate from the enzyme glycogen phosphorylase 
resulting in the cleavage of a glucose monomer to produce glucose-1-phosphate 
(G1P) [1]. G1P is then converted to glucose-6-phosphate (G6P) by the enzyme 
phosphoglucomutase. G6P can be further hydrolysed by the enzyme glucose-6-
phoshatase to give free glucose to enable the start of the glycolysis [1].   
 
 
 
(2) 
 
 
 
 
Glycoproteins are proteins having covalently bound carbohydrate. The carbohydrate 
units are involved in various biological activities, such as influencing protein 
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folding and conformation. The carbohydrate unit in a transmembrane glycoprotein 
aids the molecule orientation and anchorage of the molecule in the lipid bilayer [3].  
 
1.2 │The Molecular Biology of Cancer:  
1.2.1 │ Cell cycle 
Active, replicating cells pass through a series of stages that are collectively known 
as the cell cycle (Fig 1.5). There are two gap phases, G/G1 and G2, a synthesis 
phase, S, and a dividing phase, M.  
 
Interphase describes the processes involved in preparation for mitosis including cell 
growth and reparation in the G, S and G2 phases. During the processes there are 
certain check-points that determine whether or not cell progression should proceed.  
 
 
 
 
 
 
 
 
 
 
 
 
The first stage of the cell cycle gap  ‘G’ or ‘G1’, is the period of time when the cell 
prepares for DNA synthesis in the ‘S’ phase. It is during G1 that the decision is 
made whether or not the cell should proceed to divide. If the decision is positive 
then the cycle progresses to S phase where DNA synthesis occurs and the genome is 
duplicated. After the ‘S’ phase the cell enters another gap, ‘G2’ where the decision 
Figure 1.5 │Simplified diagram of cell cycle check points depicting G, S , G2 and M phases. Cell 
cycle arrest points are (i) if no growth factor signal received and (ii) if DNA damage or 
incomplete duplication . 
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is again made whether the cell should progress to mitosis. If the cellular processes 
have not been executed correctly up to this point the cycle is halted. This second 
check-point is designed to ensure that if DNA is damaged, or incomplete replication 
has occurred, the process is halted. The consequences for not halting the process 
would result in progeny cells that may have acquired mutations or have a lethally 
incomplete compliments of genes. Halting the process ensures time for replication 
to finish, or DNA repair to occur, or for the cell to undergo programmed cell death 
[1].   
 
An individual cell itself does not make these decisions can be signalled from 
extracellular signalling molecules, cytokines and growth factors that are secreted by 
other cells so that cell division in the tissue is co-ordinated. In brief, growth factors 
transmit signals to the nucleus via signal transduction pathways resulting in the 
control of specific genes and their activity. A mitogenic growth factor stimulates the 
synthesis of proteins necessary for proceeding to S phase [1].  
 
Cell cycle progression is halted if the mitogenic signal is not received. The cells 
enter a quiescent G0 phase in which its metabolism continues as normal, however, 
cell division does not occur. In general, cells remain in G0 phase for considerable 
time before switching to G1 phase to enter the cell cycle.  
 
M phase in the cell cycle accounts for cell division, which is called mitosis in 
eukaryote cells. Without division, the cell membrane and cell volume will steadily 
enlarge. As the surface of a spherical organism increases by the square of its radius 
(r), its volume increases at a rate of (r3). An increase in cell size (r) produces a 
relatively smaller increase in surface area (r2) than in volume (r3). The inner 
components have less surface area from which to obtain food, metabolites and 
oxygen. There is also less surface area to remove waste products and therefore cell 
death would quickly occur in the absence of cell division [1].  
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1.2.2 │ Protein kinases 
Protein kinases are essential to maintaining control of the cell cycle. Controlling the 
activation of proteins involves the chemical process of phosphorylation and the 
reverse, de-phosphorylation. In G1 phase, cycline proteins are synthesised if growth 
factors or cytokines activate their synthesis. Cyclines enable the activation of 
protein kinases.  
 
In every cell cycle the cyclin proteins are synthesised in G1 and destroyed in S 
phase. When the cell enters S phase the cyclins relevant to the G1 phase kinase 
activity are destroyed. New cyclins are also synthesised to enable progression from 
S phase into mitosis. These mitotic-related cyclins accumulate during S and G2 
phase and combine with specific kinases. The kinase complex resides in the inactive 
form as the kinase is phosphorylated in three positions. Just before mitosis occurs, 
two phosphate groups are removed which causes activation of the complex [1].  
 
1.2.3 │ Growth regulation 
Cell proliferation is a result of cell growth and cell division, resulting in an increase 
in the number of cells in a population. In situations where a balance in cell 
proliferation needs to be met, cells will undergo programmed cell death such as 
apoptosis, where the cell is given a signal to die.  This is regulated by tumour 
suppressor genes which are a heterogeneous set of genes that inhibit the cancer-
related phenotype development in cells [4]. These genes are responsible for health 
levels of cell growth and differentiation.  
 
Tumour cells are said to have altered versions of these oncogenes, resulting in 
inactivation or loss the tumour suppressor genes. Inactivation of tumour suppressor 
genes plays a crucial role in cancer pathogenesis and is just as important as the 
activation of oncogenes in many cancers.  
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1.3│Chemotherapeutic Resistance  
1.3.1│Multi-drug resistance (MDR) pumps 
The study of multidrug resistance (MDR) in tumour cell lines has led to the 
discovery of the plasma membrane P-glycoprotein (P-gp) molecule [5]. One 
explanation for high resistance towards drug treatment can be found due to the high 
level of expression of the plasma glycoprotein ‘P-gp’. 
 
It is likely that there are many factors involved that determine the intrinsic MDR 
phenotype in renal cell carcinoma, however, P-gp expression is certainly an 
important factor [6]. 
 
The protein is a member of the ATP-binding cassette transporter (ABC) super-
family. These proteins are ATP-dependent cell membrane pumps that are 
responsible for the transport of substrates of a broad specificity. They operate as a 
drug efflux pump for xenobiotic compounds responsible for decreased drug 
accumulation in multidrug-resistant cells and often mediate the development of 
resistance to anticancer drugs [7].  
 
1.3.2│Cancer stem cell theory 
Adult stem cells, originally described in the haemopoietic system, have been 
described in many normal solid tissues including bladder, brain, breast, gut, kidney, 
liver and prostate [9-19]. They are rare by comparison with the number of 
amplifying and terminally differentiated cells of the organ of origin. Stem cells are 
required for tissue development and are stimulated to differentiate in response to 
tissue injury in addition to general replacement and repair. Unlike their 
differentiated progeny, stem cells are long-lived and present throughout the lifetime 
of the organ. This longevity makes them susceptible to the accumulation of genetic 
mutations.  
 
This has given rise to the cancer stem cell hypothesis [19-21], which proposes that 
within a given tumour there exists a small population of cells with stem-like ability 
  
 
25
(Fig. 1.6). They have a capacity to exhibit properties including self renewal and the 
ability to undergo asymmetric division leading to the generation of progeny that can 
differentiate and propagate to produce a tumour with a heterogeneous phenotype.  
 
It is hypothesized that cells with stem-cell like properties may be influential in 
carcinogenesis, possessing the ability to self renew, produce differentiated daughter 
cells and resist environmental or therapeutic injury. Although there are mixed 
opinions across different cancer specialties, this has led to a surge in interest in 
identifying and characterizing the tumour initiating or cancer stem cell (CSC), with 
the aim of discovering novel diagnostic and prognostic markers [19-21]. The 
ultimate aim is to generate new therapeutic approaches and possible biomarkers. 
 
 
Tumours with ‘stem-like’ cells are more aggressive. They are said to have an over-
expression of MDR pumps and therefore have enhanced efflux capabilities of 
chemotherapy agents. The aim of cancer stem cell targeted therapy is to try and 
overcome MDR pump activity. This is challenging and difficult to achieve as adult 
stem cells or putative cancer stem cells are rare and lack of specific stem cell 
markers. This makes isolation and characterisation difficult [17]. 
Figure 1.6│Targeted therapeutic cancer stem cell treatment proposed to inhibit tumour 
relapse  
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1.4 │Renal Cell Carcinoma 
Renal cell carcinoma (RCC) accounts for 2 – 3% of cancers and the highest rate of 
occurrence is found in developed countries. RCC is accountable for the most 
frequently occurring solid lesion within the kidney and there are different types; 
each with individual histopathological and genetic characteristics. Three significant 
subtypes of RCC are conventional (clear cell), papillary and chromophobe with 
prevalence levels of 80-90%, at 10-15% and 4-5% respectively [22-23]. 
 
RCC is defined as carcinoma of the renal parenchyma, composed of tubular cells in 
varying arrangements that originate from the Proximal renal tubule epithelium. This 
is the lining of the tiny convoluted tubes that filter blood near the Bowman’s 
capsule. It is among the most resistant of tumours to therapy and unlike various 
other urological malignancies, the disease is currently fatal for over half of patients. 
The standard treatment involves surgery however 10 – 28 % will demonstrate a 
local reoccurrence or metastasis after a nephrectomy [22-23].   
 
Many renal tumours are asymptomatic until late in the progression of the disease. 
Many cases are found incidentally when using non-invasive imaging when 
evaluating a variety of symptoms and over half of RCCs are detected this way. 
Some of the most common conditions are hypertension, weight loss, anaemia and 
abnormal liver function [22-23].  
 
The general recommended system for clinical and scientific classification is the 
TNM stage system. Histological factors include the Fuhrman nuclear grade which is 
the most widely accepted histological grading system in RCC, remaining an 
independent prognostic factor, although subject to intra- and inter- observer 
discrepancies [22-23].      
 
Metastatic RCC (mRCC) in particular has very poor prognosis and limited 
treatment options. In chemotherapy, 5-fluroruracil (5FU) is said to be effective, but 
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only in the presence of immunotherapeutic agents such as Interferon-alpha (IFN-) 
[22-23]. 
 
Chemotherapy as a monotherapy should not be considered effective in patients with 
mRCC according to the European Association of Urology (EAU) guidelines. 
Equally surgical treatment alone is not a likely curative measure in mRCC unless all 
tumour deposits can be successfully removed. It has been found however that 
tumour nephrectomy used in combination with immunotherapeutic cytokine IFN-
alpha can improve the clinical prognosis [23].   
 
Therapy with similar agents such as interferon-alpha and interleukin 2 was the 
medical treatment standard for metastatic renal cell carcinoma (RCC) before 2006, 
although it carried a poor median survival rate of just one year [24]. 
  
Today medical treatment for metastatic RCC is a hot topic in the urological 
oncology field due to an increased understanding of the molecular mechanisms that 
dictate tumour angiogenesis. Signalling pathways with abnormal function are 
believed to contribute to the pathogenesis of many malignancies, particularly in 
terms of renal cancer [25].  
 
The pathogenesis of renal cancers is linked to loss of the von Hippel-Lindau tumour 
suppressor gene, leading to accumulation of hypoxia-inducible factor 1 (HIF-1) and 
the subsequent over-expression of HIF-1 target gene products, such as vascular 
endothelial growth factor. (Activation of mTOR can also lead to an increased 
expression of HIF-1). 
 
These HIF-1 induced factors are thought to be the key drivers of tumour 
angiogenesis; leading to the growth and progression of renal cancers [25] and 
studies have indicated HIF-1 mediates resistance to chemotherapy and radiation 
[26].   This has led to an increased focus on inhibiting key effectors such mTOR, 
VEGF and its receptor by multiple targeted therapy. Temsirolimus is a mammalian 
target of rapamycin (mTOR) protein kinase inhibitor, while inhibitors Sunitinib and 
Sorafenib target several protein kinases, including the VEGF receptor. According to 
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research, Temsirolimus should be considered as first-line treatment for low-risk 
patients while Sunitinib is recommended for first-line therapy for patients with good 
and intermediate-risk with Sorafenib as a second-line treatment [27]. In fact the 
EAU recommends that tyrosine kinase inhibitors should be considered as first or 
second line treatment for mRCC patients as a grade A recommendation [22-23]. 
 
 However many of the drugs used in targeted therapy are in their early stages of 
implementation and therefore the combination of surgery and systemic therapies 
represents the best management option for most patients with metastatic renal cell 
carcinoma. Many issues such as the use cyto-reductive nephrectomy, 
metastasectomy, and consolidative surgery will change as systemic therapies 
become more effective [28].  
 
1.5 │Aims of Study 
The main research focus is to develop Fourier transform infrared spectroscopy as a 
reliable analytical tool for analysing drug-based responses in chemo-biological 
material by investigating sample preparation, spectral methods of analysis and data 
interpretation.  
 
The intention is to lay the groundwork for future use whereby FTIR may play a role 
in drug-screening processes in the developmental stages of novel therapeutic 
compounds. In such a complex field, where FTIR spectroscopy is not yet a major 
player, it is important to maintain a multidisciplinary flavour to the research in order 
to validate and support findings and equally highlight the limitations.     
  
In the research field of bio-spectroscopy, analysis of cancerous material with FTIR-
spectroscopy and multivariate analysis is widely accepted based on the quantity of 
published research [29-36]. It has yet to be seen, however, if the technique will be 
implemented as a standard practice in a clinical setting.  
 
Issues of spectral distortion, such as the previously described as ‘anomalous 
dispersion’ artefact, has held back the progression of the field as spectral peak 
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assignments could not be assumed to be correct, as described in chapter 3. Recently, 
however, greater understanding of the nature of scattering in biological material has 
been determined and a new algorithm implemented to correct for the phenomena 
now known as resonant Mie scattering (RMieS) [37-39].  
 
To determine if confidence in FTIR spectral interpretation can now be increased, 
RMieS-EMSC-corrected biological spectra will be validated using multi-discipline 
methods to characterise a set of non-established renal cell lines. This part of the 
research lays the foundation for this project, and is presented in chapter 4. 
 
A second test to prove the capability of FTIR will be to extend characterisation to 
the next level of difficulty. Characterising the spectral profiles of cell lines that are 
established from different patients with different properties is a relatively 
straightforward process. Attempting to characterise a sub-population of cells from 
the same cell line, however, is somewhat more challenging. The question needs to 
be addressed if discrete chemical differences can be highlighted within a cell 
population of the same origin. In-keeping with the cancer stem cell theory, it is 
hypothesized that ‘cancer stem cells’ may be influential in carcinogenesis [40]. The 
‘side population’ is a sub-population of cells said to be enriched for stem-like cells, 
however they are difficult to isolate and characterise by conventional ‘-omic 
means’. Characterisation of these cell populations with synchrotron radiation FTIR 
micro-spectroscopy is attempted in chapter 5.  
 
Finally, the intention is to determine the feasibly of FTIR spectroscopy for cellular 
response detection to therapeutic agents in the context of renal cell carcinoma. The 
proposed model is to use 5-fluorouracil. In clinical practice, 5-fluorouracil does not 
excel in the therapeutic treatment of RCC [21-22], however unlike the more modern 
therapeutics, it is a well established agent with a wealth of information known about 
its mechanisms of action [41-42]. It is also an example of an agent that causes cell 
cycle arrest and is therefore interesting to study in FTIR spectroscopy.   
 
Another arm of the investigation involves novel gold-based therapeutic compounds 
whereby very little is known about the drug mode of action (Fig. 1.7). 
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It is thought that these novel compounds have increased stability next to older 
agents such as Cisplatin [43]. Renal carcinoma, being one of the most unresponsive 
cancers to chemotherapy alone, would provide an extremely challenging test for 
metal based agents to undergo.  
 
In an attempt to determine the feasibility of the technique, Chapter 6 includes initial 
testing and exploratory analysis of the different methods of FTIR spectroscopy that 
can be evoked. Chapter 7 seeks to separate some of the complicating spectroscopic 
factors so that spectral interpretation of purely drug-cell interactions may be 
accounted for.  
 
 
 
 
 
Figure 1.7 │The di-gold(I) organometallic complex KF0101 was found to exhibit cytotoxic 
activity in vitro (NCI Panel Testing) against a range of cancer cell types. KF0113 and KF0501 
are series analogues. 
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2.1 │ Fundamentals of FTIR Spectroscopy  
Fourier transform infrared (FTIR) spectroscopy monitors the vibrational bending 
and stretching modes of molecules that are resonant with the frequency of infrared. 
The wavelengths at which these groups absorb the infrared radiation are measured, 
resulting in a unique spectroscopic fingerprint with relative intensities dependant 
upon sample composition.  
 
2.1.1 │ Electromagnetic radiation and the photon 
Radiation can be described as an electromagnetic sine wave, comprising of both 
electric and magnetic field components. Electromagnetic interactions result from 
the exchange of photons as the electromagnetic field is quantised, in quantum 
mechanical terms. Electromagnetic radiation is classified according to the frequency 
of its wave in the electromagnetic spectrum [1].  
 
Spectroscopy is defined as the study the interaction of radiation with matter. 
Radiation is characterised by its energy, E. Radiation is emitted and absorbed in the 
tiny packets called photons. Photons can be described in two ways. Firstly, they can 
be said to hold particle properties, moving in straight lines at the speed of light. 
Photons have no detectable ‘rest’ mass, which enables them to travel at light speed 
with respect to all observers. Photons do, however, have both energy and 
momentum and the photon energy will be conserved unless emitted or absorbed by 
a charged particle. Einstein’s equation (E=MC2) cannot describe their energy 
however as they have no mass. Plank devised a constant to describe the relationship 
between photon energy and frequency [1]. 
 
The energy of the photon particle can be described mathematically (eq. 3) where h 
is Planck’s constant (6.626 × 10-34 J s) and  is the frequency (Hz).  
 
(3) 
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According to ‘wave-particle duality’ in quantum physics, it is natural for the photon 
to display either particle properties or wave properties, according to its 
circumstances. Waves have two important characteristics, frequency  and 
wavelength  related by the speed of light c in a vacuum (2.998 × 108 m/s) [1] (eq. 
4).  
 
(4) 
 
Therefore radiation, characterised by its energy E, is linked to the frequency  and 
wavelength of the radiation by the Planck relationship, extending equation (2). 
The energy of the electromagnetic wave is proportional to the frequency, or 
inversely proportional to the wavelength (eq. 5). 
 
  (5) 
 
 
Vibrational spectroscopy in particular uses the reciprocal wavelength (1 / ) which 
is the number of wavelengths per unit distance, denoted as wavenumber [1]. The 
wavenumber is usually written in the form (eq. 6): 
 
 
(6) 
 
2.1.2 │ Wave propagation and absorption  
One way to make the connection between particle and wave descriptions of a 
photon is to visualise a propagating wave packet.  
 
The speed of a wave depends upon the medium in which it propagates. The 
propagation of an electromagnetic wave in a non-absorbing medium can be 
described mathematically as (eq. 7): 
 
(7) 
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where A is the amplitude,  is the angular frequency, t is the time,  is the phase 
angle and   is the polarisation angle [1]. The angular frequency is a measure of 
how fast an object is rotating about its axis and is expressed by the wavelength and 
refractive index n [1] (eq. 8) 
 
(8) 
 
 
The refractive index must be modified to its complex form in the case for an 
absorbing medium (eq. 9).  
 (9) 
 
Here, the real part of the refractive index n is the ratio between c and the speed at 
which light travels in a material, known as the phase velocity p (eq. 10). 
 
(10) 
 
 
When infrared radiation passes through a material, or medium, some intensity is 
absorbed through interaction with the molecules, and some intensity passes through 
without interaction. For an absorbing medium, the absorption coefficient  is one of 
many ways to describe the absorption of electromagnetic waves.  can be expressed 
in terms of the imaginary part of the refractive index k and the wavelength of light 
(eq. 11). The imaginary part k indicates the amount of absorption loss when the 
wave propagates through the material [1].  
 
(11) 
 
 
Based on eq. 7, the transmittance of radiation at intensity I emerging through a 
material is related to the intensity of incident radiation I0 at the front face of the 
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material, at a particular wavenumber (eq.12).  The Beer Lambert Law results 
directly from this equation where  (cm) is the path length of the wave within the 
absorbing medium (optical thickness) and  is the molar absorption coefficient and 
c the concentration (mol dm-3) of the absorbing material (eq. 13) [1]. 
 
(12) 
 
(13) 
 
 
The proportion of absorbed intensity of radiation over the total intensity that enters 
the material has a direct relation to the concentration of the material. Absorbance 
becomes linear with concentration (eqn. 14) [2].  
 
 
(14) 
 
 
Absorbance is the negative logarithm of the transmittance (T) (eq. 15).  
 
(15) 
 
 
In the Beer-Lambert law, the concentration of an unknown material can be found by 
using the absorbance at a single wavelength. An absorbance spectrum, however, is a 
distribution of absorbance intensities for radiation passing through a sample over a 
series of wavelengths. Absorption varies with wavelength as the absorption 
coefficient has a different value at each wavelength [2]. 
 
When an interferogram is Fourier transformed it results in an output of light 
intensity at the detector versus the optical frequency. This raw, single beam 
spectrum contains information about the whole instrument; the sample, the sources, 
the ambient air, the optical components as well as any possible contamination in the 
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optical path. As only the information due to the sample itself is of interest, first a 
reference spectrum called the background must be acquired and used to remove 
unwanted information from the raw spectrum. The reference spectrum only contains 
information about the environment in the instrument and all reference spectra for 
FTIR spectrometers have the same general shape. The use of a reference spectrum 
is covered further in the next chapter (Ch. 2.2.2.).  
 
To obtain the absorbance spectrum of the sample, the value at each wavelength in 
the sample spectrum is divided against the corresponding value at the same 
wavelength in the reference spectrum and the negative logarithm is taken (eq. 16). 
[2].  
 
 
(16) 
 
 
2.1.3 │Molecular vibrations 
The absorption of light in a medium causes transitions from an energetic ground 
state to a particular excited state. Depending on the chemical nature of the 
interacting compound and the energy of radiation, the excited states may differ.  
 
Molecular vibrations range from the simple motions of two atoms in a diatomic 
molecule to the motions of every atom in a large polyatomic molecule. Molecules 
with N atoms have 3N degrees of freedom. 3N-6 degrees of freedom denote the 
number of ways that the atoms in a non-linear molecule can vibrate (the ‘-6’ 
explains translational and rotational modes about the x, y and z axes).  Each mode 
involves displacement of the atoms from their equilibrium positions and for each 
mode, i, all the atoms vibrate at a certain characteristic frequency, i [2]. 
 
Rotations and vibrations are excited in the infrared range and IR spectra result from 
transitions between quantized vibrational energy states. The energy difference for 
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transitions between the ground state (vi = 0) and the first excited state (vi=1) of most 
vibrational modes corresponds to the energy of radiation in the mid-infrared region. 
 
Molecules transition to the excited state only if their dipole moment , changes 
during the vibration. Some molecules will possess certain elements of symmetry 
such that some vibrational modes will be degenerate or forbidden. Homonuclear 
diatomic molecules, for example, are not infrared active.  
 
Due to this degeneracy, the number of vibrational modes usually observed is often 
less than 3N-6. For a linear molecule, for example, rotation about the axis of the 
bond does not involve any atom displacement, therefore one of the rotational 
degrees of freedom is lost. Thus the number of modes of a linear molecules is 3N-5 
so that a heteronuclear diatomic molecule (N=2) has a single vibrational mode. 
 
At certain frequencies, large atom displacements may only occur for a select 
number of atoms for many vibrational modes, while neighbouring atoms remain 
stationary. The frequencies of such modes are characteristic to the functional group 
in which the motion is centred thus the observation of spectral features in a certain 
spectral region often  indicates a specific chemical functional group of the molecule 
in question. [2].  
 
Complex organic molecules may involve significant atom displacements involving 
several atoms, such that the frequency may vary from one molecule to another for a 
particular functional group. These modes are known as fingerprint bands and are 
useful to distinguish similar molecules. Every molecule will have slightly different 
vibrational modes from all other molecules and so the vibrational spectrum of a 
given molecule is unique and can be used to identify that molecule. 
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2.2 │Infrared Instrumentation 
2.2.1 │Michelson interferometer 
Waves can interact with one another, if they come from a similar source or 
frequency, causing interference effects. Two waves sharing the same frequency 
with amplitude will interact favourably. Their peaks and troughs will line up and the 
resultant wave will have amplitude of the summation of the two, known as 
constructive interference. Two waves interacting out of phase result in destructive 
interference. One wave’s crests will coincide with another wave’s troughs and will 
cancel each other out, resulting in amplitude of zero. The interaction of waves is the 
key concept of an interferometer [2].    
 
An FTIR spectrometer consists of a globar light source, a two-beam interferometer 
(comprised of a fixed mirror, an adjustable mirror and a beam splitter) and a 
detector, such as mercury cadmium telluride (MCT). Modern interferometers are 
designed based on the original Michelson interferometer (Fig. 2.1). The Michelson 
interferometer divides the infrared beam into two paths by use of a beamsplitter 
which is reflected by two mirrors; one of fixed position and one that moves. The 
beams are subsequently recombined after path differences have been introduced, 
creating the opportunity for interference to occur between the beams. 
 
 
 
 
 
 
 
 
 
 
 
 
Mirror 1
M
irror 2
Be
am
 sp
litt
er
Detector
M
irror 2
Figure 2.1 │Schematic of a Michelson interferometer: The initial IR beam is split by the 
beamsplitter. The two split beams move different distances and have different phase delays 
when recombined, hence causing an interference pattern (an interferogram)  
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The split beams travel to different distances and hence have different phase delays 
when recombined. The resulting interferogram records the summation of cosine and 
sine contributions that display the signal intensity as a function of path length. The 
interferogram is Fourier-transformed which produces the sample spectrogram [2].   
 
2.2.2 │The importance of system purging 
FTIR systems are always in need of a constant supply of nitrogen or `air that has 
been filtered through a desiccator to remove moisture.  This is because an 
absorbance sample spectrum is susceptible to water and carbon dioxide 
contributions. If the carbon dioxide and water vapour levels are too high, 
absorptions of infrared energy by the gases will result in unwanted peaks that may 
obscure absorbing sample peaks.  
 
In the vapour phase small molecules display fine structure because both vibrational 
and rotational transitions can occur simultaneously. This is rarely observed in 
larger, vapour phase molecules, as the individual rotational transitions are too close 
together to be resolved. These transitions are also not observed in liquids as the rate 
of molecular collisions occurs faster than the rotational frequency [2]. The shape of 
the vibration-rotation spectra of water and carbon dioxide observed in a spectrum 
acquired with a poorly-purged system are characteristic (Fig 2.2).  
 
In a vibration-rotation spectrum of a diatomic molecule the rotational energy levels 
are characterised by a single rotational quantum number J.  Assuming a rigid rotor 
(constant bond lengths) EJ = BJ(J+1) where B is the rotational constant [2].  
 
The selection rule for a diatomic molecule in terms of a transition between 
rotational energy states is J = ±1 vibration-rotation spectrum of a rigid diatomic 
molecule, displaying the singular vibrational mode v0, results in a series of equally 
spaced lines above and below the vibrational mode at the R branch; J =+1 and P 
branch;J  
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In reality molecules are not rigid rotors and the length of bond between X-Y will 
increase due to increasing angular velocity from centrifugal forces. Due to this 
centrifugal distortion the spacing of the lines in the P branch increase, and the R 
branch decreases, as the distance from the vibrational mode increases. The spacing 
of the rotational modes in larger and less symmetric molecules decreases and the 
spectra become more complex [2]. 
 
For carbon dioxide, there is no change in the dipole moment of linear carbon 
dioxide during symmetric stretching and therefore the vibrational mode is 
forbidden. The anti-symmetric mode, however, does result in a change in dipole and 
is therefore allowed.  Linear molecules have two equal moments of inertia whilst 
non linear molecules usually have three different moments of inertia. Further 
complications arise, however, as linearity is lost in the bending and rotational 
modes, resulting in the Q branch of carbon dioxide near 670 cm-1 for example (Fig. 
2.2).   
 
 
 
 
 
 
 
 
 
 
Figure 2.2 │ A typical background spectrum with bands at ~2350 cm-1 and 667 cm-1 are due 
to carbon dioxide and bands at ~3500 cm-1 and 1630 cm-1 are due to water vapour [3]. 
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2.2.3│Basic principles of Fourier transforms  
The Fourier transform (FT) changes a signal (or any data) from the time domain to 
the frequency domain (and back again through the inverse FT) where f(t) is the 
signal in the time domain and F() is the signal in the frequency domain (eq. 17):  
 
(17) 
 
Any signal in the time domain is a sum of numbers at discrete points in time. 
Instead of a summation, it is common to let the terms approach zero and do an 
integral to reveal a convolution of the delta function that returns f(t) (eq. 18).  
 
  (18) 
 
 
As opposed to the summing up all these points, wave functions (eq. 19) are used to 
cover all points in time using Euler’s formula. 
  
(19) 
 
Wave packets have magnitude M with an exponential term eiwt. Acos(t) is the real 
part, proportional to cosine with amplitude A and imaginary part proportional to the 
sin with amplitude Bsin(t). Any time domain signal can be represented by a sum 
of all possible combinations of sinusoidal waves with n, frequencies and An, Bn 
amplitudes that stretch over all time at the right magnitude (eq. 20) [2].  
 
(20) 
  
In simplistic terms, eq.16 states the amount of signal with frequency () in f(t) is 
equal to (eq. 21):  
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This is akin to asking the quantity of x in y, which would be (y/x) or that there is 
example, there is f(t)/20Hz amount of a 20Hz frequency in a signal.  However, the 
above equation states as f(t) is a single number and does not have frequency 
components. More correctly, the amount of signal F() is calculated by integrating 
over all values of t (eq. 22): 
 
(22) 
 
 
For each frequency, the amplitudes of the real and imaginary parts as a function of 
omega F(). The output from the DFT produces a complex number where the 
magnitude is the real part of the signal and the phase which is the initial angle of the 
wave [2].  
 
In Fourier transform spectroscopy, all wavelengths of light enter in parallel, 
simultaneously producing interference patterns for each one. The multiplex 
(Fellgett) principle states this as an advantage of reduced measurement time in 
comparison with a continuous wave spectrometer that observes only a single 
wavelength at a time [2]. The FT, a decomposition of a sequence of values into 
components of different frequencies, is often too slow to compute directly from the 
definition. Modern spectrometers use the fast Fourier transform (FFT), which is an 
algorithm to compute the same result more quickly [2].  
 
There is another advantage to using over FT spectrometers over continuous wave 
spectrometers. The Jacquinot advantage states that the signal-to-noise-ratio is higher 
as the light throughput is higher. There are no requirements for entrance and exit 
slits as wavelengths are being measured in parallel so the interferometer’s output 
light intensity is almost equal to the input intensity, which makes signal detection 
easier [2]. 
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2.3│ Methodology Principles  
2.3.1 │FTIR microspectroscopy  
A beam of IR light first enters the interferometer which modulates the wavelength 
of light. Infrared microscopes are similar to conventional microscopes, with the 
exception that the optics are mirrors instead of lenses, allowing the IR beam to pass 
through the system without being absorbed. The modulated infrared beam is then 
focused onto the sample by an objective, in conjunction with a visible beam of light 
for illumination, so that the sample can be viewed. Typically, a camera is attached 
to the microscope so that an optical image can be obtained. The jaws of the aperture 
can be adjusted so that only data for the sample region of interest can be acquired 
 
In general, IR microscopes allow for two modes of data collection. In transmission 
mode, the IR light passes through the sample and below the stage and is collected 
by a second IR objective that re-collimates the beam and sends it to the detector [4]. 
 
If the sample signal is collected in reflectance mode the light reflected back off the 
sample is collected using the same objective used to focus the beam onto the 
sample. Highly reflective substrates such as MirrIR can be used, comprising of an 
infrared-reflective surface coated by a conducting metal. When the thickness of the 
sample on a metallic substrate is similar to; or thicker than the wavelength of 
incident radiation, the reflection spectrum is similar to the transmission spectrum of 
the sample. The beam passes through the sample twice as the beam transmits 
through the cell and is reflected off the substrate. The mode of collection term is 
modified to transflection spectroscopy and results in absorbance bands that are 
approximately twice as great as the corresponding transmission spectrum [2].  
 
2.3.2 │Synchrotron radiation (SR) FTIR 
Spatial resolution in infrared microspectroscopy using a standard thermal source 
can be limited to a diameter of ~20 m due to high signal to noise ratio (SNR) 
requirements. This is due to low intrinsic brightness (photon flux or power emitted 
per source area and solid angle) of the thermal infrared source [5]. 
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Synchrotron radiation (SR) is emitted by a particle when it is accelerated (or 
decelerated) along the same direction of the particle in motion. Synchrotrons (Fig 
2.3) are electron storage rings that use magnetic fields to bend electrons into a 
closed orbit, producing radiation at each bending magnet. Infrared radiation is 
generated by these electrons, travelling at relativistic velocities either inside a 
curved path through a constant magnetic field (bending magnet radiation) or by 
longitudinal acceleration / deceleration when leaving/entering a magnetic section 
(edge radiation). The SR beam is then collimated and directed into the 
interferometer and then to the microscope. The two setups have equivalent flux; the 
option depends on the engineering preferences at a particular synchrotron [5].  
 
 
 
There are several advantages to using this IR source for micro-spectroscopy. Very 
few modifications are needed to adapt commercial instruments to operate with a SR 
source. Instruments fitted with a SR source can achieve high spatial resolution and 
excellent spectral quality with a good SNR. For single cell cancer tracking, the use 
of a synchrotron light source has been implemented to reach the highest spatial 
resolution, up to 5 x 5 m, enabling the spectroscopist to monitor subtle changes at 
the biomolecular level [7-9].  
 Figure 2.3 │Simplified schematic of a typical Synchrotron Station comprising of 6 main 
sections [6]. 
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2.3.3 │Imaging FTIR microspectroscopy 
FTIR imaging shares the fundamentals from the conventional technique but 
provides additional information in the form of spatially resolved spectra, combining 
digital imaging with the attributes of spectroscopic measurements. 
 
Conventionally, a single element detector is used in FTIR microspectroscopy. 
Single-point mapping traditionally uses confocal apertures to select the region of 
interest in a sample. Spectra are measured one point at a time, creating an average 
signal from the area contained within the range of the selected aperture [2]. The 
aperture can be reduced to increase spatial resolution, allowing finer sample detail 
to be observed. Modern, motorised microscope stages are also computer-controlled, 
enabling single point spectral maps to be acquired with high spatial precision. 
 
The ability to resolve detail, however, is limited by diffraction. Diffraction occurs 
when a wave encounters an obstacle and can affect all sound, water and 
electromagnetic types of wave. Diffraction effects cause light of a wavelength 
larger than the aperture to be lost and therefore any aperture with a finite size will 
cause diffraction and hence its resolution will be limited [1]. Systems with a focal 
plane array detector do not use apertures, but an array of detectors. Therefore, 
diffraction-limited spatial resolution is possible at each wavelength.  
 
In terms of single point mapping, the sample upon the stage has to be moved point 
by point which is a time consuming process. Array detectors improve acquisition 
time.  Linear array detectors are available, typically consisting of a 16 to 28 pixel 
array. The sample on the stage, however, still has to be moved line by line. Spectral 
imaging utilising a focal plane array (FPA) detector, typically consisting of 64×64 
or 128×128 elemental pixels, is the most advanced and fastest technique. A two 
dimensional FPA detector captures the full field of view at each wavelength 
simultaneously with no movement of the stage. This enables the ability to collect 
thousands of spectra at one time, creating hyperspectral images [2]. 
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The field of view is related to the spatial resolution, where spatial resolution 
describes the minimum distance that is required to resolve and detect two adjacent 
objects. Magnification is a ratio of the physical area of the array detector (number 
of pixels) divided by the area of the sample field of view; therefore higher 
magnifications used with the same detector would image a smaller sample area [2]. 
 
2.3.4 │ FTIR Photoacoustic spectroscopy (PAS) 
The photothermal class of techniques involve an impinging light beam which is 
absorbed by the sample, altering its thermal state. This thermal state change can be 
manifested as a change in temperature or sample density, for example.  
 
Photoacoustic spectroscopy is a photothermal technique where modulated infrared 
radiation is absorbed by a sample in a gas microphone cell and the optical properties 
of the sample dictate the wavelengths of radiation that are absorbed. This absorption 
induces a temperature oscillation in the sample at depth x and width dx, proportional 
to P0(1-R)βe-βx  where P0 is the incident power, R is the fraction of incident light 
reflected by the sample surface and β (cm-1) is the absorption coefficient of the solid 
sample for the wavelength  [10].   
 
The infrared beam is modulated so that the cyclic warming and cooling of the 
absorbing sample occurs faster than the sample can expand and contract in 
appropriately. The thermal waves that are generated as a result propagate through 
the sample and into the gas layer within the photoacoustic cell. The waves decay 
according to the thermal diffusion length s where  is the thermal diffusivity of the 
sample and f is the modulation infrared beam frequency (eq. 23). The subsequent 
pressure wave is detected by the microphone that generates a voltage that is 
amplified and finally processed by FTIR spectrometer.  
 
(23) 
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The key advantage of photoacoustic spectroscopy is that only the absorbed light is 
converted to sound thus scattered radiation is not detected [11]. In other vibrational 
spectroscopic methods, if the wavelength of the IR used to probe the cells is similar 
in size to the cell nucleus, significant Mie scattering from the nucleus can occur. 
This can result in distortion of line shapes and observable shifts in peak positions. 
 
2.3.5 │Cell culture  
In mammalian cell culture, the cells are typically cultured in plastic flasks or wells 
in a suitable environment of culture medium with appropriate nutrients. All renal 
carcinoma cell lines studied were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM) with 1% L-Glutamine and 10% foetal calf serum (FCS). Both are media 
supplements that support cell growth of cells that have high energy demands. 
 
Cells are cultured in a humidified atmosphere with 5% carbon dioxide (CO2) at 
37˚C to simulate real mammalian physiological CO2 conditions.  The blood in the 
human body contains a partial pressure of 40 mmHg CO2, which is close to 5%. In 
the blood, CO2 exists in the bicarbonate form (hydrogen carbonate, HCO3-), acting 
as a pH buffer to allow for fluctuations in nutrient, gas and metabolites. Maintaining 
CO2 at 5% in cell culture ensures the same amount of CO2 is dissolved in solution 
as the bicarbonate. [12]  
 
Depending on the cell type, cells may be suspended in solution during culture, or 
will attach to the bottom surface of their container, either directly onto the tissue 
culture plastic, or a substrate such as a glass slide. Adherent cells attach in-vitro 
similarly to the in-vivo process where adhesion is mediated by cell adhesion 
transmembrane proteins [13]. Once cells have reached an appropriate density, cells 
are detached from the substrate by tryptic digestion of the cell adhesion proteins.  
 
2.3.6 │The use of chemical fixatives  
Care must be taken to consider the experiment setup that permits the researcher to 
obtain the optimal spectra for the investigation in hand. Variations of sample 
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preparation will have a significant effect on the quality of the spectra.  For example, 
cells can be dried, chemically fixed or probed when live. It is known that the IR 
spectra of cellular chemical components will change with hydration level. 
Dehydration will cause an irreversible change in molecular structure of various cell 
components including cell membranes, ultimately leading cell death caused by an 
increase in membrane permeability. 
 
Mourant et al. [14] reported the significance of air drying M1 Fibroblast cells and 
their cancerous equivalent, MR1 Fibroblast cells. In dehydrated cells Protein Amide 
II shifted with a decreased wavenumber and reduced intensity. Secondly, phosphate 
absorption bands of RNA and DNA (1050-1150 cm-1) of dried cells were not as 
clearly defined as those of cells in aqueous media which displayed much narrower 
bands.  However the use of an aqueous media translates to strong water absorption 
resulting in an unattainable protein amide I (1575- 1710 cm-1) measurement.  
 
For both investigative research and medicinal application, sample fixation is a more 
practical method, although it is critical to match the method of fixation with the 
intended analytical technique. Some types of analysis can be incompatible with 
certain fixation techniques with varying degrees of artefact contribution observed in 
the spectra.     
 
Formalin fixation at a 4% concentration is a widely utilised fixing agent in the 
biomedical sector and at low concentrations preserves lipid, phosphate and protein 
components without significant influence to the cellular infrared spectrum [15-17]. 
Cross-linking fixation via aldehydes is very effective for proteins and nucleic acids, 
forming intra- and intermolecular covalent bonds between adjacent amine-
containing groups through a Schiff acid-base reaction.  
 
Fixation by alcohol involves dehydration by chemical removal of water from the 
sample. The potential problems of dehydration are shrinkage and the removal of 
soluble components from the cells.  A cell in a hypertonic environment has a higher 
concentration of solute in the environment than in the inside of the cell, making the 
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net flow of water move out of the cell. Ethanol fixation has also been shown to 
poorly preserve lipid structure [17]. 
 
2.3.7 │Supporting multidiscipline techniques   
2.3.7.1│ Cytotoxicity sulforhodamine B (SRB) assay 
The SRB assay is one of the most used methods for in vitro cytotoxicity screening 
for determining the IC50, which is the concentration of agent needed to inhibit a 
given cell process by half. In this case, the process is cell proliferation measured by 
protein quantification. Sulforhodamine B is a fluorescent dye with uses spanning 
from laser-induced fluorescence, to the quantification of cellular proteins of 
cultured cells. 
 
SRB is an aminoxanthene dye with two sulfonic groups which binds to the basic 
amino acid residues under mild acidic and consequently dissociating under basic 
conditions. SRB binds to the protein components of cells that have been fixed in 
trichloroacetic acid (TCA) in a stoichiometric reaction and therefore the quantity of 
dye extracted from stained cells is directly proportional to the cell mass [18]. 
 
The SRB assay has a high level of sensitivity, adaptability to a 96-well plate format 
(Fig. 2.4) and also a good endpoint stability due to the fixing process, meaning the 
assay is not only applied in scientific research, but on larger-scale screening, such 
as at the National Cancer Institute (NCI) [18]. The assay is often compared to that 
of the tetrazolium dye, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT).  
 
The MTT assay has the advantage of detecting only viable cells whereas the SRB 
cannot distinguish them. This is because the MTT assay requires cellular activity to 
reduce the colourless tetazolium dye to its purple coloured formazan dye form. This 
may mean that IC50 values determined may be slightly higher than that of MTT, but 
this does not detract from the ability of the SRB to detect cytotoxic effects.  
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The major disadvantage of the MTT assay, however, is that some compounds can 
directly interfere with MTT reduction without having any effects on cell viability 
and SRB assays are rarely affected by this interference [18].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.7.2│Label-free liquid chromatography mass spectrometry (LC/MS) 
Liquid chromatography–mass spectrometry (LC/MS) is a powerful tandem 
technique that combines the physical separation capabilities of liquid 
chromatography with the mass analysis capabilities of mass spectrometry. In brief, 
a LC/MS system comprises of a high-performance liquid chromatography column 
(HPLC) connected to a mass spectrometer through an ionising interface. The HPLC 
system can practically separate any dissolvable compound, while the mass 
spectrometer can then ionize the separated solution, providing a molecular weight 
for each peak component.  
 
Figure 2.4 │ SRB-stained cell protein aggregates in a 96 well plate reader. Cells were seeded at 
ascending densities to establish the optimum density for the cytotoxicity assays using the renal 
carcinoma cell lines 
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Mass tags can be introduced into proteins or peptides metabolically, by chemical 
means, enzymatically, or by spiked synthetic peptide standards. Most label-based 
quantification approaches include limitations such as complex sample preparation, 
the demand for high sample concentration and incomplete labelling [19] Instead, 
quantitative, label-free approaches have been introduced. [20-21] In contrast, label-
free quantification aims to correlate the mass spectrometry signal of peptides, or 
peptide sequencing events with relative or absolute protein quantities directly [22]. 
 
An LC-MS/MS system can fragment the parent ion into a distinctive pattern, 
separating daughter ions for identification and quantisation [23]. The MS/MS 
spectrum is comprised of peptide fragments resulting from collision induced 
dissociation. MS/MS spectral matches use the un-interpreted peaks in a peptide 
fragment spectrum to match to a theoretical fragment spectrum in a sequence 
database. In a protein ID experiment multiple peptides are usually found and all of 
their fragment spectra are used to correlate to a protein. The larger the number of 
peptides identified, the greater the confidence in the protein correlation.  
 
In order for a sequence database search algorithm to perform peptide and protein 
ID, a number of constraints are places as the MS/MS data heterogeneity is rich. The 
process typically initiates with an enzyme specificity constraint, using index 
searching. Theoretical tryptic peptides are generated and mass lists pre-made from a 
protein database. Next the parent mass of the intact peptide is matched to a short list 
of database peptides. The theoretical fragment masses are compared to the 
experimentally derived fragment spectrum. The peptides are then ranked by how 
many of the fragment masses match the theoretical fragment masses in the sequence 
database. If more than one peptide is searched all of the peptides found are 
correlated to their prospective proteins and the protein with the greatest number of 
well correlated peptides is usually the most significant hit and most programs 
include a probability number for the proposed match. 
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2.3.7.3│ Western blotting 
Gel electrophoresis enables analytical separation of small protein quantities, 
working on the principal that charged molecules migrate in an electric field. A 
polyacrylamide gel is used as the stationary phase because it is solid and easier to 
handle. Polymerisation of the gel occurs in situ between two glass plates, made to a 
recipe of suitable porosity so that the proteins migrate in the electric field 
appropriately [24]. The porous gel acts as a molecular sieve, where small molecule 
move faster through the gel and the largest ones are slow, or may not even move at 
all. The key feature of the gel is the detergent sodium dodecylsuphate (SDS), a 
hydrophobic tail and a negatively charged sulphate group. The protein sample itself 
it also dissolved in SDS prior to introduction to the gel and it denatured because of 
it. The SDS molecules attach to the protein by the hydrophobic tail while the 
negatively charged SDS swamp the native protein charge. A major advantage is that 
SDS also solubilises water-insoluble hydrophobic membrane proteins so that they 
may also be studied. When the SDS-protein complexes are electrophoresed on the 
SDS gel they all move towards the anode and separation is dependent of the size of 
the molecules. The result is a band of proteins, visualised by Coomassie or Ponceau 
blue staining [24]. 
 
To make the proteins accessible to antibody detection they are transferred from the 
gel to a nitrocellulose membrane by electro-blotting, which uses a current to pull 
proteins from the gel onto the membrane. It is necessary to first block any 
interaction between the membrane and the antibodies used to detect the target 
protein as the membrane itself is chosen for its ability to bind protein. Blocking of 
non-specific binding reduces background noise at the end result and eliminates false 
positives. This is achieved by the addition of a dilute protein milk solution which 
attaches to the membrane in all areas where the target proteins have not attached 
[25].    
 
To detect the target protein a primary antibody and a secondary antibody is 
required. After non-specific blocking, the primary antibody is incubated with the 
membrane. Primary antibodies bind with high affinity to their unique target antigen 
and are generated when a cell culture or host is exposed to the target as part of the 
  
 
58
immune response. The secondary antibody is added to recognise the primary 
antibody and has an enzyme attached to it. When a luminescent substrate is exposed 
to the enzyme on the secondary antibody, chemiluminescence occurs, proportional 
to the amount of target protein staining. This is recorded by a CCD camera that 
quantifies the result in terms of optical density [24].  
 
2.3.7.4│ Fluorescence activated cell sorting (FACS) 
FACS is a powerful method used to sort cells at high purity. Individual cells in 
solution flow through a liquid chamber that passes through one or more laser 
beams, causing light to scatter. Fluorescent dyes in the cell also emit light at certain 
frequencies.  The way the light bounces off each cell gives information about the 
cell’s physical characteristics. Light bounced off at small angles is called forward 
scatter. Light bounced off in other directions is called side scatter. Forward and side 
scatter are used for preliminary identification of cells and to exclude debris and 
dead cells. Forward Scatter measures approximate cell size, and side scatter 
measures the granularity of the cell [26].  
 
Cell structure or function can be investigated by fluorescent staining. For example, 
FACS can be used to study DNA cell content. Propidium iodide (PI) and Hoechst 
dyes bind to DNA and become fluorescent. Some Hoechst dyes can enter live cells. 
DNA staining can be used to study the cell division cycle. Relative DNA content 
shows the proportion of cells in G1, and S and G2M phases. By using a DNA 
binding dye such as propidium iodide, a DNA Histogram can be obtained, profiling 
the DNA content thereby identifying each cell cycle phase [27-28]. 
 
2.4 │ Experimental Methods and Materials  
2.4.1│Cell culture protocol  
A cell cryovial, removed from storage in liquid nitrogen, was left to warm up for 15 
seconds. There were approximately 3~5 million cells from cryovial contained cells 
from a confluent T75 flask (A flask which has capacity of 75 cm2 surface area). The 
cryovials were warmed in a water bath at 37ºC until the last slither of ice liquefied 
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in the vial. After transport to a biological safety cabinet the cryovial contents was 
aspirated and dispensed in a drop wise manner into 15 mL falcon tube containing 
Dulbecco’s Modified Eagle’s Medium (DMEM). 1 ml of the media was added to 
the original cryovial and aspirated and put back into the falcon tube containing cells 
in media, to ensure the complete removal of any residual cells left in the cryovial. 
The contents of the tubes were then centrifuged for 1600 rpm for 5 minutes to form 
a cell pellet at the bottom of the tube. The culture media was removed and the cells 
were re-suspended cells in 6 mL of fresh, complete culture media (DMEM 
containing 10 % foetal calf serum (FCS) and 1% L-glutamine).  
 
For sub-culturing with a cell density of 1 in 3 creating a new cell passage twice a 
week, the cells/media were distributed in 2 mL aliquots into new T75 flasks 
containing 9 mL of complete culture media and incubated at 37ºC with 5% CO2. 
 
2.4.2│FTIR sample preparation 
2.4.2.1│Cultured slides 
For sample preparation using infrared slides, the substrates (MirrIR or calcium 
fluoride CaF2) were sterilised in 70% ethanol (EtOH) for 1 hour and left to dry for 1 
hour. The sterile slides were then placed in 6-well plate tissue culture plastic.  
Culture medium from an 80% cell confluent T75 flask was removed and the cells 
were washed twice in PBS (10 ml for each wash). Trypsin (2 mL) was then added 
and the flask was placed back into the incubator at 37˚C for 1 minute. Following 
this, the flask was removed from the incubator firmly tapped to loosen cells from 
the bottom of the flask. Using an optical microscope the flask was checked to 
ensure that the majority of cells have detached from the flask bottom. Culture media 
(4 mL) was then added so that the FCS contained within the media neutralised the 
effect of trypsin and no further proteins were digested from the cell surface.  The 
contents of the flask was removed and centrifuged at 1600 rpm to obtain a cell 
pellet. The media was removed and replaced with fresh media (1 mL). The cell 
pellet was aspirated before a 10 L aliquot containing cells and media was removed 
and mixed with 10 L of Trypan blue. 10 L of the mixture was pipetted onto an 
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improved Neubauer hemocytometer to determine the estimated concentration of 
viable cells (unstained by Trypan blue) per 1 mL in the sample.  The cell density 
was then adjusted to the required density needed for each well containing the IR 
slide (typically to achieve a total starting concentration of 1×105 cells per well) and 
incubated at 37ºC with 5% CO2 for the required period of time. When required, 
cells were fixed by removing the growth medium, washing twice in PBS and then 
adding 4% formalin (in PBS) to each well. The samples were left for approximately 
40 minutes before removing the cell cultured-slide. The slide was then rinsed in 
deionised water by dipping in three times with 2 seconds each dip and then left to 
air-dry. 
 
2.4.2.2│Cyto-spinning for single cell experiments  
For single cell work the cells must be proportionally dispersed throughout the 
sample. Cyto-spinning is means of doing this to achieve spread out single cells. 
Conveniently, the cells can be fixed in their Falcon centrifuge tube and used at any 
time. Using cell pellet of predefined density, cells are re-spun in PBS (X2) to 
remove all traces of media and then suspended in 4% formalin for at least 40 
minutes. Fixed cells were spun at 800g for 5 minutes using 200 l aliquots. After 
spinning it was important to leave the samples to air dry for 24 hours before 
washing with de-ionised water, as the centrifugal force may have squashed the cells 
onto the slide, but washing with water straight away might have loosened them. For 
particularly small cells that may ‘bounce’ off the slide during the spinning, a 5 
minute spin at 400g then a further spin for 5 min at 800g was performed to ensure 
firm plating.  
 
2.4.3│FTIR methodology 
2.4.3.1│’Bench-top’ single point FTIR Spectroscopy 
Single point transflection spectra were taken using a BioRad FTS 7000 equipped 
with a liquid nitrogen-cooled MCT detector and a KBr beam-splitter, attached to a 
microscope using WinIRPro Software (Varian Inc., U.S.A.). The cells were viewed 
on a movable х,y stage using a 15× objective lens. The aperture was opened to a 
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size of 250 μm2 to sample a large population of cells. Sample images were ratioed 
against a background spectrum of a blank MirrIR slide that had been acquired 
before every new sample spectrum. 
 
2.4.3.2│Single cell Synchrotron radiation FTIR spectroscopy (SR-FTIR) 
SR-FTIR single point transmission spectra were acquired on the SMIS beamline at 
the French Synchrotron Facility Soleil (Saint-Aubin, France) using a Nicolet 
Continuum XL microscope equipped with an MCT detector. The size of the 
aperture was adjusted to match the diameter of the cell such that it was fully 
illuminated, typically 12-16 m2. Sample spectra were ratioed against a background 
spectrum of a blank MirrIR slide that had been acquired before every new sample 
spectrum. 
  
2.4.3.3│Focal plane array (FPA) imaging FTIR spectroscopy 
Transflection-mode FTIR imaging spectroscopy was performed using a Varian 670-
IR spectrometer coupled with a Varian 620-IR imaging microscope. The 
microscope was equipped with a 128 x 128 pixel focal planar array detector and a 
10 × eye-piece coupled with a 15 x IR objective lens. Each pixel covered a 5.5 µm x 
5.5 µm sampling area; the hyperspectral image covered a total area of 700 µm2 
consisting of 16,384 spectra. The hyperspectral image was collected in the 850-
3700 cm-1 range, at a resolution of 4 cm-1 with 128 co-scans for the sample and 
background. Sample images were ratioed against a background spectrum of a blank 
MirrIR slide that had been acquired before every new sample spectrum. 
 
2.4.3.4│Photoacoustic spectroscopy (FTIR-PAS) 
Measurements were taken using BioRad Win-IR Pro® software (Varian Inc., USA, 
formerly BioRad) with an MTEC (Model 300) photoacoustic cell (MTEC 
Photoacoustics, USA) coupled to a Biorad FTS 6000 spectrometer. Per spectrum, 
256 scans were co-added using the triangular apodization function in rapid scan 
mode with a mirror velocity of 0.32 cm s-1, acquired at a 16 cm-1 spectral resolution 
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and ratioed against a carbon black spectrum. The contribution of the substrate to the 
spectra was removed by subtracting the spectrum of a blank MirrIR substrate. 
 
2.4.4│Cytotoxic SRB assay 
Before cytotoxic SRB assays may be performed, an initial seeding density assay 
must assess the starting requirements of the assay, which can differ depending on 
the nature of the cell. Cells were seeded at increasing densities between 0 and 8000 
cells/well (Fig. 2.4) for a range of renal cell carcinoma cell lines (2220R, 2245R, 
2246R, 2247R, A-498 and Caki-2) .The optical density readings for the experiments 
were plotted against initial seeding density to determine the optimal starting point 
which would be just before the log phase of growth. On all cell lines this was 
determined to be approximately 3000 cells per well (Fig. 2.5).  
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To deduce inhibitory concentrations (IC) for the drugs against the renal cell lines 
Caki-2 and A-498, the widely used sulforhodamine B (SRB) cytotoxicity assay was 
implemented. Cells were seeded (3000 cells in 100 l medium per well) in 
triplicates and left for 24 hours to ensure cells were well-established and adhered to 
the bottom of the well plate. A range of 12 drug concentrations between 0.15 and 
20.0 M were used by the addition of drug/media (100 L at twice the desired 
Figure 2.5│ Determination of cell density for the SRB assay using 6 renal cell lines, 2220R, 
2245R, 2246R, 2247R, A-498 and CAKI-2. Levels of fluorescence recorded for the SRB stained 
protein aggregates, excited at a wavelength of 490 nm. An appropriate density at the start of 
exponential growth at 3000 cells per well was selected for all renal cell lines used. 
  
 
64
concentration) to the established cells in media (100 L) giving the correct final 
concentration range. Each concentration point was performed in triplicate. For the 
control group, media only was added (100 L). The well plates were incubated at 
37°C for 3 days in 5% CO2. After 3 days the media was discarded and wells washed 
with PBS (X2) (100 L). The remaining cells were fixed with TCA (100 L; 10% 
w/v double distilled (dd) H2O), refrigerating at 4˚C for 1 hour. The wells were 
washed with PBS(X2) (100 L) and dried at room temperature (RT) for 1-2 hours. 
The cells were stained with SRB (100 L; 0.4% w/v dd H2O) and left for 15 
minutes at RT. The plates were then washed  with acetic acid (1% w/v dd H2O) 
until the acid ran clear, then dried at RT for 1-2 hours. The protein residues were 
then re-suspended with Tris-HCl (100 L; 1.5M; pH 8.8) and agitated on shaker for 
5 minutes before reading on a Versamax plate reader (Molecular Devices) at 490 
nm absorbance. Each concentration point was repeated in triplicate as was each 
experiment to obtain mean absorbance values. 
 
2.4.5│Label-free liquid chromatography mass spectrometry 
(LC/MS) 
The LCMS sample preparation and instrument operation was conducted by the 
Biological Mass Spectrometry Facility, Paterson Institute for Cancer Research, 
University of Manchester.  
 
For each cell line, cells were grown to confluence in three T75 flasks for cell lysis. 
The adherent cells were treated with four PBS washes (25 ml) and aspirated. Cells 
were then scraped into a solution of triethyl ammonium bicarbonate (TEAB) buffer 
(500 l; 500 mM), sodium dodecyl sulphate (SDS) (0.05%) and PPase inhibitors I 
and II (both at 1%, Sigma Aldrich) and stored on ice for 5 minutes. The cell lysates 
were spun (4˚C; 1600 g) for 10 minutes and the supernatant transferred to a fresh 
tube. Cell lysates were separated into aliquots and stored at -80˚C.  
 
Protein concentration was measured using 2D Quant Kit (GE Healthcare) as per 
manufactures instructions. In brief, the protein lysates are pelleted by centrifugation 
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and re-suspended in an alkaline solution of cupric ions, which bind to the 
polypeptide backbones of any present protein. A colorimetric agent is then added 
which reacts to unbound cupric ions. The colour density is inversely related to the 
protein concentration of the sample.  Protein concentrations were calculated for the 
cell lines as 2245R [0.905 g/l]; 2246R [1.329 g/l] and 2247R [2.211 g/l]. 
Samples were scaled to a 20 g reaction with a dilute of TEAB (500 l; 500 mM), 
SDS (0.05%) and PPase (protein phosphatase) inhibitors I and II (both at 1%). The 
reducing agent tris(2-carboxyethyl)phosphine) (TCEP) (2 l) was added used to 
break disulphide bonds within and between the proteins. The protein samples were 
then incubated for 60 minutes at 60˚C.  
 
After allowing the samples to cool, proteins were alkylated with the cysteine 
blocker methyl methanethiosulphonate (MMTS) and incubated for 15 minutes at 
room temperature. Blocking any free cysteine residues prevents formation of new 
disulphide bonds. Tryptic digestion was performed at an enzyme: substrate ratio of 
1:10 (2 g trypsin to 20 g protein). Sequencing grade trypsin (20 g) was re-
suspended in TEAB (1 ml, 500 mM) and 100 l of this stock was added to each 
protein sample vial, resulting in a final reaction volume of 125 l with an SDS 
concentration of 0.01% in the digest. The samples were incubated at 37˚C with 
gentle agitation for 24 hours before quenching the digest reaction by addition of 
formic acid (475 l, 1%). The final solution therefore contained approximately 20 
g digest on 600 l [33 ng/l]. Each LCMS injection at 15 l equated to 
approximately 500 ng per injection. 
 
Peptides from each sample were analysed a total of 5 times. The inlet method of 
choice was a Nano-Acquity ultra performance liquid chromatography (UPLC) 
system (Waters). 500 ng of peptide was loaded onto a Waters C18 Symmetry trap 
column (180μm ID, 5 μm, 5 cm) in water, 0.1% (v/v) acetonitrile, 0.1% (v/v) 
formic acid at a flow rate of 7 μl/min.  Peptides were then separated using a Waters 
NanoAcquity bridged ethylene hybrid BEH C18 column ((75 um ID, 1.7 um, 25 
cm) with a gradient of 1 to 25% (v/v) of acetonitrile, 0.1% formic acid at a flow rate 
of 400 nl/min. 
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The nano-liquid chromatography (nLC) effluent was sprayed directly into the LTQ-
Orbitrap XL mass spectrometer aided by the Proxeon nano source at a voltage 
offset of 1.8 KV. The mass spectrometer was operated in parallel data dependent 
mode where the MS survey scan was performed at a nominal resolution of 60, 000 
(at m/z 400) resolution in the Orbitrap analyser between m/z range of 400-2000 
(target value of 1 million ions, maximum fill time of 500 ms). Dynamic exclusion 
was enabled to prevent the selection of a formally targeted ion for a total of x 
seconds.  nLCMS data was acquired for 50,000 multiply charged ‘features, 10,000 
of which MSMS data was  also acquired.    
 
All the nLCMSMS data was imported into and processed by Progenesis LCMS vx 
(Nonlinear Dynamics).  Progenesis generated peak lists files were submitted to 
Mascot vy (Matrix science) for a database search using the following criteria. 
Database was Uniprot vx restricted to human with a precursor tolerance of 20 ppm, 
fragment tolerance 0.9Da, enzyme specificity trypsin, allowed missed cleavages.  
The false discovery rate was calculated with the use of decoy search. Progenesis 
LCMS calculated the relative abundances of all the multiply charged features 
detected.  The most significant features were selected that had a fold change >2.47 
and an ANOVA value (P) = 2.85e-5 with Power ≥0.9995.  
 
2.4.6│ Western blotting 
The Western blot was conducted by the Genito-Urinary Cancer Research Group at 
the School of Cancer and Enabling Sciences in the Patterson Institute for Cancer 
Research, University of Manchester.  
 
In preparation a 13.5% electrophoresis resolving gel was prepared for sodium 
dodecyl sulphate polyacrylamide gel electrophoreises (SDS-PAGE). The following 
were components were added into the blot holder: Milipore water (2.6 mL), tris 
(1.5M; pH 8.8; 1 mL), acrylamide (4.1 mL), SDS (10%; 185 L), ammonium 
persulfate (APS) (10%; 36 L) and tetramethylethylenediamine (TEMED) (18 L). 
Ethanol (2 mL) was added on top of the gel to remove air bubbles and to prevent 
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oxygen from getting into the gel which could oxidise it and inhibit polymerisation. 
The gel was left for 10 minutes to polymerise, after which the ethanol layer was 
removed and the gel was washed with Milipore water.  
 
The stacking gel comprised of Milipore water (2.37 mL), 
tris(hydroxymethyl)aminomethane  (0.5M; pH 6.8; 1 mL),  acrylamide (0.59 mL), 
SDS (10%; 34 L), ammonium persulfate APS (10%; 16 L) and 
tetramethylethylenediamine (TEMED) (8 L) was loaded into the resolving gel in 
the blot holder, and a comb was inserted to create the protein loading wells. The gel 
was left to polymerise for a further 10 minutes. The gel plates were connected to the 
Western blot apparatus and the electrophoresis buffer tris-buffered saline and 
Tween 20 (TBST) was pored into the chambers to allow for electric current.  
 
Sample preparation: For protein reduction, ß-mercapto-ethanol (BME) (20 µL) was 
added to a ×4 loading buffer (80 µL) comprised of tris(hydroxymethyl) 
aminomethane (0.5M; pH 6.8; 25 ml); glycerol (20 ml); SDS (10%; 160 mL), 
Milipore water (14 mL) and bromophenol blue (40 mg). To each of the cell line, 10 
l, 8l and 5 l of BME in loading buffer was added to the protein lysates at 27.2 
g, 13.7 g and 6.7 g respectively; a total of 9 samples to load. The samples were 
boiled for 5 minutes before being microcentrifuged (30 seconds at 8000 g), and 
loaded into the gel wells. The gel was run at 60 V for 5 minutes and then 130 V for 
1.5 hours.   
 
Wet gel transfer: The SDS-PAGE gel was stacked next to a nitrocellulose 
membrane, centred in between two layers of filter paper and two sponges, all 
submerged in cooled transfer buffer comprised of TRIS base (3.03 g), glycine (14.4 
g), methanol (200 mL) and Milipore water (800 mL).  To remove air bubbles a 
pipette was used as a roller.  The sandwich was then submerged in the transfer tank 
so that the proteins migrated from the gel towards to the nitrocellulose membrane at 
the positive electrode (taking 1.5 hours at 100V). At the end of the transfer Ponceau 
blue staining was used to confirm the presence of proteins on the membrane. The 
membrane was kept in a container filled with TBST (a mixture of tris-buffered 
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saline and TWEEN 20) comprised of NaCl (8 g), TRIS base (3 g; pH 7.4), 0.1% 
TWEEN 20 (Polysorbate 20 detergent) (1 mL).  
 
Antibody Staining: A 0.3% membrane blocking milk (0.15 g Marvel in 50 mL 
TBST) was used with a SNAP ID system under manufacturer protocol (Milipore). 
For the primary staining, 10 l of Histone H2A Antibody (Cell Signalling 
technologies) was used in 3 mL milk and 2 l in 5 mL milk for the anti-rabbit 
secondary antibody solution. A glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) antibody was used as a control to confirm protein loading quantities (4 l 
in 3 mL for primary; 2 l in 5 mL for anti-rabbit secondary antibody). To obtain the 
blot images, the membranes were treated with chemiluminescence developer 
supplied with the SNAP ID kit and exposed in a BioSpectrum Imaging System 
(UVP) for 5 minutes.   
 
2.4.7│ FACS sorting 
A-498 cells were seeded at 5×105 cells in Falcon (T25) flasks. After 24 hours, 
agents KF0101, KF0113, KF0501 and 5FU were added at IC25 and IC50 and were 
left for 24 and 72 subsequent hours.  For the control group no agent was added to 
the cells. After the appropriate time the media from each flask was removed, 
containing dead cells. The viable cells remaining adhered to the flask were washed 
with PBS. The cells were trypsinised, removed and centrifuged. The cell pellet was 
re-suspended in the smallest possible volume of PBS and agitated. PBS (1 mL) was 
added to the cell suspension, transferred to Eppendorf tubes and spun (800g; 5 min). 
The supernatant was aspirated and the Eppendorf agitated to break up the pellet. Ice 
cold EtOH(1 mL; 70% in H20) was added and the Eppendorf vortexed to prevent 
cell clumping. The cells were fixed for 30 min at RT. Cells were adjusted to 
approximately 5×105 cells/ mL and washed twice in PBS (in 1% BSA). Cells were 
spun (1000g; 5 min) and re-suspended in staining buffer (1 mL) comprised of 
propidium iodide (50 mg/mL), Triton–X (0.1 % v/v), PBS and ribonuclease A (50 
mg/mL). Cells were incubated at RT for 20 minutes, protected from light.  The cells 
were sorted using an Influx FACS analyser. Samples included cells treated with 
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5FU and KF1 at IC50 concentrations for 24 hours and 72 hours after agent 
introduction. Untreated cells were also sorted as a control for both time periods.  
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Chapter 3 │ Spectral Pre-processing and Analysis  
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0 A R T SI I I I I   
3.1 │Spectral Pre-processing 
3.1.1 │The influence of light scattering 
Incident IR light with intensity I0 may be partially reflected IR, scattered IS and 
absorbed IA upon interaction with a sample. The remainder of light will be 
transmitted IT. According to the law of conservation of energy, the energy balance 
(eq. 23) must be:   
 
 (23) 
 
 
To evaluate IA, ideally, I0 and one of either IS, IT, or IR is measured, with zero 
contribution from the other intensities.   
 
Light scattering is the redirection of light that occurs when the incident light (an 
electromagnetic (EM) wave) encounters a non-homogeneous obstacle, i.e. the 
scattering sample.  Light scattering, however, is not as straight-forward at Figure 
3.1 suggests as it not simply a case of electromagnetic waves bouncing off the 
surface of the sample [1].  
 
The EM wave will interact with the particle; periodically perturbing the electron 
orbits within the particles constituent molecules at the same frequency as the 
electric field (of the incident light wave). Electron cloud perturbation results in an 
Figure 3.1 │The interaction of incident light and the sample [44] 
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induced dipole moment, due to periodic charge separation within the molecule. The 
oscillating dipole moment causes the molecule to re-radiate the light in all 
directions. The majority of light scattered by the particle emits at the same incident 
frequency, which is termed elastic scattering (Figure 3.2).  
 
 
 
 
 
Rayleigh and Mie scattering describe two forms of elastic light scattering. Rayleigh 
scattering concerns small spherical particles much smaller in diameter than the 
wavelength of the incidence and scattered wave and usually exhibit as gaseous, 
aerosol form in the nanometre range [1].   
 
Mie scattering, however, applies to a general theory of the scattering of 
electromagnetic radiation by homogenous spherical particles. The formulae and 
calculations are more complex than those of Rayleigh scattering for both absorbing 
and non-absorbing spherical particles with no boundary on particle size.  (Rayleigh 
scattering is simply a limiting case of Mie theory for particles much smaller than the 
incident wavelength).  
 
The Van de Hulst approximation for Mie scattering efficiency is descriptive of a 
non-absorbing spherical particle [2]. Biological samples, however, are absorbing 
materials and can exhibit severe scattering. In recent advances, the approximation 
Figure 3.2 │The interaction of the incident light as an electromagnetic wave, inducing 
temporary dipole moments in the electron clouds of the sample molecules. As a result scattered 
light is emitted at the same frequency as the light of incidence [45]. 
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was modified to describe absorbing materials, coining the term RMieS (Resonant 
Mie Scattering). 
 
As Mie scattering depends non-linearly on α, the product of the radius and the 
imaginary part of the refractive index of the scatterer [3] (eq. 11) the approximation 
was modified by using a refractive index spectrum of a reference, rather than using 
a constant value.  
 
The mid infrared range studied for biological materials is typically  ~4000–700 cm-
1, equating to wavelengths of 2.5–14 m. Incidentally this range is of similar 
magnitude to a biological cell and its cellular components [4].  
 
Aside from the refractive index, there are a number of significant properties that 
affect the severity of the scattering sample. Firstly, scattering is more severe when 
the scattering sample is closer in diameter to the wavelength of light. Another factor 
is sample uniformity. A flat surface will not give rise to scattering and IR substrates 
are polished to high standards for this reason. An uneven surface will cause some of 
the incident light to be scattered in such a direction that it will not reach the 
detector, resulting in a 'false' absorption profile [5].  
 
Three types of biological material were considered comprising of a microtomed 
tissue specimen, an adhesive cultured cell and cell that has been detached by trypsin 
and cytospun onto an infrared substrate. The spectrum of an isolated cell that has 
been dropped or deposited onto a slide such that is has no protein attachments to the 
substrate will present the most severe RMieS scattering. Not only is the cell 
smallest in diameter, closest to the wavelength of incident light, it is relatively 
spherical (Fig. 3.3c). The cultured cell will have extended across the surface of the 
substrate, appearing larger and relatively more uniform than the previous cell (Fig. 
3.3b). A tissue specimen will be larger and more uniform, displaying the least 
amount of RMieS scattering. A uniform sample layer, such as a film of Matrigel, 
however, will not display scattering (Fig. 3.3a).      
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Figure 3.3│ Schematic diagrams illustrating the occurrence of RMieS scattered light emitted from 
biological sample and reaching the detector. A matrigel film of uniform thickness will display no 
scattering (a). An adhesive cell will be fairly larger than the incident wavelength of light but will 
not be as uniform. (c) A single cell that has been spun onto a substrate will be most spherical and 
closest to the incident wavelength of light and will therefore exhibit the most severe scattering 
perturbations within its infrared spectrum.
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The consequences of Mie scattering in an affected spectrum include broad 
oscillating baselines, shifted peak positions and distorted peak shapes. The 
oscillating baseline is a remnant of non-resonant Mie scattering, which the 
Extended Multiplicative Signal Correction (EMSC) algorithm developed by Kohler 
et al. successfully removes [3].  
 
 
Another notable Mie distortion can be observed as a classic negative dip near the 
amide I region of the fingerprint at ~1750 cm-1, formerly known as the ‘dispersion 
artefact’.  This artefact is now understood to be a consequence of absorbing Mie 
scattering materials, such as biological samples. The RMieS-EMSC correction 
algorithm combines the corrective benefits of EMSC and additionally removes the 
‘anomalous dispersion artefact’ to a considerable degree (Fig. 3.4); if not 
completely in some circumstances. This, however, can only be determined with 
simulated data, where the ‘true answer’ for the sample spectrum is known.  
 
The RMieS-EMSC algorithm works by linear regression with the use of an 
appropriate reference spectrum, such as a uniform layer of Matrigel, which works as 
the next best solution to a reference of a pure absorbance spectrum. The initial 
RMieS corrected spectrum will exhibit spectral information from the reference and 
so improvements are made by iteratively looping the RMieS corrected output and 
Figure 3.4│An example of a highly RMieS scattering single cell, acquired at the SMIS 
beamline at Soleil, Paris. The spectrum has been corrected with the iterative version of the 
RMieS-EMSC algorithm with 100 iterations. The cell was ~12 m in diameter and had been
cytospun onto CaF2. 
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feeding that into the algorithm such that the new corrected spectrum becomes the 
new reference spectrum and the original raw sample spectrum is then evaluated.  
 
3.1.2 │Spectral derivatives 
Derivative spectra, obtained by differentiating spectral intensity with respect to 
wavelength, have a number of uses.  
 
Flat baselines can be achieved as baseline drift is removed with the use of spectral 
derivatives. Narrower bandwidths i.e. higher resolution of differential spectra 
potentially allow for subtle differences between spectra to be more easily resolved. 
To resolve overlapping bands, mathematical derivates are used to narrow their full 
width at half height value (FWHH). First-order derivative spectra measure the 
change in the peak slope, with the absorbance peak maxima coinciding with zero on 
the y-axis of the derivative spectra.  
 
Odd derivatives typically have a dispersive character whereas the even derivates 
have a symmetrical band shape, parallel to the original band [1]. Therefore the 
second derivative can be more useful for spectral interpretation as the peak 
frequency identical to the original peak frequency.  
 
The drawback of implementing derivatives is a cost in the SNR. Noise is higher 
than in non-derivative spectra and becomes progressively worse as the derivative 
order increases, as observed in Figure 3.5. 
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Figure 3.5│ A typical infrared spectrum from a biological cell (upper) and its first (middle) 
and second derivative transformations (lower).
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3.1.4 │Fourier self deconvolution 
Fourier self deconvolution (FSD) is another mathematical procedure that allows the 
width of spectral bands to be narrowed. It is a deconvolution approach as the 
inherent line shape function of each band in the spectrum is altered. FSD aims to 
reduce the bandwidth without affecting positional or area. The FWHH can often be 
reduced by as much as a factor of 2 without introducing excessive noise [1]. Over-
deconvolution can occur, however, whereby the line width has narrowed to such an 
extent that the line shape adopts sidelobes. A contribution of sidelobes from two 
adjacent peaks can lead to a mis-identification of a new peak. FSD can be a 
powerful tool under correct use. Conversely, it can also result in misleading 
interpretations.   
 
3.1.5 │Vector normalisation 
It is fairly common place in chemometric analysis of FTIR spectra to normalize the 
derivatives during the pre-processing step before analysis to remove thickness 
differences between sample spectra.  
 
To carry out vector normalisation, the average value of the absorbance is calculated 
for each spectral region. This value is then subtracted from the spectrum such that a 
new average value equals zero. Finally, the spectra are scaled such, that the sum 
squared deviation over the indicated wavelengths equals one [6]. 
 
3.2 │Spectral Signals of Cancer Bio-molecules  
Fourier transform infrared spectroscopy monitors the vibrational bending and 
stretching modes of molecules that are resonant with the frequency of infrared. The 
wavelengths at which these groups absorb the infrared radiation are measured, 
resulting in a unique spectroscopic fingerprint with relative intensities dependant 
upon sample composition. FTIR is an attractive option for biomedical applications. 
Sample preparation is minimal, simple, reproducible and non-destructive to the 
material and usually, depending on the material type, only small quantities are 
required, such as micron-thick tissue specimens for example. 
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Absorbance peaks in vibrational spectra correspond to different molecule bonds, 
ratios or conformations of bio-molecules. Differences in the chemical environment 
of these bonds can cause changes in shape, position or intensity of these peaks. 
Spectral analysis of biomaterial is heavily based on the interpretation of spectral 
changes associated with spectral features that dominate the infrared signal at 
specific wavenumbers and Figure 3.6 displays the characteristic peaks from protein, 
lipid, nucleic acid and carbohydrate signals. Underlying contributions from bio-
groups can also contribute to the signal at particular wavenumbers. To analyse 
underlying bands, spectral processing can be performed in an attempt resolve these 
peaks (Ch. 3.1.3/4). 
 
The infrared amide I band can be useful for predicting protein secondary structure. 
The amide I stretching carbonyl mode has been determined to have specific 
frequencies associates with -helices, -sheets, and other characteristic structures 
such as turns and bends and random coils. The approximate wave numbers 
corresponding to the three common structures found in proteins are: -helix, 1650 
cm-1; -sheet, 1632 cm-1 and 1685 cm-1; and random coil at 1658 cm-1 [7].  
 
In a review by Movasaghi et al. [8], it is apparent that spectral interpretation of 
comparable areas of bio-material reveals a good agreement in wavenumber 
assignments, despite the use of different sample preparation techniques, suggesting 
a certain level of confidence of peak position.   
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Significant research, with a substantial quantity of cancer-related biomaterial, has 
been conducted over recent years with a view to clinical application. Studies have 
included cervical, melanoma, prostate, oesophagus, lymphoma, gastric, endometrial 
adenocarcinomma and fibrosarcoma [9-16]. Many studies have investigated the 
difference in cancer signatures by use of peak ratios, spectral shifts and absorbance 
differences.  
 
As Figure 3.6 suggests, there are a considerable number of spectral peaks that are 
associated with lipid absorbencies in a typical biological sample and hence possible 
biomarkers of carcinoma. For instance, the ratio of methyl (CH3) and methylene 
(CH2) peaks have been assessed in a number of studies. Fung et al. reported on 
differences between normal and malignant epithelial tissue in endometrial 
adenocarcinomma between the membrane lipid methylene stretching mode at 2853 
cm-1 and an asymmetric methyl stretch from cellular proteins nucleic acids and 
lipids at 2959 cm-1 [16]. The ratio between these two lipid markers decreased in 
methyl/methylene in the malignant epithelial tissue, relative to the normal tissue. 
This is said to be consistent with the hypomethylation observed during 
carcinogenesis in other tissues, which may alter gene expression and facilitate 
Figure 3.6│Assignments of the four biomolecular groups in a typical biological spectrum: 
lipids, proteins, nucleic acids and carbohydrates
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mutations [18]. This conclusion was also reached by Maziak etl al [13] who in 
addition found an increase in methylene peak absorption suggested an accumulation 
of triglycerides in malignant tissue.  
 
Conversely, Andrus et al. [19] claimed an increasing CH3/CH2 ratio with increasing 
grade of malignant non-Hodgkin’s lymphoma. Similarly, Yao et al. [20] recently 
found that the lipid ratios of 2925/1460 cm-1 and 1740/1460 cm-1 decreased in the 
cancer spectra, indicating lower quantity of lipids in the colon neoplasm. Liu et al. 
also found a marked decrease in lipid content in papillary thyroid carcinoma [21].  
 
The discrepancy between the findings of Fung and Maziak et al. compared to 
Andrus and Yao et al. suggests that these spectral biomarkers may not be 
translatable to all cancers. For instance, Mordechai et al. compared spectra of both 
cervical and melanoma tissue and found that while a reduction in the glycogen 
carbohydrate was a good diagnostic marker for malignant cervical tissue, the same 
trend was not observed for the malignant melanoma [9]. Despite the lack of 
correlation with these cancers there is a striking case to support a relative reduction 
in glycogen in malignant tissue, compared with non-malignant tissue.  
 
The glycogen/phosphate ratio with absorbance intensities at 1030 and 1080 cm-1 has 
been investigated as a marker in malignant tissue. Reduced glycogen and increased 
phosphate levels were found in cancer of the cervix [11], prostate [12] and 
oesophagus [13]. The mutual trend may be indicative of malignancy due to an 
increased metabolic turnover, and is explored further in chapter four. 
 
Perhaps the most obvious spectral signals that exhibit characteristic differences in 
malignant samples will be the peaks associated with nucleic acids due to the 
differences in genetic sequencing.  A difference in the phosphodiester symmetric 
and anti-symmetric stretching bands associated with the sugar-phosphate backbone 
of DNA and also phosphorylated proteins and phospholipids has been observed in 
many studies.  Pronounced increases in these bands have been observed in 
malignant cervical and gastric samples [11, 15]. Yao et al. found a peak shift to a 
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higher wavenumber in the phosphodiester band at 1080 cm-1 in malignant tissue 
relative to benign colon neoplasm [20].  
 
For ribose in particular, it has been observed that malignant samples display an 
increased level. Mordechai et al. found the RNA/DNA ratio at 1121/1020 cm-1 
increased in malignant cervical and melanoma tissue [9]. This result is supported by 
the findings of Andrus et al., where an increase in ribose content at 1121 cm-1 was 
seen to correlate with an increase in the 996/966 cm-1 ratio, another index of 
RNA/DNA, with increasing malignancy grade in lymphoma [19].   
 
While Maziak et al. observed an increase in the nuclei-to-cytoplasm ratio in tissue 
samples of adenocarcinoma of the oesophagus, the relative amount of DNA 
increased and the content of RNA decreased, suggesting the opposite to the studies 
by Mordechai and Andrus et al. [13].  
 
The research suggests that while there are spectral markers that consistently 
discriminate differences in the biochemistry between non-malignant and malignant 
biological samples. The trends of these markers, however, appear to differ and seem 
to be cancer specific. In future research, now that there is increased understanding 
about the issue of the ‘dispersion artefact’, there will hopefully be an increase in the 
number of studies that concentrate on spectral assignments at the single cell level, 
which may give us increased understanding about how we can relate any infrared 
biomarkers to the biological processes that govern their change.  
 
3.3 │Chemometric Techniques for Spectral Analysis  
3.3.1 │Principal component analysis  
PCA is a method of finding patterns in a set of data, highlighting similarities and 
differences when patterns are difficult to find in data of high dimension. When a 
dataset is comprised of two variables, the dataset is two-dimensional and therefore 
fairly easy to analyse. An infrared spectrum, however, will include hundreds or 
thousands of data points, depending on the chosen resolution and spectral range. 
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The data is ‘n dimensional’ and extremely complicated to interpret. Therefore 
spectroscopists regularly use PCA as a way to explore the reasoning behind which 
particular spectra may class together and what spectral features may determine their 
classification. There are several examples of the use of this technique in 
characterising cancer cell lines [22-25]. 
 
The initial dataset coordinates are transformed into new versions in order to display 
the variance of the experimental data much more clearly [26]. The principal 
components are calculated in such a way so that the largest amounts of variance are 
covered. They consist of linear combinations which are weighted sums calculated 
from the initial variables, which are the absorbencies measured at each wavenumber 
in a spectrum. In terms of spectroscopy, the new linear combinations do not relate 
to particular spectral bands, but a collection of bands, each with different weighting 
or variance contribution to the PC.  
 
The input matrix is the experimental observation data consisting of absorbance data 
points of particular spectrum at a particular wavenumber. The raw data is usually 
mean centred initially the mean is subtracted from each spectrum, producing a 
normalised data set with mean of zero [26].  
 
Variance is a measure of the spread of data within a data set, very similar to 
standard deviation, only applies to one dimension.  Covariance is calculated in PCA 
as data of more than one dimension can be assessed and can allow comparisons of 
how much two dimensions will vary with respect to one another. Positive 
covariance occurs when two dimensions increase together, i.e. they vary together in 
positive correlation. If covariance is negative, then one dimension increases while 
the other dimension decreases. Zero covariance indicates that the dimensions are 
independent of each other. If there are more than two dimensions in a data set then 
more than one covariance can be calculated and a covariance matrix is calculated 
[26].  
 
The covariance matrix is then split into the score matrix, which is comprised of the 
scaling coefficients (also known as eigenvalues), and the loading matrix (also 
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known as eigenvectors or principal components).  The loadings or eigenvectors are 
non-zero vectors and can only be found for square matrices that are multiplied with 
a vector that results in a new vector that has been scaled from the original vector’s 
position (Fig. 3.7).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Eigenvectors allow the most important patterns in a data set to be pinpointed and 
displayed in a PCA plot.  All eigenvectors are orthogonal to one another. This is 
important in PCA as data can be expressed in terms of these perpendicular 
eigenvectors, for example comparing the data in PC1 versus PC2 [26].  
 
Since the calculation of the principal components uses the criteria that the largest 
amount of variance should be covered in the experimental data, the first principal 
component features the maximum variance, with sub sequential PCs carrying 
decreasingly less variance. If the dataset was not mean centred initially, the first PC 
would be equal to the mean of the dataset and the second PC would explain the 
Figure 3.7 │PCA in practice: The raw data (a) is first normalized (b). The axes are then rotated 
to explain maximum variance in the dataset (c). This is shown by the PC1 line in red which 
explains the most variance. The next best explanation is the line through PC2 in green. Each 
data point can be classified as a summation of the contributions from each of those lines (d).  The 
PC1 loading plot will determine the sub-component (i.e. spectral peaks) contributions to 
variance in the PC, each with a different weighting (e). 
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most variance in the dataset. The principal components towards the upper limit 
usually describe miniscule data variance and merely contain spectral noise as well 
as unnecessary information from the experimental spectra. 
 
3.3.2 │Linear discriminant analysis  
LDA is different to PCA in that it directly discriminates data between classes 
whereas PCA only examines the principal component analysis as a whole set of 
data and does not give much indication of underlying class structure [27].    
 
A set of independent variables are used to separate data points based on the 
categorical dependent variables which are the groups that are user defined. New 
variables create a line onto which the centroid of different clustered groups are 
projected as far apart as possible, based on linear combinations of the dataset (hence 
the term linear discriminant analysis is used). If the model is for classification 
purposes the model can be assessed for classification efficiency by a report of 
correctly assigned groups using training and test datasets.  
 
Usually the dataset encompasses a series of principal components which have been 
calculated in PCA prior to LDA. PC-LDA is a method of improving intra-group 
clustering whilst maximising inter-group clustering (Fig. 3.8).   
 
 
 
 
Figure 3.8│ LDA allows for reduction in inter-group variance whilst maximising the distance 
between different cluster groups
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There is, however, a level of subjectivity associated with the technique, namely the 
number of principal components to use. The topic has been debated extensively and 
there are a number of methods offered in the literature to determine this factor, such 
as the Kaiser rule, parallel analysis, Cattell’s scree plot analysis, or simply taking 
the number of PCs that account for a fixed level of variance explained [28-31]. 
LDA will be used in the experimental analysis of various renal cancer cell lines and 
will be further explored and discussed in chapters five and six.  
 
3.3.3 │Cluster analysis 
One method of analysis, k-means clustering, aims to separate data points in k 
clusters in which each data point belongs to the cluster with nearest mean. The user 
is asked to define how many clusters are desired [27].  
 
 
The initial k-means are randomly assigned (Fig 3.9a) and each individual data point 
is grouped to whatever k-mean the data point is in closest proximity to (Fig 3.9b). 
Each k means centre then calculates its centroid based on its acquired data points 
(Fig 3.9c). The centroid of each cluster becomes the new mean (Fig 3.9d) and each 
individual data point surrounding the new mean is grouped. This continues until 
convergence has been reached. 
Figure 3.9 │A simplified demonstration of standard K-means clustering 
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4.1 │ Introduction and Aims 
 
Evidence suggests that FTIR spectroscopy can provide a means to analyse 
biological material, with an emphasis on clinically relevant research [1].  It has been 
shown to enable identification of cancerous tissue biopsies and in some cases 
provide an estimation of cancer grade with comparable sensitivity and specificity to 
conventional approaches [2-6]. There is also emerging evidence that FTIR could be 
implemented to assess cellular drug interactions that may aid screening for 
therapeutic efficacy in the future [7-11].  
 
There has been a major limitation which has held back the progression of Mid-IR 
FTIR spectroscopy. As previously mentioned (Ch. 3.1), FTIR spectral analysis of 
biological material has been hampered due to spectral distortions associated with 
Resonant Mie Scattering (RMieS).  Examples of such distortions include sinusoidal 
baselines and peak shifts, particularly in the carbonyl(C=O) peak at ~1730 cm-1, 
associated with lipid esters [12].  
 
Until recently RMieS was not fully understood. Measures to avoid the issue 
included simply ignoring the amide I band, or baseline correcting using the rubber 
band method [13]. This involves a conceptual rubber band that is stretched beneath 
the spectrum. A new baseline is constructed where the rubber band touches the 
spectrum at selected points in the spectrum.  This type of correction can introduce 
bandshape and intensity errors. Consequently, spectral results may be mis-leading 
and therefore conclusions formed on the basis of such data are likely to be 
erroneous.   
 
High demands are placed on any clinically-targeted technology in terms of their 
performance, confidence and accuracy. If the spectroscopy community cannot be 
confident in the results of FTIR spectral analysis for bio-materials then it is 
probable it will not be implemented in the clinic. The RMies-EMSC correction 
algorithm has provided a means to increase our confidence in terms of ability to 
separate real chemical information from spectral perturbations caused by physical 
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affects. The algorithm has been demonstrated to work well using simulated data, 
where it was possible to assess the robustness of the correction [14].   
 
The cell lines, selected to specifically test the robustness of the algorithm, the renal 
cell lines were 2245R and 2247R, established from primary kidney resections, and 
2246R derived from a metastatic pleural nodule, derived from different surgical 
specimens from different patients diagnosed with clear-cell renal carcinoma at the 
N.C.I., U.S.A. Cell line 2247R has a Fuhrman nuclear grade 3. No grades were 
reported for cell lines 2245R and 2246R. 
 
For the FTIR-based characterisation of the renal cell lines, three different 
approaches were taken in terms of sample preparation and spectral acquisition, as 
outlined in Figure 4.1.  
 
Figure 4.1│ Schematic diagram of the different spectral methods employed in the cell 
characterisation study: Method I utilises focal plane array FTIR imaging technology with 128 
×128 elements, simultaneously acquiring the hyperspectral image of the sample at a resolution of 
5.5 microns per pixel. Method II uses conventional bench top single point Microspectroscopy 
where the aperture (in blue) is opened to record the average signal of numerous cells (orange) in 
a population. Method III is also single point micro-spectroscopy but utilises a synchrotron 
radiation source for high brilliance, increasing the signal to noise of a single cell spectrum 
relative to a bench top infrared source.  
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Recently factors affecting cell line discrimination using principal component 
analysis have been investigated, such as use of different cell culture media [15]. The 
results indicated that the use of different culture media did not provide the basis for 
chemometric separation in different prostate cell lines. Method I (Ch. 4.2.2) was 
designed to take the idea of this investigation further. Firstly, the cell lines were 
cultured under the same conditions. Secondly, the cells were co-cultured onto the 
same substrate at different points of reference and allowed to reach complete 
confluence. In doing so, more confidence could be placed in the sample preparation, 
i.e. culture media or use of different substrates was not a factor of separation 
between cell lines.  
 
In addition, the use of the glycogen/phosphate ratio at 1030 cm-1/1080 cm-1 peaks 
has been investigated to assess cancer biopsies and is thought to be a metabolic 
marker [2, 16]. Method I provided a means to relate chemical information in terms 
of phosphate and glycogen absorptions to the results of the biological proliferation 
assay to test this biomarker of metabolism, as a high rate of metabolic turnover 
could have a link with a high rate of proliferation.  
 
The second stage of analysis involved single point spectra of the cell monolayers 
using two approaches (Method II, Ch. 4.2.3). Conventional FTIR transflection 
measurements were made as well as measurements by FTIR-PAS, a technique 
relatively free from scattering perturbations (Ch. 2.2.4). Method II provided 
optimum conditions for the FTIR-PAS measurements and so a direct comparison 
could be made with the conventional FTIR approach, using transflection MirrIR 
substrates. It was determined that alternative substrates such as calcium fluoride 
(CaF2), silica chips and quartz gave poorer results in terms of signal-to-noise 
(SNR); the SNR for a CaF2 substrate was 25 compared to a typical spectrum 
obtained from a MirrIR substrate at 88 [17]. It has been proposed that the highly 
reflective silver coating on the MirrIR substrates give rise to a ‘double absorption’ 
effect whereby light reflected off the surface of the substrate, as well as incident 
light, will be absorbed by the sample, further increasing the intensity of the signal 
[17].  
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Single point spectra of a cell monolayer that provide an average signal from a cell 
population radiation whereby hundreds of cells are simultaneously irradiated, result 
in a spectrum with excellent signal to noise and an overall chemical signature of a 
cell population. Method III enabled single cell infrared measurements to be made. 
Good signal to noise spectra for single cells may be obtained with the use of 
synchrotron radiation [18]. The spectrum of a single cell may present more detailed 
information in comparison to that of the average signal from cell monolayers, 
however they typically suffer the most severe spectral distortion due to RMieS. 
Single cell spectra therefore present the biggest challenge in terms of RMieS 
correction.  
 
When implementing the RMieS-EMSC algorithm to assess experimental (non-
simulated) sample data, the ‘true answer’ in terms of result validity could not be 
known. It was accepted that a multidisciplinary approach were required to validate 
corrected experimental spectra. Protein-based techniques namely LCMS (Ch. 
2.3.7.2) and Western blotting (Ch. 2.3.7.3) were employed to validate results from 
the FTIR spectroscopy analysis. 
 
 
4.2│Experimental Methods 
4.2.1│ Proliferation 
All three cell lines were cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
with foetal calf serum (FCS) (10%) and L-glutamine (1%), grown at 37˚C in a 
humidified atmosphere (5% CO2) until confluent. Cells were seeded at a density of 
1x105 cells per well in a six well plate, one for each day. At each time point cells 
were removed. To do this, the cells in each specific well were pre-washed twice in 
phosphate buffered saline (PBS) before trypsin (1 mL) was added and incubated at 
37˚C for approximately 3 minutes to detach the cells. After cell detachment DMEM 
media with 10% FCS was added and the cells were transferred to Falcon tubes for 
centrifugation (800g for 5 minutes), along with the PBS washes. A Trypan blue 
exclusion assay was performed for the proliferation characterisation. Total viable 
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cell number per day was counted using a hemocytometer and a ratio of 1:1 Trypan 
blue: cells in media. The Trypan blue dye permeated the membranes of dead cells 
which were excluded from the count. For robustness each time point would be 
counted with triplicate wells, taking the average result as the final count.  
 
4.2.2│FTIR method I: Imaging of dual-cell monolayer 
The targeted positions for 2245R and 2247R cells were marked on the non-
reflective side of the MirrIR substrate. Micro-droplets (1000 cells in 20 l /media) 
were positioned on top of the IR reflective surface such that the two cell type micro-
droplets did not mix (Fig. 4.2). H20 (1 mL) was added to the tissue culture plastic 
well holding the slide and incubated for 15 minutes to allow the cells to adhere 
without drying out. Media (DMEM with 10% FCS, 1% L-Glutamine) was then 
added to submerge the slide. The cells were left to proliferate until 100 % 
confluence was reached. 
 
 
 
 
 
 
 
 
  
 
 
 
Transflection-mode FTIR imaging spectroscopy was performed using the method 
outlined in Ch. 2.4.5.3. The obtained infrared image was then corrected with the 
RMieS-EMSC algorithm with 10 iterations and vector normalised. For analysis of 
Figure 4.2 │Schematic diagram for method I sample preparation: Micro-droplets of 
concentrated 2245R and 2247R cells were placed at designated points on the IR reflective side of 
the substrate. Designated points were marked on the non-reflective side of the MirrIR slide. The 
cells were left to establish as a monolayer until an interface between the two cell types was 
reached. 
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the glycogen/phosphate ratio, the peak heights at 1030 cm-1 and 1080 cm-1 were 
assessed for every spectrum. 
 
4.2.3│FTIR method II: Cell monolayers  
Cells were cultured and prepared for FTIR as outlined in Ch. 2.4.1 and 2.4.2.1. The 
FTIR samples were cultured onto standard size slides (2.5 x 7.5 cm2). Single point 
transflection spectra were taken using the method described in Ch. 2.4.3.1. The 
dataset was acquired with a spectral resolution of 4 cm-1 with 256 co-added scans 
per spectrum. The data comprised of 20 spectra taken from 10 samples per cell line, 
in randomised order and on different sampling days.   
 
The sample preparation of the FTIR-PAS samples followed the same protocol as for 
standard FTIR spectroscopy; however they were cultured onto smaller MirrIR 
substrates (0.5 x 0.5 cm2) to fit the sample chamber of the photoacoustic accessory. 
Measurements were taken using the instrumentation described in Chapter. 2.4.3.4. 
The system was allowed to purge for a period of 4 minutes per spectrum. The data 
set comprised of 20 spectra acquired from 10 samples per cell line.  
 
4.2.4│FTIR method III: Single cell SR-FTIR microspectroscopy  
Cells were cultured then cytospun onto calcium fluoride (CaF2) slides as described 
in Ch. 2.4.2.2. SR-FTIR transmission spectra were acquired on the SMIS beamline 
as described in Ch. 2.4.3.2. 240 spectra were recorded at 4 cm-1 resolution with 256 
co-scans and the size of the aperture was typically 14 m2.  
 
4.2.5│Spectral pre-processing 
All FTIR datasets were transformed in Matlab (The Mathworks Inc.) to second 
derivative with 7 point Savitsky-Golay smoothing and a polynomial order of 3, over 
a selected analytical range of 1825-1015 cm-1. The datasets were finally vector 
normalised and mean centred prior to principal component analysis, performed as a 
single routine in Matlab.  
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4.2.6│Amide I analysis 
Fourier self deconvolution (FSD) and curve fitting was performed using Omnic® 
software (Thermo Electron Corp.). The Fourier self-deconvolution (FSD) process 
can be manipulated to optimise the result and therefore it is not a quantitative 
solution. It does, however, enable an estimation to be made for protein secondary 
structure. The parameters that can be manipulated include the bandwidth of the 
overlapped bands and the enhancement factor. The enhancement factor is a measure 
of the degree to which features are revealed and determines the ‘strength’ of the 
resolving power applied to the data. 
 
FSD was carried out at full band width at half height of the peak (FWHH) at 16 cm-
1 and a resolution enhancement of 1.4 for the spectral range covering the amide I 
band between 1720 and 1600 cm-1. The enhancement factor used was subtle enough 
to avoid over processing the spectrum which would result in distorted and negative 
band shapes of complex functions which no longer describe the data. Peak fitting 
employed a Voigt fitting profile with low sensitivity in order to avoid over-fitting of 
bands (Fig. 4.3).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 │Comparing different FSD spectra from (1) the original mean spectrum of 2245R (2) 
displays the chosen parameters for FSD; a bandwidth of 16 cm-1 and enhancement factor of 1.4. 
The FSD spectrum is similar in shape to the original, but features have been further resolved. (3, 
4) illustrate examples where FSD is over-manipulated; the resulting spectrum is no longer 
similar to the original spectrum. FSD Spectrum (3) has a bandwidth of 16 cm-1 but a greater 
enhancement factor at 2.8 while FSD spectrum (4) has a bandwidth of 32 cm-1 and an 
enhancement of 1.4. 
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4.2.7│Label-free LCMS  
The LCMS sample preparation and instrument operation was conducted by the 
Biological Mass Spectrometry Facility, Paterson Institute for Cancer Research, 
University of Manchester.  
 
Sample preparation is detailed in Ch. 2.4.5. Peptides from each sample were 
analysed a total of five times in five equivalent LCMS injections (Fig. 4.4). A 
technical replicate of 2245R was prepared to ensure consistency in the sample 
preparation technique.  
 
 
 
Figure 4.4 │Schematic for proteomic sample preparation; Protein lysates obtained from whole 
cells are injected into the LC-MS for analysis. A technical replicate was prepared for cell line 
2245R to test the robustness of sample preparation and instrumentation. 
 
4.2.8│Western blotting  
The Western Blot was conducted by the Genito-Urinary Cancer Research Group at 
the School of Cancer and Enabling Sciences in the Paterson Institute for Cancer 
Research, University of Manchester.  
 
The level of the protein Histone H2A expression was assessed by Western blot for 
all cell lines following standard protocol, described in Ch. 2.4.6. A total of nine 
samples were loaded: protein lysates at 27.2 g, 13.7 g and 6.7 g were loaded 
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respectively for each cell line; to ensure loading consistency. For a control, GAPDH 
was also loaded.  
 
4.3│Results and Discussion 
4.3.1│Assessment of growth characteristics  
Cell lines were initially characterised by their morphology and growth pattern. This 
was achieved by seeding each cell line at the same density (1×105 cells per well) 
and monitoring changes in the cell wells over a period of 5 days.  
 
Cell lines 2245R and 2246R were similar in morphology with a long, oval-shaped 
cellular structure and extensive cytoplasm characteristic of clear cell renal 
carcinoma. The 2247R cells, however, were more rounded with stellate growth 
characteristics and radial expansions similar to mesenchymal morphology (Fig. 
4.5).  
 
Figure 4.5│ In vitro photo-micrographs of cell lines over time. Cell lines (a) 2245R, (b) 2246R 
and (c) 2247R were seeded at an initial density of 1×105 cells per well in standard growth 
medium. Morphology and growth patterns were assessed by taking daily photo-micrographs 
with a 10× magnification under phase contrast. 
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A viable cell count was also performed during this study, as described in the 
experimental section (Ch. 4.2.1). The 2247R cell line exhibited a higher 
proliferation rate, in relation to cell lines 2245/6R, resulting in an exponential 
increase after two days (Fig. 4.6).  
 
 
 
 
 
 
 
 
 
 
 
4.3.2│FTIR imaging of the dual cell line monolayer 
A dual cell line monolayer was established by cell culture onto a MirrIR slide 
(experimental section 4.2.2). In terms of growth behaviour, 2245R cells appeared to 
spread, extending outwards across the substrate surface in a 2D fashion. In contrast 
the 2247R cells started to stack on top of each other once 100% confluence had 
been reached across the surface. This can be observed in the optical image where 
the 2247R cells appear much darker than their counterparts due to the higher optical 
density of the 2247R section of the monolayer (Fig. 4.7). 
 
Figure 4.6│Growth characteristics of the renal cell lines: cells were seeded at 1×105 cells initially 
and incubated at 37˚C with 5% CO2 for a period of 5 days. Cells were counted daily using Trypan 
blue; viable cell quantities are plotted for each cell line.
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To compare the 1030 / 1080 cm-1 glycogen / phosphate ratio, which is said  to be 
indicative of metabolic turnover, a hyperspectral 128×128 image, consisting of 
16384 spectra was acquired from the 2245R-2247R monolayer interface. Figure 4.8 
displays the pre-processing steps applied to the image. The total intensity raw image 
(Fig. 4.8a) maps out the two cell lines, with the more abundant 2247R cell line on 
the upper right-hand side and the 2245R cell line on the lower-left side, as observed 
in the larger optical image (Fig. 4.7). 
 
 Figure 4.8b displays the resulting image if RMieS-EMSC is not used prior to 
vector normalisation, where the total intensity chemistry still appears to distinguish 
between the cell lines. Once the raw image had been RMieS-EMSC corrected and 
vector normalised (Fig. 4.8c,d) the total intensity appeared to be more homogeneous 
across the image.  
 
It was noted that in the 2245R region there are still patches of areas that are thinner 
and this may be due to the fact that the cell line has more contact inhibition, as seen 
in Figure 4.5. 
Figure 4.7│Optical image taken using a 4× objective using the FTIR-Microscope. The 2247R 
cell line appears much darker in colour than the 2245R cell line due to its higher cell density. 
The position of the section used for the FTIR spectral acquisition with a ×36 aperture is 
highlighted in the yellow box: a sampling area of 700 x 700 microns. 
700 700  
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Figure 4.8│(a-d) Total intensity heat maps of the hyperspectral image of the 2245R/2247R 
monolayer during pre-processing and analysis. All intensity maps were auto-scaled in Matlab. 
Low absorbance is shown in blue and high absorbance in red. Images (a,b) display the raw 
intensity image and its vector-normalised format (c,d) Display the pre-processing steps used in 
the analysis. The raw image was RMieS-EMSC corrected with 10 iterations before vector 
normalisation.  (e). The mean spectrum is displayed for the raw (red) and RMieS-EMSC 
corrected spectrum (green). 
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The RMieS effect in highly confluent monolayers is relatively subtle, in contrast to 
single cell spectra. Use of the RMieS-EMSC algorithm, however, is still required. 
Figure 4.8e displays the mean spectrum of raw and RMieS-EMSC corrected data, in 
where the most notable difference is the correction of the baseline. 
 
After the RMieS-EMSC correction and subsequent vector-normalisation, the peak 
heights of all 16384 spectra were determined at the spectral wavenumbers 1030 and 
1080 cm-1 and ratioed. Figure 4.9 displays the heat map for the 1030/1080 cm-1 ratio 
across the interface of the two cell lines.  A decreasing ratio is said to indicate a 
higher rate of metabolic turnover, where glycogen stores are depleted (Ch. 1.1.4) 
and may be indicative of increasing malignancy [16, 19]. The FTIR imaging result 
does appear to correlate with the higher rate of proliferation in 2247R cells, as noted 
by the cell viability assay (Fig. 4.6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9│the glycogen/phosphate ratio intensity image was constructed using the peak 
heights at wavenumbers 1030/1080 cm-1 for each spectrum in the image. (*) shows the rough 
interface between the two cell lines where 2247R was cultured on the upper right hand side, 
and 2245R towards the lower left hand side.  
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4.3.3│Assessment of RMieS-EMSC correction   
As mentioned previously, Resonant Mie scattering is inherent in all spectra from 
biological samples that are not comprised of a thin, homogenous film. Severity of 
the spectral perturbation can depend on the morphology of the ‘scattering object’ 
[12]. The impact of morphology in relation to RMieS has been highlighted by the 
two preparation methods. Mid-infrared radiation has a wavelength range of 2.5-14 
m and therefore samples exhibiting components closer to this range will suffer 
from severe distortion [14] and scattering from the edges of cells may also make a 
significant contribution [14]. 
 
The effect of RMieS is apparent in the spectral datasets for the methods II and III, 
which included single point cell monolayer spectra and spectra of single cells. As 
the cell lines used for the two methods were identical, the only difference was in 
morphology due to sample preparation (i.e. cells were cultured onto a surface in 
method II and cells were detached and spun onto the surface in method III). It was 
therefore been shown that samples of different morphology will have a different 
RMieS profile. 
 
The adherent cells, cultured onto the substrate were able to extend across the 2D 
substrate surface, appearing significantly larger and more uniform in thickness and 
therefore displayed less obvious baseline distortions as observed in the 
corresponding raw spectra in Figure 4.10a.  In contrast the single cells, which were 
lifted off the surface of the tissue culture plastic and cytospun onto substrates were 
typically more spherical and smaller in size (approximately 14 m in diameter) and 
their spectra displayed severe distortions (Fig. 4.10c). Using the EMSC-RMieS 
algorithm the raw absorbance spectra were subjected to 150 iterations of the 
RMieS-EMSC algorithm and the results can be seen in Figures 4.10b and 4.10d 
illustrating the extent of correction to the distorted baseline. As it is difficult to 
suggest how many iterations of the algorithm to use, the general rule of thumb was 
used that the number of iterations increased until the using RMieS scattering 
distortions were no longer apparent.  
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Figure 4.10│The raw and RMieS-EMSC corrected spectra for the cell monolayers (a, b) and 
for the single cell spectra respectively (c, d). Sample spectra were colour coded as 2245R 
(black), 2246R (blue) and 2247R (red). 
 
4.3.4│Principal component analysis  
The PCA results for the FTIR spectral datasets before and after EMSC-RMieS 
correction are shown in terms of their clustering, relative to the FTIR-Photoacoustic 
result in Figure 4.11.  
 
It is apparent that cell line 2247R does display cluster separation, with respect to the 
two other cell lines in the uncorrected score plots (Fig. 4.11a, c). It is probable, 
however, that the different RMieS scattering profile of each cell line had a degree of 
influence in the cluster separation. The uncorrected score plots from the raw spectra 
illustrate that simply ignoring the issue of RMieS can potentially lead to misleading 
result conclusions.  
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Cell classification was desired in terms of the global chemistry differences within 
each cell type, rather than physical effects, such as different RMieS scattering 
profiles due to cell morphology. Figures 4.11b and 4.11d display the PCA score 
plots for data that has undergone RMieS-EMSC correction for the monolayer and 
single cell spectra respectively. The cell line clusters are more distinguishable and 
show a better relation to the PCA score plot from the FTIR-PAS data that did not 
require RMieS correction.  
 
Cell line 2247R aside, the SR-FTIR single cell data (Fig 4.11d) displayed better 
discrimination of cell lines 2245R and 2246R in contrast to the monolayer datasets. 
This may reflect increased technique sensitivity in terms of cell classification and 
may be due to the specific targeting of cells during data collection, whereby the 
aperture is adjusted to capture the dimensions of the single cell itself. In contrast, 
the monolayer technique captures a broader range of cells, and possibly sections of 
surrounding protein secretions and blank substrate sections, which will also 
contribute to the averaged single point spectrum, possibly ‘diluting’ the cellular 
signal. 
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Figure 4.11│ The PCA score plots of raw data and  RMieS corrected data for method II FTIR 
monolayer spectra (a, b) respectively; method III SR-FTIR single cell spectra (c, d); method II 
FTIR-PAS monolayer spectra (e)
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The single cell spectra are most difficult to interpret as they include intra-cell type 
variation; each measured cell may be slightly different due to biochemistry 
associated with cell phase or viability and have complex mean derivative profiles 
(Fig 4.12c) and this is reflected in the corresponding loading plot (Fig. 4.12d). 
 
Analysis of the PCA loading plots generally suggest strong variance in the amide I 
region of the different cell spectra. This amide I variation is clearest both in the 
loading plot for the FTIR monolayer data (Fig. 4.12b), the dataset benefiting from 
the greatest signal to noise in the second derivative form (Fig 4.12a).  
 
The fact that the 2245/6R spectral cluster lies in negative PC2 space whilst the 
2247R cell spectral cluster in positive space of PC2 (Fig. 4.11b), suggests that these 
two groups are anti-correlated and that 2247 will be different in amide I 
composition, relative to cell lines 2245/6R which appear relatively similar. Due to 
the differences in these PCA loading plots, subsequent analysis focused on the 
protein compositions of the cell lines.   
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Figure 4.12│The mean 2nd derivative spectra of the cell lines and the resulting PCA loading 
plots for method II FTIR monolayer spectra (a, b) respectively; method III SR-FTIR single 
cell spectra (c, d); method II FTIR-PAS monolayer spectra (e, f)
2nd Derivative             PC Loading 
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4.3.5 │Estimation of protein secondary structure 
Protein secondary structure was analysed using the mean spectrum for each cell line 
from the Method II, the FTIR monolayer dataset. Deconvolution and curve fitting 
techniques were employed to maximize the amount of information retrieved from 
the complex amide I region. Voigt curve-fitting of the amide I band was used to 
give the best estimation of protein secondary structure, as the fractional areas of the 
fitted component bands are directly proportional to the relative quantity of structure 
they represent. The band centres were approximated to the frequencies observed in 
the deconvoluted spectra. The fitted curves were checked by second derivative 
analysis, whereby underlying peaks and shoulders should be resolved at the 
locations of negative peak minima in the derivative. Band widths and heights were 
allowed to attain best fit values by iteration (the resulting composite spectrum) (Fig. 
4.13). The bands were fitted iteratively and a composite spectrum was created so 
that closely matched the FSD spectrum. Tentative band assignments were made in 
reference to bands characterised in isolated proteins [20]. 
 
 
 
 
The results (Table 4.1, Appendix) estimated a higher occurrence of -helical 
contributions in the 2247R cell line compared to cells lines 2245/6R, which were by 
contrast richer in -structure.  
 
Figure 4.13│The amide I secondary structure curves displaying alpha and beta components 
matched to the superimposed 2nd derivative spectrum at 2.0 units. In determination of the overall 
 ratio, the fitted curve associated with turns and bends ~1690 cm-1 (in grey) was not considered. 
For each cell type, the fitted composite spectrum (crosses) closely matched that of the original 
deconvoluted spectrum (solid line).


  


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Analysis of protein secondary structure by means of Fourier self-deconvolution and 
curve fitting is only an estimate in samples of such complex biochemistry. The 
assignment of protein secondary structure is not straightforward process and can 
only be applied as a general rule, based on model calculations and previous findings 
from known proteins. Model calculations on the amide I bands of globular proteins 
have demonstrated that the spectral contributions of structural elements other than 
alpha and beta components, such as random coils turns and bends are spread over a 
wide wavenumber region.   
 
A number of experimental issues are presented by use of band-narrowing and 
curve-fitting procedures. Secondary structure prediction accuracy can vary based on 
the band narrowing parameters used [21]. In both FSD and 2nd derivative 
techniques, noise is amplified and noise can be mis-interpreted as a real band [22]. 
A low enhancement factor in the FSD and low sensitivity in the subsequent curve 
fitting parameters were used to avoid this issue.  
 
In order to demonstrate the difference with high sensitivity curve-fitting, the results 
were re-processed, resulting in an increased number of fitted-bands (Fig. 4.14). This 
is a more in-depth estimation of the nature of the protein secondary structure and 
these bands do have references for not only alpha helices and beta sheets, but also 
for random coil, and turns and bends. When analysed in terms of percentage 
expression (Fig. 4.15), the results were in agreement with the initial curve fitting 
using the low sensitivity parameters. The major caveat, however, is that the 
references for these bands are derived from pure protein samples. In an infrared 
spectrum of a complex biological cell, there will be underlying bands from 
macromolecules other than protein signals that are present in the same region. This 
makes any estimation of protein secondary structure difficult to substantiate.    
  
 
116
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14│The repeated amide I secondary structure curves fitted with a higher sensitivity. For 
each cell type, the fitted composite spectrum closely matched that of the original deconvoluted 
spectrum, however in this instance there are more fitted bands. These bands do correlate with the 
spectral wavenumber positions of known alpha helix, beta sheet, random coil, turns and bends, 
however the reference material for these positions is comprised of protein alone [20].  
Figure 4.15│ High sensitivity-fitted bands were analysed as a percentage of -helix, -structure, 
turns and bends, estimated by addition of the areas of all the component bands assigned to each of 
the structures and then expressing the sum as a fraction of the total amide I area. Increased 
expression of -helix structure in cell line 2247R agreed with the first instance curve fitting with 
low sensitivity (Fig. 4.14). 
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Protein analysis by FTIR does give the advantage that whole cells can be probed 
with very little sample preparation and with little disruption to the cell-
biochemistry. It was noted, however, that underlying contributions from other 
biochemical molecules, such as nucleic acids can display absorbance peaks within 
the amide I wavenumber region [1]. It was recognised, therefore, that the analysis of 
protein secondary structure by this process is not ideal.  
 
It was therefore important to investigate the cell line protein difference by other 
means in order to validate such a result. This led to further investigation by means 
of liquid chromatography mass spectrometry and Western blot.  
 
4.3.6 │Proteomic data analysis 
The MS dataset of 58225 features, comprised of both identified peptides and non-
identified molecular entities.  A list of these features was generated in Progenesis 
with information regarding mass to charge (m/z), retention time (min) the retention 
time window (min), charge, significance (anova P value) and maximum fold 
change, the later describing the difference in feature abundance across all cell types. 
For example, if the abundance level of feature X was (20, 20, 40) in 2245R, 2246R 
and 2247R respectively, the fold change would be (1, 1, 2).  
 
The normalized relative abundance for all feature data and each individual injection 
was subjected to PCA for visual protein discrimination between the cell lines. A 
duplicate lysate of one cell line (2245R) was prepared to demonstrate sample 
preparation and MS instrumentation robustness (Fig 4.16).  In a similar stance to the 
FTIR data, 2247R was in contrast from cell lines 2245/6R in terms of feature 
abundance. 
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The normalised injection replicates of MS peptide feature abundance were averaged 
for each cell line and mean centred (Fig. 4.17). The data was analysed separately for 
each cell line for features that were 2.5×106 more/less abundant than the group 
mean. The reasoning behind this chosen threshold was to select for a snapshot of 
features that were most different from mean abundance and therefore most 
discriminatory. These features were matched to peptide sequence and then 
correlated to a protein from the feature data list (Table 4.2, Ch.9, Appendix).  
 
 
Figure 4.16 │ The PCA score plot of peptide feature abundance. Every data point represents a 
single LCMS injection for 2245R (black circle); 2246R (blue triangle) and 2247R (red down-
triangle). A technical lysate replicate was made for cell line 2245R (white circle) showing good 
methodological consistency by grouping with its 2245R counterpart cluster. Cell line 2247R 
protein lysate injections are notably anti-correlated with the other two cell lines in PC1.  
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Figure 4.17│ Analysis of peptide feature abundance related to Figure 4.13. Each peptide 
feature was mean centred for 2245/6/7R (a, b, c respectively). As the dataset contained 
thousands of features, a set of 27 features which were furthest in distance from the mean 
were selected for closer evaluation.  
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The protein was cross-checked with the MSMS protein abundance fold change list 
and secondary structure contributions analysed (Table 4.3, Ch. 9, Appendix). 
 
To create the MSMS protein abundance list, a total of 2700 proteins were identified 
from MSMS sequencing data of 10,000 peptide features. Using p < 0.05, protein 
abundance fold change ×2 or greater, the list was filtered down to 1485 proteins.  
681 proteins in 2247R and 666 proteins in 2245/6R were higher in terms of mean 
protein abundance. 137 proteins were undefined using the strict selection rule that 
abundance of proteins in 2247R had to be lower or higher and not equal to the 
abundance in both 2245R and 2246R. This was to identify discriminatory proteins 
which may have caused the PCA profile of cell line 2247R to be distinctly different.  
 
Databases containing protein secondary structure information were used to 
determine the level of alpha/beta structure. For proteins yet to be structurally 
characterised, secondary structure was predicted (Table 4.3, Ch. 9, Appendix). A 
total of 4 methods of structural identification were used to predict secondary 
structure with descending levels of confidence whereby the next best possible 
method would be used if protein secondary structure information was not available 
for the primary method.  
 
The ‘Primary’ method with highest level of confidence information from protein 
structures found in the DSSP is derived directly from the Protein Data Bank (PDB). 
This data makes the assumption that the protein IMDH2_HUMAN for example will 
be homologous to IMDH2_MOUSE, i.e. they share a common ancestor protein, and 
their structure will be constrained because their function will depend on their 
structure. Differences may have been introduced but in a sequence that does not 
affect structure. Therefore where structure of the human protein is not available, 
structure from other species were used.  
 
The ‘Secondary’ method used alternate identifiers which are results gained from a 
search using different identifiers of the same protein. The ‘Tertiary’ method uses 
available protein structure results from the Basic Local Alignment Search Tool 
(BLAST). BLAST searches find homologous proteins with more than 85% identity. 
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Finally the ‘Quaternary’ method uses results gained from trying to predict 
secondary structure 'de novo', i.e. predicted it from sequence alone. 
 
Differences in peptide feature abundance analysed in Figure 4.17 are summarised 
below (Fig. 4.18). There were 27 peptide features that were notably different in 
abundance from the group mean. The most discriminatory feature was detected at 
966.094 m/z (‘Feature 25’ in Fig. 4.17, 4.18). This feature was notably ‘up’ in 
2247R expression and considerably ‘down’ in both 2245 and 2246R. The best 
peptide match score was 87.07% and was correlated to the protein 
B2R5B3_HUMAN (Table 4.2, Appendix). A protein search in the MSMS ID list 
for 2247R (Previously defined as proteins with twice or more as abundant in 2247R 
than 2245/6R) equated to a histone H2A fragment, and similarly other features of 
notable abundance also highlighted a large difference in subunits H2A (Table 4.3, 
Appendix).  
Figure 4.18 | Summary of MS peptide abundance for selected features furthest from the 
group mean. Details of each feature is listed in Table 4.2 in the Appendix (Ch. 9). 
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4.3.7 │Proteomic validation by Western blot 
To confirm the validity of the label-free method of quantisation and subsequent 
protein identification, a Western blot confirmed protein identification of histone 
H2A and its levels of expression in the cell lysates following standard protocol. 
This was performed in triplicate for differing protein loading levels. Results 
confirmed histone H2A expression in cell line 2247R to be extensively greater (Fig. 
4.19).   
 
 
 
4.3.8 │Correlating FTIR and proteomic results   
For all associated proteins that were identified with secondary structure available, 
the mean alpha and beta components were ratioed (Table 4.4, Ch. 9, Appendix).  
 
The ratios of  contribution to overall secondary structure from the proteomic 
analysis were compared with the FTIR prediction (using the initial, low-sensitivity 
curve-fitting parameters). Both methodological approaches resulted in the same 
trend of estimated protein secondary structure contribution (Fig. 4.20). 
 
 
 
 
Figure 4.19 | Western Blot results: each cell line was loaded with (i) 27.2 g (ii) 13.7 g and (iii) 
6.7 g of protein. GADPH expression was used as a control to assess the consistency of the 
protein loading. Higher levels of histone H2A expression were observed for cell line 2247R.  
 
GAPDH 
Histone 
 i.  45R        46R        47R   │ii.  45R    46R     47R   │iii.  45R   46R    47R
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4.4│Conclusions and Future Prospects 
The main aims of the investigation were two-fold. The initial aim was to use FTIR 
spectroscopy as a tool to characterise cell lines, not by their physical scattering 
properties, but by true biochemical difference, an aim that was previously 
somewhat questionable. Secondly, it was important to link and validate conclusions 
from FTIR spectroscopy to other methods, to increase perspective.  
 
With the use of chemometrics, the RMieS-EMSC corrected FTIR data, global 
cellular chemistry of three renal carcinoma cell lines were focused down to a 
notable protein difference in cell line 2247R, indicating protein secondary structure 
differences. Estimation of these differences predicted a larger abundance of alpha 
helical arrangements in cell line 2247R and comparatively larger -structure in 
2245/6R.    
 
Using state of the art label free proteomics, whole cell lysates were analysed in a 
snapshot of most significant proteins were identified with protein secondary 
structure.  
Figure 4.20 | Comparing the  ratio results of general protein secondary structure for FTIR 
(left) and LCMS (right). 
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Despite both techniques using some degree of estimation, generally both 
approaches resulted in the same trend of alpha/beta ratio, estimated from protein 
secondary structure contributions. 
 
The field of cancer biomarker detection has been likened to ‘finding the needle in 
the haystack’ [23]. It is therefore important to use multiple viable methodologies to 
fully understand complex processes, and in the same instance self-validate findings.  
 
It is hoped that this investigation has helped to prove the legitimacy as FTIR 
spectroscopy as a tool that can be used to aid biomarker discovery in a clinical 
setting.  
 
For example, it has been noted in this study that the glycogen/phosphate ratio is a 
good discrimination marker for different cell lines. Further work on this ratio may 
include progression to primary cell lines, resected from patients to correlate the 
ratio with increasing malignancy grade in renal carcinoma.   
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Chapter 5 │ Discrimination of Renal Cancer cells 
Displaying Stem Cell Characteristics    
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5.1 │Introduction and Aims 
 
As previously discussed, there is a hypothesis that cells displaying cancer stem cell 
properties exist (Ch. 1.3.2). Adult stem cells and putative cancer stem cells are rare 
and due to the lack of specific stem cell markers, making isolating and subsequent 
characterisation of these cells challenging.  
 
One method to enrich for cells which possess many of the characteristics of stem 
cells [1-3] is the Hoechst 33342 dye efflux assay developed by Goodell et al. in the 
haematopoietic system  and has been adapted to solid tissue tumours and cell lines 
in the isolation of a ‘side population’ (SP).  
 
Uptake of the DNA-binding dye Hoechst 33342 is universal in a cell population, 
however, the ability to efflux the dye is restricted to a sub-population. The efflux 
process can be blocked with Verapamil, a calcium channel blocker which inhibits 
the ABCG2 transporter system. Without Verapamil, effluxing-able cells can pump 
out dye, reducing the fluorescent signal. The stem-like cells are called the ‘Side 
Population’ (SP) cells as they appear on the ‘side’ of the main cellular population in 
the FACS profile (Fig 5.1).  
Figure 5.1│ Hoechst 33342 profile of the 2245R renal clear-cell carcinoma epithelial cell line. A 
typical Hoechst 33343 red/blue profiles of 2245R cells stained with Hoechst 33342 prior to 
sorting on a FACS Vantage cell sorter. SP gate was defined using the SP inhibitor Verapamil.
The SP can be sub-sorted into proximal (PSP) and distal (DSP) side populations.  
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The SP itself is enriched for these stem-like cells, but is still heterogeneous. A 
further sub-fraction of cells with greater efflux-ability can be isolated. These appear 
further down the tail of the SP FACS profile. The ‘distal’ SP cells (DSP) are said to 
be more primitive, hence more closely resembling true stem cells [4]. 
 
Characterisation of the SP subpopulations is problematic enough due to the very 
low numbers of cells within each subpopulation, often below the level required for 
traditional cellular and ‘-omic’ techniques. Characterising these sub- side 
population cells is a further challenge, yielding even lower quantities. The use of 
SR-FTIR provided a way to analyse small numbers of single cells. The aim was to 
generate spectral chemical profiles of these small cellular sub-populations which 
could possibly provide more insight into the nature of these rare cells. 
 
5.2 │Experimental 
5.2.1 │FACS Sorting of cell populations  
The FACS sorting and isolation of the cell populations and sub-populations was 
kindly performed by M. Liew in the Genito-Urinary Research Group at the 
Paterson Institute of Cancer Research, University of Manchester.  
 
The 2245R renal carcinoma cell line was cultured in DMEM with FCS (10%) and 
L-glutamine (1 %) at 37˚C in a humidified atmosphere (5% CO2) until 80% 
confluent. Hoechst 33342 staining was conducted according to the method of Addla 
et al. [40]. Briefly, 1x106 2245R cells in 1 ml Hoechst buffer (Hank’s buffered salt 
solution, 10% FCS, 20 mM HEPES, and 1% D-glucose) were stained with 5 mM 
Hoechst 33342 for 90 min at 37°C with continuous agitation (5 Hz). Cells were 
washed and re-suspended in ice-cold Hoechst buffer prior to FACS analysis. 
Hoechst 33342 dye efflux SP was defined by 50 mM Verapamil hydrochloride 
blockade of Hoechst 33342 dye efflux. Hoechst 33342 staining was detected using a 
Becton Dickinson FACS Vantage SE flow cytometer (FACS), exciting at 357 nm 
and detecting Hoechst Blue with a 424/44 broad pass (BP) filter and Hoechst Red 
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with a 675/20 BP filter (Omega Optical, Brattleboro VT) SP, as well as distal- and 
proximal-SP, and non-SP cells were ‘sorted’ based on pre-defined profiles. 
 
5.2.2 │Sample preparation for spectroscopy 
Following cell sorting, the isolated cell populations were fixed in formalin (4 % in 
PBS). The cells were subsequently spun and re-suspended in 500 L of PBS. The 
cells were then mixed to form a homogeneous suspension and 150 L aliquots were 
used for deposition with a cell cytospinner onto CaF2 substrates, as described in Ch. 
2.4.4.2. The cells were initially spun at a gentle 400 g for 5 minutes, then 
additionally at 800 g for 5 minutes. The substrates were left overnight to dry before 
washing with distilled water to remove residual salt, originating from the PBS.  
 
5.2.3 │Data acquisition  
SR-FTIR transmission spectra were acquired on the SMIS beamline of the French 
Synchrotron Facility SOLEIL (Saint-Aubin, France) [5] using the instrumentation 
setup described in Ch. 2.4.5.2. Spectra were recorded at 4 cm-1 resolution with 256 
co-scans. A total of 25 spectra were recorded for each cell type.  
 
5.2.4 │Data analysis 
The raw spectra were corrected with an ATR Matrigel reference spectrum and 100 
iterations of the RMieS-EMSC algorithm [6-7]. The corrected spectra were 
transformed to the second derivative with 7 point Savitsky-Golay smoothing with a 
polynomial order of 3 in Omnic 7.2 (Thermo Electron Corporation).  
 
Analysis was performed on the second derivative corrected spectra with a range of 
1475-1000 cm-1 to achieve maximum chemometric separation between the Non-SP 
and the SP cells. The corrected spectra were then vector normalised and mean-
centred before principal component analysis (PCA), performed in Matlab (The 
Mathworks Inc.). PC-LDA models were generated using SPSS (SPSS Inc.).  
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5.3 │Results and Discussion  
5.3.1 │Sample assessment  
The Hoeschst dye efflux model was used to enrich populations of stem-like cells 
prior to further characterisation and analysis. The dye is known to be effluxed out of 
the cell after several hours or days. At the 1-2 hour time point, however, cells would 
still contain certain levels of dye allowing them to be sorted by their fluorescent 
signals.  
 
The FACS blot (Fig. 5.1) shows an SP ‘Tail’ containing cells with various 
concentrations of dye within. If Hoechst 33342 dye was no longer present their 
signal would fall within the bottom left hand corner of the plot of the cell FACS 
profile threshold and would not be collected for the study.  
 
The Hoechst 33342 red blue FACS profile generated by 2245R displayed a 
Verapamil sensitive SP containing up to 16% (average 6%) of the renal epithelial 
cells. This enabled the isolation of 3 subpopulations for analysis; the non-SP which 
contained differentiated cells and two SP sub-populations. The subpopulations were 
proximal side population (PSP), containing putative transit amplifying cells and the 
distal side population (DSP) which is thought to contain the most primitive (stem) 
cell types.  
 
 
 
 
 
 
 
 
 
Fig. 5.2│(a) Isolated FACS sorted cells, chemically fixed immediately after sorting for 
Synchrotron experiment, spun onto CaF2 slides (b) in vitro photomicrographs of NSP and (c) 
SP cells after 24 hours of cell culture post FACS sorting. 
  
 
133
Figure 5.2 compares centrifuge cytospun Non-SP cells onto CaF2 slides and 
photomicrographs of the cell types in vitro, after 24 hours of cell sorting. Cellular 
differentiation is illustrated by morphological changes that may occur if the cells are 
not fixed and instead cultured. The Non-SP cells (Fig. 5.2b) begin to extend their 
cytoplasmic boundaries, a characteristic morphology of the clear-cell renal 
carcinoma phenotype. The SP cells remain spherical in morphology more in 
keeping with a stem cell phenotype (Fig. 5.2c). 
 
The cells were chemically fixed in formalin (4%) immediately after FACS (Fig. 
5.2a) for the FTIR experiments. By doing so, the cellular content at the time of 
sorting was preserved and no further differentiation could occur before the spectral 
fingerprint acquisition.  The cells are analysed in a ‘snapshot’ of time, representing 
a controlled and fair comparison. All cell types analysed were typically of the same 
size and appeared spherical by plating the cells onto a CaF2 substrate at a 
predetermined force so that the cells remain intact whilst attaching to the substrate. 
  
5.3.2 │SR-FTIR assessment  
It is also understood that even small differences in cell size may dominate 
chemometric discrimination, as different sizes of cells would correspond to 
different resonant Mie scattering profiles which would be detected in chemometric 
discrimination. This concern, however, was reduced with use of the RMieS-EMSC 
correction algorithm [6-7].  
 
Figure 5.3 presents the mean infrared spectrum with standard deviation of each type 
of sorted cell. The non-side population displayed the greatest spectral variance, 
particularly in the 1250-1000 cm-1 region. This is understood to represent the 
heterogeneity of the non-side population, with single cells more likely than the SPs 
to be present at different stages of the cell cycle at the time of FACS sorting.  
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5.3.3 │PCA of the total dataset  
Changes in cell cycle phase can influence the overall chemical signature of the 
individual cell [8-10]. This is also apparent in the PCA score plot of the total dataset 
(Fig. 5.4a) where the non-SP cell spectra are more dispersed than the side 
population cells of DSP, PSP and SP. PCA separations of different cell lines is more 
straightforward than discriminating differences in a single cell line as there is partial 
overlap between the non-SP and SP spectra, as would be expected. 
 
It is apparent, however, that there is some degree of separation between non-SP and 
SP spectra in PC3. The SP contained a mixture of DSP and PSP cells and therefore 
it was expected that the SP cluster would fall on the same trajectory as the DSP and 
PSP spectra. The associated loading plot for PC3 is displayed in Fig. 5.4b.  
 
As second derivative peak minima are directly aligned to the centre of the 
absorbance peak of the original spectra, the loadings can be interpreted as biological 
references. There are many features that contribute to the differences between the 
non and side-populations. 
Fig. 5.3│ SR-FTIR mean fingerprint spectra +/- standard deviation from single cells of  (a) 
non-side population  (b) side population, (c) sub-side population; proximal, (d) sub-side 
population; distal. For multivariate analysis the range was reduced to 1475-1000 cm-1 and the 
spectra transformed to the second derivative.    
  
 
135
 
 
 
These include: δas(CH2) scissoring vibration of lipids at ~1468 cm-1; sC=O (of 
COO-) at ~1400 cm-1;  δs(CH3) at ~1380 cm-1;  asP=O (of PO2-) of phosphodiester 
group of phospholipids, phosphorylated proteins and nucleic acids (arising from the 
phosphate sugar backbone of DNA and RNA) at ~1237 cm-1;  Amide III band 
protein components at ~1240-1310 cm-1, as(CO-O-C) ring vibrations of 
carbohydrates at ~1180 cm-1;  sP=O (of PO2- ) of phosphodiesters at ~1080 cm-1  , 
s(CO-O-C) of carbohydrates at ~1050 cm-1 and s(C-O) of carbohydrates at ~1030 
cm-1. 
 
For clarity, principal component analysis was repeated for the three specific cell 
types in the dataset, namely, DSP, PSP and Non-SP. Fig. 5A illustrates the resulting 
PC score and plot for PCs 1, 2 and 3, and the loading plot of PC1 corresponding to 
the discrimination of the Non-SP from the SP spectra (Fig 5.5b).  
 
The lipid signals, mentioned in the previous PC analysis, dominate the loadings plot 
of PC1. However, differences in the phosphodiester stretching absorptions also 
remain apparent in the loadings of PC2, along with carbohydrate vibrations (Fig. 
5.5c).  
 
Fig.5. 4│Total dataset analysis (a) PCA plot of PC2, PC3 and PC4 (b) The loadings of PC3. 
Discrimination of the Non-SP cells can be seen through principal component 3.   
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Gault et al. looked into the effect of the Hoechst 33342 dye on cell FTIR spectra as 
a negative control when investigating alpha particle cellular irradiation. They found 
that Hoechst 33342 treatment of cells did not damage DNA.  
 
They also found the binding of Hoechst 33342 did not induce intensity or band shift 
changes in the IR regions characteristic of proteins and lipids and there was only a 
subtle change in DNA conformation. (There was a 4 cm-1 shift in asP=O (of PO2-) 
centred at 1238 cm-1  to 1242 cm-1 however the sP=O (of PO2-) centred at 1086 cm-
1 remained unchanged) . 
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Fig. 5.5│PC analysis of the sub-side populations DSP and PSP versus non-SP cell spectra (a) 
the score plot of PC1, PC2 and PC3 (b) The corresponding loadings of PC1 and (c) PC2. Key 
biochemical differences are outlined in lipid, phosphodiester and carbohydrate absorption 
bands 
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5.3.4 │Qualitative spectral analysis  
As a comparison, the mean second derivative spectra for Non-SP, PSP and DSP 
were qualitatively assessed (Fig. 5.6). There is however, always a danger when 
comparing averaged spectra for a cell type, particularly if one population is more 
heterogeneous, and the sample population is small. This approach was therefore 
more subjective than analysing PCA loadings which take account all individual cell 
spectra. 
 
The assignments [11] of notable differences in the second derivative spectra were; 
(1) δas(CH2)  shift from 1464 to 1468 cm-1  between DSP to NSP and an increase 
peak height; (2) Increased peak height for DSP/PSP at 1452 cm-1 (C-H bending); 
(3) Increase in peak height for PSP at 1414 cm-1; (4) δs(CH3) shift from 1384 cm-1  
to 1387 cm-1  between DSP to NSP; (5) DSP is shifted to 1365 cm-1 relative to 
PSP/NSP at 1367 cm-1; (6, 7) Notable absorption bands at 1341 cm-1 and 1331 cm-1 
for NSP; (8) Prominent band in PSP/NSP at 1308 cm-1; (9) Carbohydrate marker at 
1255 cm-1 for DSP/PSP, increasing in peak height and shift to 1258 cm-1 in NSP; 
(10) Increased peak height of asP=O (of PO2-) at 1236 cm-1 in DSP relative to  
PSP/NSP at 1234 cm-1; (11) Band at 1169 cm-1 shifting to 1173 from DSP to NSP, 
band most prominent in PSP; (12)Possible RNA band at 1115 cm-1 shifting to 1119 
cm-1 from DSP to NSP; (13) sP=O (of PO2-) AT 1085 cm-1 in DSP/PSP shifted to 
Fig. 5.6 │ Qualitative evaluation of the mean second derivative spectrum for DSP, PSP and 
Non-SP. Differences in spectral shifts are minimal whereas absorbance differences are most 
distinctive.   
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1087 cm-1 in NSP; (14) Glycogen band at 1030 cm-1 for DSP/PSP shifted to 1026 
cm-1 with an increase in peak height for DSP.  
 
In the assessment into the effect of Hoechst 33342 on the cell spectra, Gault et al. 
observed a small shift of 4 cm-1 in the anti-symmetric asP=O phosphodiester  band 
in mean spectra between stained and unstained cells. For the same band in the 
experimental renal data, there was no shift greater than 2 cm-1 between the all cell 
types.  
 
The DSP has a larger asP=O peak height relative to the PSP/Non-SP. Gault et al. 
also observed that the sP=O at 1086 cm-1 remained unchanged [12].  
 
In the renal data of this experiment, a 2 cm-1 shift and an increased absorbance for 
NSP was found relative to the SP subtypes, whereas Gault et al. found no striking 
changes in the lipid and protein signals between stained and unstained cells [12]. In 
the renal data analysis the differences in lipid signals studied in the wavenumber 
range appeared to significantly contribute to chemometric separation. 
 
5.3.5 │Linear discriminant analysis 
To confirm the residing differences between the three cell types, principal 
component–linear discriminant analysis was performed (PC-LDA). LDA optimises 
inter-group separation whilst minimises intra-group separation [13]. Cross-
validation was performed as is highly recommended when classifying a limited-size 
dataset. The model was validated by using a training data set where the algorithm is 
supervised with a priori knowledge of each data type, followed by the use of a test 
data set, introduced to the model as an independent validation.  
 
As it is common practice to input into the model data of reduced dimensionality the 
principal components from PCA were invoked. Reduced data is used to overcome 
issues of over-fitting whereby good classification but poor significance can result. It 
is reported that over-fitting can be seen when using ‘(n-g)/3’components or more, 
where g is the number of groups and n is the total number of data points [14].  
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For the LDA classifier variables, the principal components were calculated in PCA 
for the DSP, PSP and Non-SP dataset (g = 3, n = 75). A total 8 principal 
components were used, a number securely far from the over-fitting threshold (24 
PCs using the equation ‘(n-g)/3’). 8 PCs accounted for 71 % of the total variance. It 
is generally recommended not to use PCs that explain 100 % of variance as this will 
introduce PCs calculated on noise and will cause over-fitting of the LDA data. A 
training set comprising randomly selected data points from the total data set was 
constructed. 15 spectra per cell type were used for the training set (60 %).   
 
Figure 5.7a displays the PC-LDA plot for the training set consisting of 45 spectra in 
total. Relative to the original PCA, the clustering and separation between cell types 
has greatly improved. Results show that the non side population cells are clearly 
differentiated from the side population cell types in discriminant function 1 (DF1). 
The proximal ‘PSP’ cells clustered relatively closer to the non-SP population than 
the distal DSP cells. This is accountable to the fact that the PSP cells share more 
chemical similarities to the Non-SP than the DSP cells share; the PSP cells are on 
the frontier of the SP cell gate in the FACS profile.  
 
The DSP however are most different, separating from the non-SP in DF1 and even 
the PSP in DF2. It has been shown previously that the renal SP from human primary 
cells is a heterogeneous population [15] and that it is possible to sub-fractionate the 
populations based on the dye efflux status of the cells to generate sub-populations 
which are increasingly primitive. The results seem to confirm the existence of 
chemical difference within these sub-populations which can be used to further 
characterise or be utilised as a spectroscopic markers for these cells. 
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In terms of model classification 93.3 % of training spectra correctly classified. Of 
the total dataset only a 3 spectra were misclassified. 6.7 % of DSP and 13.3 % of 
Non-SP were misclassified as PSP.   In cross-validation using the ‘leave-one-out’ 
method, 84.4 % of spectra correctly classified. 13.3 % of DSP and 20 % of Non-SP 
were misclassified as PSP. 13.3 % of PSP were misclassified as DSP.  
 
Figures 5.7b, c and d display the same PC-LDA plot but also include the 
independent validation DSP, PSP and Non-SP datasets respectively. 10 spectra per 
cell type were used to test the algorithm. The correct classification scores of the 
independent validation DSP, PSP and Non-SP dataset are 80 %, 90 % and 100 % 
respectively. In general, the resulting plots and relative scores of each independent 
validation set reveal that the spectra have been correctly assigned. The similarity in 
the phenotype of the sub-side populations is a probable explanation where a small 
percentage of data points have been misclassified.  
Fig. 5. 7│PC-LDA of DSP and PSP versus Non-SP spectra (a) The training set, n=45 (b) DSP test 
set (c) Non-SP test set (d) PSP test set 
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5.3.6 │Further assessment of the distal side population  
PC analysis was performed using only the DSP versus the Non-SP to get a clearer 
picture of the distinction of the non-side population and stem-like cells relative to 
the most separable sub-side population. The DSP are the greatest distance away 
from the non-side population in the Hoechst FACS profile. The chemistry of the 
DSP should be the most distinctive due to the more primitive nature of the cells.  
 
The PCA score plot (Fig. 5.8a) of PC1 versus PC2 accounts for 40 % of total 
variance. The distal side population clearly tightly clusters separately from the non-
side population. The clustering of the DSP suggests that the cells within the DSP 
are more chemically and spectrally homogeneous than the non-SP which appears to 
form two clusters, separated in PC2.  
 
The non-SP variability may be due to actively proliferating cells at various stages of 
differentiation within the overall non-SP population. In contrast the DSP is much 
more likely to be quiescent and more clonal in nature leading to a more uniform 
spectral profile, as it is hypothesised to contain the most primitive stem like cells. 
The noteworthy differences between the distal and non-side populations are shown 
in the PC1 loading plot (Fig. 5.8b).  
 
There are significant phosphodiester and carbohydrate signals but these are 
secondary to the biochemical lipids signatures that dominate the loading plot at 
δas(CH2) ~1468 cm-1 and  δs(CH3) at ~1380 cm-1. 
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Carbohydrate bands are highly loaded in PC2 where the Non-SP separate into two 
clusters. Coupled with the symmetric and anti-symmetric phosphodiester stretching 
bands this suggests differences in metabolic activity, possibly due to cell cycle 
effects. The glycogen: phosphate ratio at 1030/1080 cm-1, a known marker of 
Fig. 5.8 │DSP versus Non-SPs (a) The PCA plot of PC1 and PC2. PC1 separates the DSP and 
NSP populations, whereas PC2 shows clustering in the NSP, indicative of heterogeneity in the 
population (b) the corresponding loadings for PC1 and PC2. 
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metabolic activity [16]. This is thought to correspond to increased metabolic 
activity, as glycogen stores are broken down at a greater rate. The PC2 loading plot 
displays the re-occurring symmetric and anti-symmetric phosphodiester band 
features also seen in Fig. 4b and Fig 5c.  
 
For a final evaluation, the differences in cell chemistry between the DSP and PSP 
cells were analysed (Fig 5.9). Clear separation can be seen between the cell types in 
PC1 shown in the score plot. In the comparison of DSP and non-SP spectra, the 
main differences were highlighted by lipid chemistry. Also highlighted are the 
phosphodiester stretching bands as a significant discriminatory feature.  
 
 
 
A possible explanation as to why the asP=O (of PO2-) is most apparent in this 
comparison is that the DSP and PSP cells have greater similarity in terms of their 
proliferative and morphological phenotype. When possible differences due to cell 
cycle or overall cellular heterogeneity are removed, it is apparent that the 
phosphodiester stretching bands may be a prominent marker in the distinction of 
these stem-like cells. Differences in the symmetric and asymmetric phosphodiester 
Fig. 5.9 │ The PCA score plot of distal (DSP) versus proximal (PSP) second derivative spectra. 
Sub-side population discrimination is shown in the first principal component (28.1%). The 
loading plot highlights the asP=O stretch a distinct marker, which has also been present in the 
previous loadings comparing NSP to the SPs.  
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stretching bands continually re-occur throughout the analysis and are always anti-
correlated in the loadings plots.  
 
This may be indicative of reported DNA conformational changes where the 
symmetric phosphodiester modifications ~1080 cm-1 were detected as a significant 
marker of putative stem cells in human intestinal crypts [17]. The symmetric and 
anti-symmetric phosphodiester stretching vibrations refer to the central phosphorous 
atom in a phosphodiester linkage (--O--PO2---O--), seen in DNA, RNA and some 
phospholipids. In DNA, the negatively charged phosphorous atom is countered by 
Na+ ions [18].  
 
A recent study [19] of other stem-like cell line populations supports this 
discriminatory band along with a carbohydrate marker at 1054 cm-1.  However,  
rather than looking for a univocal specific maker of stem-like cell discrimination, 
the authors propose using a change in a global absorption pattern as  a better 
approach, particularly monitoring the carbohydrate rich vibrations at 1000-1200 cm-
1, which they report to be a particular stem-cell like discriminator range. Yet 
spectral changes in carbohydrate bands may be more indicative of cell cycle effects. 
This would contribute greatly to chemometric discrimination and therefore it is 
important to bear this in mind when interpreting cell characterisation. The later 
research characterises the stem-like cells during a live cell suspension.  
 
Throughout the time of data acquisition there are a range of variables that may 
affect the absorption pattern of a single cell. For instance, cell viability may be 
reduced and dying cells have previously been reported to have different spectral 
features to viable cells [9]. The spectra may be recording the independent cellular 
response to the non-ideal conditions of their environment for the respective cell 
types. Also considerations would have to be taken into account for the cell 
suspension fluid and the contributions to the spectra. However, if these factors can 
be monitored and perhaps controlled, a live cell approach would be a very useful 
application when monitoring side population cells after subsequent passage, or their 
chemical response to anti-cancerous agents for instance.  
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PCA and LDA were used as part of a data-reduction analysis to elucidate chemical 
difference between the SP and Non-SP cell types. All chemometric analysis was 
performed on the second derivative corrected spectra with a range of 1475-1000 cm-
1 to achieve maximum separation between the Non-SP and the SP cells. The full 
fingerprint region including the amide I and II bands reduced the clarity of 
separation (Fig. 5.10). For example, use of the full fingerprint range 1800-1000 cm-1 
produced a poorer discrimination in PCA in scores for DSP/PSP versus NSP (Fig. 
5.4). The percentages explained by PC1, PC2 and PC3 were 19.8, 13.6 and 11.2% 
respectively for range (44.6% of total variance explained in 3 PCs). If the full 
fingerprint range was used, the values decreased. (15.1%, 10.9% and 9.9% 
respectively, 35.9% in total).  
 
Figure 5.10a is the score plot for PC1 versus PC2 for the full fingerprint range 
where PC1 displays no separation of the different subtypes. In the loadings plot the 
cause of the spread of scores is predominantly due to the amide region (Fig. 5.10b). 
PC2 (Fig. 5.10c, d) displays some separation and the PC2 loadings show distinct 
phosphate and lipid signals are present, along with the amide I and II which still 
appear to worsen the separation (relative to omitting the amide region). In PC3 (Fig. 
5.10e) again there is no separation between the SP and the Non-SP sub types, 
however the Non-SP clusters into two groups. In the PC3 loadings it is the amide I 
and II regions are again largely contributing, along with the carbohydrate 
absorptions, as noted in the comparison of DSP and Non-SP (Fig. 5.8).   
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5.4│Conclusions and future prospects 
It has been successfully demonstrated that it is possible to isolate a side population 
from a human renal cancer cell line as well as from solid tissue. However these 
‘side population’ cells only account for a small proportion of the total cell 
population (typically <5%), creating difficulties for analysis, which increases with 
Fig. 5.10 │The PCA analysis of extended spectral range (1800-1000 cm-1) resulted in poorer 
cell type separation of distal (DSP) versus proximal (PSP) and Non-SP cells using second 
derivative spectra;  (a) score plot of PC1/PC2 and (c) PC2/PC3 and corresponding loading 
plots of (b) PC1 (d) PC2 and (e) PC3.  Prevalent phosphodiester and lipid peaks evaluated 
previously are apparent in PC2 whereas PC1 and PC3 denote intra-cellular heterogeneity 
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the further sub-fractionation required for increasing primitive cell isolation.  It is 
therefore difficult to characterise cell populations of this type by conventional 
biological methods. 
 
High brilliance synchrotron FTIR- spectroscopy made it possible to record the 
spectral fingerprint of these different cell types after FACS. PC and PC-LDA 
analysis confirmed the biochemical differences of these cell types, providing further 
support that the side population contains a different subpopulation of cells and that 
this side population can be further sub-fractionated to give distinct populations 
based on their cellular biochemistry.  
 
Interpreting the cause of discrimination of the cell types revealed variances within 
lipid and phosphodiester signals, whereas carbohydrate and protein signals in the 
loadings plots suggested heterogeneity within the non-SP cells.  
 
It is perhaps the phosphodiester signals that were most revealing, as they may 
represent conformational changes in the DNA/RNA, as well as some phospholipids.  
These are indicated in the loadings plots in Figures 4b, 5c, 8c and most prominently 
in 9b. The anti-symmetric phosphodiester vibrations at ~1237 cm-1 are partially 
overlapped by complex amide III vibrations, whilst the symmetric phosphodiester 
vibration at ~1080 cm-1 can be masked by carbohydrate vibrations. However, with 
the use of the second derivative combined with chemometric data reduction 
techniques, the phosphodiester bands are distinguishable and seem to be a 
significant cause of variance in the biochemical fingerprints of these side population 
cells relative to the general cell population.  
 
Another key factor of cellular distinction in the loadings (Fig. 5.4b 5.5b, 5.8b, 5.9b, 
5.10d) and in the qualitative mean spectral analysis (Fig. 5.6) were shifts and a 
higher absorbance for Non-SP in δs(CH3) and δas(CH2) and a higher absorbance in 
for DSP/PSP at 1452 cm-1 (C-H bending).   
 
At this point, the impact of the differential chemistry results surrounding the SP 
cells can only be speculated. The concluding analysis suggests possible DNA and 
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lipid differences. There may be a link between these features and it is known that 
DNA and phospholipids share a common motif recognizable by proteins [20]. Also, 
it is generally accepted that lipids play both functional and structural roles in the 
nucleus as well as in the plasma membrane and that lipid metabolism in the nucleus 
may be regulated separately from that of the plasma membrane [21]. Perhaps this is 
a possible route of further investigation into DSP evaluation.  
 
In conclusion this novel approach offers considerable potential as a tool to 
distinguish small cell numbers associated with potential cancer stem cells and the 
SP phenotype and may be of particular use in facilitating the understanding of 
cancer stem cell biology.    
 
Finally, it is possible after FACS to obtain live cells which have shown limited cell 
culture of the side population phenotype. Further studies could involve time-course 
experiments, monitoring the rate of differentiation. These cells are also under 
investigation with chemotherapeutic agents and perhaps FTIR spectroscopy could 
shed some light on the responses of these cells to such toxins.  
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Chapter 6 │ Investigating Cellular Response to 
Chemotherapeutics 
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6.1 │ Introduction and Aims 
In the previous chapters, spectral analysis focused on cell characterisation. 
Discriminating the FTIR signatures of different cell lines can be relatively 
straightforward. Comparing differences in cells from the same population, however, 
can be more challenging, as described in Chapter 5.    
 
Cells are said to have specific infrared signatures in terms of cell cycle, viability, 
apoptosis and stress [1-7]. If a chemical spectroscopic signature, unique to a 
particular mode of drug action, was discovered it would be very beneficial in the 
early stages of the drug development process as novel chemotherapeutic agents with 
potential regularly fail during their progression to clinical trial testing. Currently, 
high throughput procedures used in the development of a novel compounds include 
cytotoxicity multi-cell line panel testing and the assessment of agent interaction and 
involvement in parts of numerous biological pathways [8].  
 
Implementing FTIR spectroscopy as a tool in this area would only be appropriate 
for the assessment of global changes in cellular chemistry. Attempting to 
understand the interaction drug activity upon cellular processes is a complex area. 
Despite this fact, there are a number of key questions that may be answered:- 
 
 Is it possible that cellular responses to drugs can be detected in an infrared 
spectral fingerprint and is there a biomarker to monitor this? 
 Is it possible to discriminate between cells that have been treated with 
different drugs that act through different mechanisms / or have different 
modes of action? 
 Is it possible to detect cellular response to drugs in the infrared that is not 
apparent early on by conventional testing? 
 Is it possible to deduce common biomarkers to show cellular response that 
may help to predict drug efficacy?  
 
The cell line model comprised of an established renal carcinoma cell line, CAKI-2, 
dosed with a drug of known mode of action as well as a set of novel gold-based 
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compounds with unknown efficacy. The novel compounds studies were gold 
analogues, KF0101, KF0113 and KF0501, (which will be referred to as KF1, KF13 
and KF5 respectively). 
 
As discussed in Chapter 1, the study of multidrug resistance (MDR) in tumour cell 
lines has led to the discovery of the plasma membrane P-glycoprotein (P-gp) 
molecule. The protein functions as an efflux pump to remove foreign compounds 
such as drugs. P-gp-mediated MDR tumour cells have been found in human cancers 
and are highly likely be a determining factor in negative response to treatments in 
patients [9].  
 
Anti-tumour agents from the platinum family such as cisplatin and carboplatin have 
been widely used in clinical therapy. They have DNA cross-linking activity, 
inhibiting further replication or transcription to inhibit tumour proliferation and 
have received special interest due to their different kinetics and geometries. 
Synergistic treatments can enhance apoptosis, such as combinations of Cisplatin 
with Lexatumumab, a human agonistic antibody that targets a tumour necrosis 
factor [10].  
 
Cisplatin treatment alone, however, performs poorly in RCC due to resistance. 
Altered DNA process and changes involving glutathione and metallothioneins are 
some examples where resistance has developed. This has prompted a recent surge in 
new non platinum drugs and old species have received much attention due to their 
strong tumour cell growth inhibiting effects [11]. The mechanism of action of anti-
proliferative gold complexes is still speculative and due to a vast library of gold 
species with different oxidation states and ligands it is unlikely for there to be a 
unique mode of action to account for them all.    
 
The novel gold compounds of the KF series comprise of two covalently bound 
Au(I) atoms within an aromatic ring with triphenylphosphine ligands. They exhibit 
a high potency in cell toxicity studies and DNA cross-linking assays that indicate 
these compounds should show efficacy in the treatment of carcinomas [12]. It is 
supposed that the highly stable gold(I)-carbon covalent bonds, due to the similar 
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electronegativity of Au(I) and carbon, facilitate the DNA cross linking. This 
increased facilitation may improve activity of these novel compounds in cell lines 
that are perhaps platinum resistant [12].  
 
The use of FTIR as a tool for analysing drug response in cells is relatively new, 
although there are already a number of studies that have investigated this which 
have shown promise [13-15]. In the following experiment, complimentary 
techniques such as proliferation and cytotoxicity assays were employed in parallel 
to infrared spectroscopy to corroborate any possible findings.  
 
6.2 │Experimental 
6.2.1 │Determination of inhibitory concentrations 
To deduce inhibitory concentrations (IC) for the drugs against the Caki-2 cell line, 
the widely used sulforhodamine B (SRB) cytotoxicity assay was implemented 
according to the Nature protocol [16] described in Ch. 24.6. The data was exported 
to Graphpad Prism where it was normalised and plotted in the classic sinusoidal 
logarithmic form to calculate the IC50 values for each agent (Fig. 6.1).  
 
6.2.2 │ Proliferation assay 
Caki-2 cells were added to well plates at a density of 1x105 cells/well and left to 
establish. 72 wells were setup to allow for triplicate measurements over a 6 day 
period. After 24 hours, agents KF1, KF13 KF5 and 5FU were introduced at the IC50 
level determined by a 3-Day SRB assay (3.51, 3.52, 5.32 and 2.39 M 
respectively). For each subsequent day (1–6 days after drug introduction) viable 
cells were identified using Trypan blue dye and then counted using a 
haemocytometer. 
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6.2.3 │ Spectral sample preparation 
The samples were prepared as described in the FTIR single-point spectroscopy 
protocol for sample preparation (Ch. 2.4.2.1). In brief, Caki-2 cells were added to 
well plates at a density of 1x105 cells/well and left to establish. After 24 hours 
agents KF0101, KF0113 and 5FU were introduced at the IC50 level, as determined 
by the SRB assay. At the appropriate time point the cell cultured slides were 
washed twice in PBS and fixed in formalin (4%) for 40 minutes. The slides were 
then dripped in distilled water to remove salt residues.  
 
6.2.4 │Data acquisition 
6.2.4.1 │ Single cell measurements  
SR-FTIR transflection spectra were acquired on the B22 beamline of the British 
Synchrotron Facility Diamond (Oxford) using a Bruker80 V spectrometer equipped 
with an MCT detector and coupled with a Hyperion 3000 microscope. Spectra were 
recorded at 4 cm-1 resolution with 256 co-scans and the size of the aperture was 
adjusted to match the diameter of the cell such that it was fully illuminated, 
typically 15m2. 
 
6.2.4.2 │ Monolayer measurements 
Imaging measurements were taken using a Varian 670-IR FTIR spectrometer as 
described in Ch. 2.4.5.3. Hyperspectral images of 700 x700 m were recorded using 
a spectral resolution of 4 cm-1 resolution with 128 co-scans.  
 
Single point measurements were acquired as described in Ch. 2.4.3.1 with 128 co-
scans using an aperture of 60 x 60 m.  
 
6.2.5 │Spectral pre-processing 
All datasets were subject to the RMieS-EMSC correction algorithm at 150 iterations 
for the SR-FTIR and single-point monolayer data and 80 iterations for the 
hyperspectral images. A Matrigel transflection spectrum was used as the reference.  
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The corrected spectra were transformed to the second derivative with 7 point 
Savitsky-Golay smoothing with a polynomial order of 3 in Matlab. Analysis was 
performed using the fingerprint range of 900-1825 cm-1. The corrected spectra were 
vector normalised and mean-centred before principal component analysis (PCA) 
and discriminant function analysis (PC-LDA) also in Matlab. 
 
6.3│Results and Discussion 
6.3.1 │Cell cytotoxicity  
Gold (I) complexes with labile ligands such as chlorine interact readily with DNA. 
Cisplatin for example, a drug with a cytostatic effect, is an effective TrxR inhibitor. 
However, complexes with tightly binding ligands such as Auranofin, will not bind 
to DNA [11].  
 
A gold compound with multiple phosphine ligands is [Au(dppe)2]+, a tetrahedral 
bi-chelated Au complex, has shown antitumor activity in vitro and in vivo and 
induced DNA protein cross linking and DNA strand breaks in cells[11] .  
 
A similar complex, [Au(dppp)(PPh3)-Cl] was tested at the N.C.I., U.S.A. 29 cell 
lines of a 60 cell line panel and shown to have  IC50 values in the lower M range 
where the cells displayed an apoptotic response with decreased expression of anti-
apoptotic proteins . Gold triphenylphoshine complexes have also shown to have 
IC50 values in the lower M range [17]. 
 
The KF series for the drugs tested displayed similar IC50 concentrations to the 
above compounds, with KF1, KF13 and KF5 values of [3.51 M], [3.52 M] and 
[5.32M] respectively. The KF5 curve, however, did not fit as accurately as the 
other analogues therefore the value obtained was not taken with confidence and 
more repetitions would be needed.  In contrast the IC50 value for 5FU was [2.39 
M], almost one and a half times less-concentrated than the KF series (Fig. 6.1).  
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5FU is typically dosed at 12 mg/(kg day) to cancer patients, giving a plasma 
concentration of [0.75 mM] [18]. It is difficult, however, to relate IC50 values 
obtained in vitro to human in vivo pharmacology. There are many factors that may 
explain why such a concentration is used in the human body including 
bioavailability and pharmacokinetics. The disposition of a pharmaceutical 
compound within an organism can be described by four principal criteria: 
absorption, distribution, metabolism and excretion of a drug (ADME) [19]. They 
influence the drug levels and kinetics of drug exposure to the human body and 
hence influence the performance and pharmacological activity of the compound as a 
drug. For example in drug discovery clinical trials, failures of drug progression are 
often down to clinical ADME. Adverse events or poor pharmacokinetics may be 
observed that are not predicted by animal studies. Drugs may also fail to 
demonstrate the efficacy expected from animal studies or results from early in vitro 
studies [20]. 
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6.3.2 │Single cell SR-FTIR analysis after 24 hours exposure to 
compounds  
6.3.2.1 │Principal component analysis (PCA) 
One of the aims of the study was to determine if there was an obvious, general 
global infrared maker distinguishing cell response to chemotherapeutic agents. 
Spectra of drug-treated cells after 24 hours of drug exposure were assessed against 
the (non-drug treated) control group (Fig. 6.2). There was little difference to be 
observed in the mean spectra for each cell type in general (Fig. 6.2a), although 
subtle differences in absorbance of peaks associated with  δas(CH)2 at  ~1480 cm-1, 
vas (PO)2  at  ~1240 cm-1 and vs (PO2) at 1080 cm-1 were noted for KF1 and KF13-
treated cells.   
Figure 6.1 │ Dose response curves to determine IC50 values for the Caki-2 cell line from 
the SRB assay data (repeated in triplicate). Graphs were created in Graphpad Prism 
using mean values ± standard error. 
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It was difficult to make any distinction between control cells and drug treated cells 
using principal component analysis (PCA) alone (Fig. 6.2b).  This may due to the 
intra-sample heterogeneity observed in the cell populations. Cells exhibit specific 
chemistry in a certain phase of the cell cycle and therefore it may difficult to see 
any chemistry purely associated with drug response.  Another complicating factor 
may be the influence of the agents on the cell cycle. It is known that 5FU does 
affect cell cycle in the S phase; however there is no information on whether the KF 
series will also have an influence.  
 
It is also this reason that analysing these variables by using mean spectra alone may 
be misleading. The mean spectra represent a small portion of a complete population 
Figure 6.2 │ (a) Mean spectra for drug treated cells versus control, (b) PCA score plots and (c) 
Eigenvalue scree plots for determining the number of PCs to use in LDA for (I) KF1, (II) KF13 
and (III) 5FU respectively   
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of cells studied. There may be bias as more spectra from cells in one phase in the 
cell cycle may have been sampled in one group more than group due to chance and 
may not be completely representative of the true cell population.  
 
6.3.2.2 │Principal component linear discriminant analysis (PC-LDA) 
In the previous chapter, PC-LDA was used to classify the cellular sub-types in a 
population.  SPSS software was used, enabling results to be cross-validated in terms 
of categorising cell spectra into distinct groups. A slightly different approach was 
used to assess cellular responses to chemotherapeutic agents. The use of IC50 
values, by their definition, will equate to half the population of cells being affected 
at that specific concentration. The implication for single cell analysis will mean that 
the agent may elicit a cellular response in a given period of time for some cells, but 
not others.  It was therefore unpractical to assume that the cell spectra would fall 
into rigid clusters and it was not the aim to categorise the spectra in such a way. 
Subsequent model testing by the input of ‘blind’ spectra as a means of cross-
validate to the robustness of such distinct classified cell spectra did not seem 
relevant to the samples in question.  
 
PC-LDA was useful, however, as a measure to maximise overall differences in the 
cells treated with different agents in an attempt to detect general trends.  As 
previously described (Ch 5.3), there is no strict formula to know how many 
principal components should be used to for PC-LDA. As sample numbers were 
small, further methods were used in an attempt to assess the number of principal 
components to use in LDA (Fig. 6.2c), rather than simply following the (n-g)/3 
over-fitting rule [21]. The Kaiser rule recommends discarding principal components 
after the Eignenvlaues are no longer equal to or above 1.0 [22]. Another approach is 
to use the number of PCs that explain 95% of total variance. A fourth method 
commonly used is Cattell’s scree plot analysis, whereby the number of components 
taken should equal the point before the plot reaches the ‘elbow’ [23]. Finally, 
Horn’s parallel analysis was tested. M. Watkins suggested Monte Carlo PCA for 
parallel analysis whereby PCA is performed to obtain Eigenvalues for a correlation 
matrix constructed by random numbers, equal in size to the experimental data [24]. 
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The scree plots for simulated and experimental data are compared and the threshold 
is the PC before the experimental plot crosses over the simulated plot [25]. The 
results can be seen in Figure 6.2c where it is apparent that the lowest number of 
acceptable components is four.   
 
The LDA score plots shown in figure 6.2c resulted from four principal components 
that explained 91%, 91% and 89% and of variance in 5FU, KF1 and KF13 
respectively (Fig 6.3a).  
 
 
 
As expected, there was still an overlap of drug-treated and control spectra. Drug 
treated cell spectra were primarily distributed in negative DF1 space and control 
spectra in positive DF1 space for KF1 (Fig. 6.3Ia) and KF13 (Fig. 6.3IIIa). No 
distinction could be seen for 5FU treated cells at this point. It could be argued that 
the cells are showing a greater response to the gold analogues than 5FU at this 24 
hour check point, as separation in DF1 is marginally better. The weighting in the 
KF1 and KF13 loading plots of the 1300-900 cm-1 region, associated with 
Figure 6.3│ (a) LDA score plot using 4 PCs for KF1 (I), KF13 (II) and 5FU (III). (b) LDA 
loadings are displayed for DF1 respectively. 
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carbohydrates and nucleic acids, appears greater than in the 5FU loading plot, 
where the region weighting is considerably less (Fig. 6.3b).    
 
6.3.2.3 │Use of second derivative spectra 
To determine if discrimination between the treated and non-treated cell spectra 
could be enhanced PCA and subsequent LDA was repeated for the second 
derivative-equivalent of the dataset. Generally it was noted that more PCs were 
required to explain the same amount of variance in the 2nd derivative dataset (Fig 
6.4).  
 
 
 
 
 
 
 
 
 
 
 
A possible suggestion is that more PCs may be required to explain the equivalent 
variance. Derivatives assess the rate of change in absorbance with respect to 
wavenumber and consequently the strong amide I and II signals dominate derivative 
spectra and subsequent loading plots. Information from other regions of the 
spectrum with small derivative peaks do not become significant until later 
components are used. As more and more PCs are used, however, more noise 
contributes to the signal and a fine balance must be made.  
 
Figure 6.4│Cumulative variance explained by principal components for the un-derivatised and 
equivalent 2nd derivative dataset 
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6.3.2.4 │Second derivative spectra for LDA using 90% PC variance explained  
To obtain an equivalent ‘variance explained’ value as the non-derivative dataset at 
90%, 8 PCs were used as opposed to 4 PCs. The score plot separation (not 
displayed) was only slightly better at distinguishing the control from the drug-
treated cell spectra.   
 
Loading plot analysis suggested a possible reason for this result. Figure. 6.5a 
displays the DF1 loading plots for the second derivative forms using 8 PCs.   There 
were notable peaks for amide I (~1657 cm-1) and amide II (~1547-62 cm-1) regions 
in the loading plot.  These signals, however, were indistinguishable from the signals 
in the DF2 loading plot (not pictured). Discriminant analysis (DA), like PCA is a 
form of eigen-analysis and for k groups, DA finds the k–1 discriminant axes that 
maximally separate the k groups. In a two group case of LDA, there will be only 
one discriminant function that will be meaningful, i.e. one discriminant axis for the 
two groups.  This indicates that these regions covering the amide bands are not that 
informative in terms of describing different chemical features between the control 
and the drug treated cells at this 24 time point.   
 
6.3.2.5 │Second derivative spectra for LDA using 95% PC variance explained  
To determine if any discriminative features were present in the loadings, LDA was 
re-analysed using 14 PCs, accounting for 95% of variance in the 2nd derivative 
dataset (Fig 6.5b-d). The LDA score plots in all cases showed distinction, 
separating control cell spectra from those treated with the agents (Fig 6.5b).  
 
For the loadings observed for DF1 (Fig 6.5c), there are two common markers that 
stand out that are not present in the loadings of DF2, suggesting that the markers are 
informative with regard to the group separation.  The first is at 966 cm-1, associated 
with C-O stretching of the phosphate monoester group of phospholipids, 
phosphorylated proteins and nucleic acids [26]. This peak in the loading positively 
correlates with 1084 cm-1 peak in KF13 and 5FU and 1051 cm-1 in KF1. The 
assignment of ~1084 cm-1 is mainly linked to a symmetric stretch s(PO2-) of the 
phosphodiester group of nucleic acids and membrane phospholipids, and partially 
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protein (amide III) . The absorption at ~1051 cm-1 is associated with C-O-C 
stretching of DNA and RNA [26].  
 
The second universal marker of drug-treated cell spectra versus the control is found 
at ~1470 cm-1, connected to C bending vibration of lipids and proteins and 
scissoring vibrations of the acyl chains in phospholipids [26].  KF1 appeared to 
have a unique marker at 1387 cm-1 associated with CH3) bending modes of lipids. 
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Figure 6.5 │ KF1 (I), KF13 (II) and 5FU (III) displaying LDA loadings (a) using 90% dataset 
variance from PCA (b) using 95% variance scores and subsequent LDA loadings in DF1 (c) 
and DF2 (d) for the 2nd derivative dataset.  
 
 
 
 
 
  
 
168
6.3.2.6 │Second derivative spectra for multiclass LDA  
Data groups CTL, 5FU, KF1 and KF13 were combined and analysed as a whole 
dataset. Figure 6.6 (I a-c) displays the LDA results of the non-derivative version of 
the dataset with 4 PCs, where no distinction or interpretation of the loadings could 
be made, as found in the two class case previously. 4 PCs explained 90% of 
variance for non-derivative data but only 79% in the 2nd derivative data. Therefore 
an equivalent 9 PCs was used for the 2nd derivative data and there appeared to be a 
vague separation of 5FU spectra in DF2 (Fig. 6.6 (II)). 
 
The variance explained for 95% in the 2nd derivative data equated to 16 PCs (Fig 
6.6 (III)). The KF13 cluster, being furthest from CTL in DF1, suggests that the cells 
are responding, or have been affected  most to KF13 at this 24 time point, This was 
also proposed in the single–drug analysis (6.3a). 5FU clustering appeared more 
distinct in DF2. This is promising as it may suggest that the cells are responding 
differently, or that the drugs act in a different mode to 5FU.   
 
The use of 95 % variance explained and was tested to further resolve differences in 
the highly complex dataset. The markers at 966 cm-1 and 1084 cm-1, seen before for 
the single group analysis were clearly resolved. The extra level of noise introduced 
by adding more PCs did not have an impact from 9 PCs to 16 PCs.    
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There has been some research into the relation of signal to noise contribution of PC 
loads to determine the number of PCs to use in discriminant analysis and there is no 
definite threshold [27]. It has been said that determining the PC cut-off by 
increasing contributions of noise serves as a practical way to deduce a threshold. 
Ultimately, adding more and more PCs will introduce more noise as exampled in 
Figure 6.7; where the first PC to introduce 99% VE was 47. This is definitely a case 
of over-fitting the data, as both the clustering in the DF score plot is perfect, and no 
markers can be resolved above the nose in the loading plot. 
 
 
Figure 6.6 │ LDA score plot (a) and loadings (b, c) for non-derivative format for (I) 4 PCs 
(90% VE) (II) 2nd derivative equivalent (90% VE) and (III)2nd derivative using 16 PCs (95% 
VE)   
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6.3.2.7 │Qualitative assessment of mean derivative spectra  
In further assessment of the mean second derivative spectra for each group (CTL, 
5FU, KF1, and KF13; number of spectra, ‘n’, was 35, 24, 24, 29 respectively), there 
no apparent shift in peak minima (Fig. 6.8a). There were, however, five areas where 
variation was apparent when the derivative mean spectra were overlaid (Fig. 6.8b). 
The peak minima at these positions were at (1)1171; (2) 1155; (3) 1084; (4) 1061; 
(5) 968 cm-1.  These spectral regions are said to be associated with (1) as (CO-O-
C); (2) s(C-O); (3) s (PO2-); (4) s (C-O) and (5) s (C-O).  
 
There is said to be a triad of infrared peaks which are characteristic of nucleic acid 
vibrations at 1031 cm-1, 1060 cm-1, and 1081 cm-1 [28].  Markers at points 3 and 4 
may highlight differences in two of these associated triad peaks. Marker 3 is 
associated with the phosphodiester bonds of DNA whilst marker 4 is due to 
stretching C-O of deoxyribose. It is likely there are differences in the third 
referenced nucleic acid peak at ~1031 cm-1, however this peak is situated in a region 
of noise and therefore it is not possible to make definitive observation for this peak 
(Fig. 6.8b).   
 
Figure 6.8c displays the un-derivatised, equivalent mean spectra (vector 
normalised). Throughout the entire region of 1200-900 cm-1 there is a considerable 
decrease in absorption in the KF-treated cell spectra. The predominant peaks around 
~1080 cm-1 and ~968 cm-1 (markers 3, 5 in Fig. 6.8b) also highlight differences in 
absorbance. Without making assumptions, it may be possible that KF drug activity 
Figure 6.7 │ Example of over-fitting: too many PCs using 2nd derivative data (99% VE) by 
LDA score plot (a) and the loadings for DF1 and DF2 (b, c)
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with DNA, is detectable, possibly causing DNA damage at this time point. As 5FU 
is cell cycle specific, it may be that the majority of cells are yet to progress to the 
next phase at this time point. Whatever the reason for the difference, it does seem 
apparent that the KF analogues are acting in a different mode, relative to 5FU.  
 
 
 
 
 
 
 
 Figure 6.8 │ (a) Mean 2nd derivatives, stacked for each group (CTL, 5FU KF1 and KF13-
treated cell spectra). (b) The same mean derivatives, overlaid (c) The non-derivative, 
normalised equivalents. 
  
 
172
6.3.3 │ FPA-FTIR-imaging analysis after 24 hours exposure to 
compounds  
FTIR hyperspectral images were acquired using same samples as for SR-FTIR. As 
another method of analysing drug-treated cell spectra, these images included data of 
multiple cells, providing thousands of spectra to manipulate. The aim was to 
determine of the same trends as seen in the single cell data could be reproduced 
using LDA, and also to ascertain if clear biomarkers could be determined by using 
mean spectra and PCA.  
  
Infrared images from the same samples were taken in triplicate per group (CTL, 
5FU or KF1) from areas of similar confluence. There were, however, substrate 
regions with spaces where the cells had not grown (Fig. 6.8a). It is known that cells 
secrete chemicals into the surrounding area for a number of purposes. Rather than 
quality testing these ‘vacant’ areas, removing them from spectral analysis, an 
alternative approach was taken.  
 
The individual spectral images were corrected using the RMieS-EMSC algorithm. 
Subsequently, one image each for CTL, 5FU and KF1 were stitched as one mosaic, 
to analyse the images as a whole. K-means clustering was performed to obtain 
clusters that described all groups simultaneously (Fig 6.8b). The spectra were not 
normalised and therefore K-means clustering classed the spectra into groups 
predominantly by sample thickness. This can be seen in Figure 6.8c where the class 
colours match thin (class 2; orange), medium (class 1; grey) and thick (class 3; 
white) areas of the sample.  
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For robustness, the process was repeated a further two times in different areas of 
each slide. Figure 6.9 displays total intensity and corresponding k-means clustering 
for the replicate groups (a), (b) and (c).  
 
 
Figure 6.8 │ (a) optical images of the sample regions (b) IR hyperspectral images were 
acquired for each sample type and stitched together. Total intensity infrared images where 
intensity ranges from blue (minima) to red (maxima). (c) The resultant k-means clustering of 
the three images, split into class 1 (grey), class 2 (orange) and class 3 (white).  
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The resulting mean spectra representing each replicate and for each group (CTL, 
5FU and KF1) can be seen in Figure 6.10. Cancer cells have less contact inhibition 
than non-cancer cells and are more likely to grow on top of one another [29]. This is 
possibly why there are thickness differences on each slide. Alternatively, it may be 
a case of random attachment to the substrate when the cells are first introduced into 
the substrate-containing well. Class 3 spectra highlight the thickest sample areas 
displaying the highest absorbencies in the spectra.  
 
Class 1 was most abundant (~8,000 spectra) and class 2 the least (~200 spectra). 
The class 2 spectra displayed characteristic fringing patterns and represented the 
thinnest sample areas of the slide. It was interesting to note that class 2 areas 
appeared vacant in the optical images, yet signals rich in protein, nucleic acid, lipid 
and carbohydrate are present. These spectral features may be evidence of cellular 
secretions.  
 
Figure 6.9 │ Stitched tiles of total intensity for replicates a, b and c (left) and the corresponding 
k-means clustering analysis (right). 
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The three classes of spectra were analysed separately by PC-LDA using 15 PCs 
(60% of variance explained). The LDA results in general (Fig 6.11) echo the 
general trend seen for the initial SR-FTIR dataset (Fig 6.7a) as cells treated with 
5FU seem to project more on the DF2 axis, whereas the KF drugs appear further 
along the DF1 axis, respective to the control cells.  
Figure 6.10 │ Mean spectra are represented for CTL, KF1 and 5FU for each class. (a), (b) and 
(c) are replicates equivalent to a,b and c in Fig. 6.9.  Class 1 represent the grey shading in the 
K means cluster images, and are spectra of medium thickness. Class 2 represent the orange-
shaded areas of the cluster images, with spectra of very low absorbencies where no cells 
appeared to be present. Class 3 represent the white-shaded cluster image areas and highlight 
regions of greater absorbencies, particularly in the fingerprint region. 
  
 
176
 
 
 
It is clear, however, that even though the mean spectra per replicate appear similar 
by class, the discriminant analysis of replicates in different areas of the sample 
illustrate that the trend is not completely representative of the entire cell population 
and there are fluctuations. This may be due to differences in cell chemistry as a 
result of cell cycle differences or cell density. 
 
Figure 6.11 │ LDA scores of the spectral groups shown in Figure 6.10, using 15 PCs. Typically 
15 PCs accounted for ~60% of variance. (a), (b) and (c) are replicates equivalent to a,b and c in 
Fig. 6.9 and in Fig. 6.10. 
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6.3.4 │ Single cell SR-FTIR analysis after 72 hours exposure to 
KF compounds 
The clustering patterns from PC-LDA in the 24 hour datasets suggested that the 
Caki-2 cells may have been more sensitive to KF13 than KF1. This was most 
apparent in Figure 6.6 (III a) whereby KF13 cluster points were the furthest 
removed from the CTL data points on the DF1 axis.  
 
As the calculated IC50 values were based on a three-day cytotoxicity assay it was 
thought necessary to see any differences in cell response at this same time point i.e. 
after 72 hours of drug exposure. At this time point, we could be sure that at least 
half of the cellular population should have been inhibited by the agent concentration 
and possibly larger spectral differences. Due to the washing steps involved before 
formalin fixation, dead cells and debris that would have lifted off the surface of the 
substrate would have been removed. In general, only viable cells that either did not 
receive a dose of drug or chemically differentiated cells that may show resistance 
would have remained.   
 
Figure 6.12a displays the PC-LDA score plot of the total dataset (CTL, KF1 and 
KF13), compiled using 4 PCs and non-derivative spectra.  Relative to KF1, KF13 
data points again appeared to be more differentiated from the control. There was 
also a larger spread of data points for KF13. This could also be observed in the 
equivalent group mean spectra. KF13 appears to have greater variance in the protein 
amide I and II peaks (Fig 6.12b).   
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Figure 6.12│ LDA score plot of the total dataset for drug exposure over 3 days (a). Mean spectra 
± standard deviation for each group. KF13 has maximum variance in the amide regions of the 
fingerprint (c). LDA score plot (d) and DF1 loading (e) for KF13 spectra against CTL spectra 
only. (f) displays viable cell proliferation counts acquired over a period of 6 days.  
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The KF13 dataset was analysed singularly against the control spectra (Fig 6.12c) in 
the same manner as the 24 hour equivalent set (Fig. 6.3). It appeared that the drug-
treated cell spectra were again potentially distinguishable from the non-drug treated 
control as there is some separation in PC1. As well as changes in the amide I band, 
differences in the nucleic acid regions below 1200 cm-1 were anti-correlated with 
the mid-fingerprint range (1200-1500 cm-1), rich in lipid and carbohydrate signals 
(Fig 6.12d).  
 
There are many possible reasons as to why the drug-treated cell spectra are 
distinguishable against the control spectra due to a multitude of processes 
occurring:-  
 
 The cells may be sensitive to the drugs and the cells are cells are being 
damaged  
 The cells are responding to the drugs and are actively trying to repair and 
remove the foreign molecules 
 Upon exposure to the KF agents, the cells have evolved and developed 
resistance to and that is why their infrared signature is separable to the 
sensitive control cell population.  
 
A 6 day proliferation assay was performed in order to try and determine the 
eventuality of the cellular response (Fig 6.12e). In all cases, the cells treated with 
the KF series seemed to recover in viable cell number after 72 hours. In contrast, 
the viable cell count for 5FU treated cells remained more or less constant and 
relatively low, eliciting a profile indicative of a cytostatic drug effect.  
  
6.3.5 │ Comparison between 3/6 days after initial drug exposure 
The results of the proliferation assay in 6.3.4 prompted a final investigation into the 
cellular signatures after several days of drug exposure. In particular, it was 
questioned if the KF-treated cell population at ‘day 6’ were now indistinguishable 
to the control cells, as they were under proliferative recovery. 
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The single cell analysis in previous sub-chapters had highlighted issues affecting 
interpretation. There was a high level of data complexity, due to parallel processes 
in the cell cycle. The issue with choosing the number of PCs for LDA was also 
subjective. Upon consideration of the issues associated with single cell analysis it is 
perhaps more advantageous to acquire single-point spectra of cell monolayers and 
use PCA alone to ascertain a general trend. The single point technique has the 
advantage that a large aperture may be used to capture the average signal of several 
cells in one area of the substrate in a single acquisition. This approach also reduces 
the impact of cell cycle differences in chemistry. 
 
 
A new set of samples and a second proliferation assay were prepared for the final 
experiment. Figure 6.13 displays the PCA plot of the non-derivatised spectra. KF13 
data points were distinguishable against the control only at the 72 hour time point 
(Fig. 6.13a). There was no distinction of theses two groups after 6 days of drug 
exposure (Fig 6.13b). Figure 6.13c displays the same KF13 data as figure (b) but 
with added 5FU data as an additional validation of this result. 5FU treated cells 
were very different from the control cells in terms of cell viability from days 3-6 in 
the previous proliferation assay.  
Figure 6.13│PCA of single-point monolayer spectra of  (a)  KF13 versus CTL after 3 days (b) 
KF13 versus CTL after 6 days (c) 5FU and KF13 versus CTL after 6 days of exposure 
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The second proliferation assay displayed the same pattern of proliferation (Fig. 
6.14). The difference between 5FU-treated cells and the CTL/KF13 cells were again 
apparent. A proportion of 5FU-exposed cells remained viable but no longer 
proliferated, whereas the KF-exposed cells recover from proliferation inhibition 
after three days. This result could support why the chemistry of 5FU-cell spectra 
separate from the chemistry of the KF-treated cell spectra in the PCA score plot 
(Fig. 6.13c). 
 
Visual differences were also noted in the in-vitro photomicrographs taken for CTL, 
5FU and KF13 (and KF1 in addition) in Figure 6.15 at the 6th day before cell 
counting protocol was implemented. There was a large display of un-healthy 
apoptotic cells in the 5FU image, with instances of cell blebbing. In contrast, there 
were smaller instances of blebbing however in general KF treated cells appeared 
similar in morphology to the control cells, suggesting a similar viability. 
Figure 6.14│ The repeat of the cell viability proliferation assay for CTL, KF13 and 5FU 
treated cells. 
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6.4 │Conclusions and Future Prospects 
The analysis has shown heterogeneity in the cell populations treated with different 
chemotherapeutic agents. This was observed in the spread and overlap of data point 
for the single cell experiments and in the hyperspectral FTIR images. Single-point 
spectra of large cell monolayer areas, in combination with PCA was shown to be 
the best current method for detecting overall trends in the different cellular 
responses.  
 
One reason may be simply due to sampling numbers:  ten to twenty spectra were 
taken for the single point data, encompassing numerous cells simultaneously. In 
comparison, the imaging investigation was performed with only 3 images per drug 
variable, due to the nature and size of the files. However, it could be said that the 
imaging technique provided the advantage of spatial resolution, where each 
Figure 6.15│ In-vitro photo-micrographs of the Caki-2 cells after 6 days of drug exposure: (a) 
CTL, (b) 5FU (c) KF1 (d) KF13   
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spectrum related to a pixel are of 5.5 m2. This meant that individual cells would 
have been probed every few pixels and cell cycle differences may have contributed 
to the differences in trends. It may also be that certain areas of the sample were 
denser than others. It has been shown that chemical differences in the infrared 
spectra of cells may differ depending on whether cells are in the exponential 
(proliferating) or plateau (non-proliferating) phase of growth [31].  
 
As cells communicate with one another receiving chemical signals from nearby 
cells [1] (Ch. 1.1.2), this may also account for the different relationship patterns in 
the areas surrounding the cells (low-absorbance spectra, k means class 2, orange 
cluster areas), which most likely included traces of cellular chemical secretions. The 
mean spectra from these regions displayed relatively high intensities in the sub-900 
cm-1 spectral region. (The area 1200-800 cm-1 included many nucleic acid signals 
[30]). In selected areas of the sample, these class 2 spectra were sometimes 
differentiated in terms of drug variable (CTL, 5FU or KF1) during discriminant 
analysis.  
 
It is also possible that the spectral signatures in these sparse regions arose from cell 
secretions or signals due to stress. Normally in the human body, dead cells can 
attract phagocytes that engulf the dead cells before their cell membrane integrity is 
lost.  This prevents the release of toxins into the extracellular matrix which would 
otherwise affect nearby cells [33]. In an in-vitro environment, the cell line cannot 
exhibit such a mechanism and it is feasible that there may be traces of cell debris or 
toxins.   
 
The KF analogues appeared to recover in viable proliferative cell count, as seen by 
the proliferation assays after 3 days and the PCA plot after 6 days. One possible 
explanation is that the drugs were readily effluxed out of the cells, i.e. the drug 
effect was no longer observed as the drug was no longer present; P-gp and other 
membrane transporters such as MRP1, and ABCG2 recognize a wide spectrum of 
compounds, however, they share a common feature in that their transport substrate 
are typically hydrophobic, especially the case for P-gp and ABCG2. Therefore 
many drugs that exhibit similar hydrophobic properties could be substrates for these 
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drug efflux pumps and may readily cross lipid bilayer by passive diffusion [34]. For 
P-gp substrates, the now widely accepted 'hydrophobic vacuum cleaner' model, 
accounts for the lipophilic nature of P-gp substrates [34-36]. It is suggested that 
drugs that have entered into the phospholipid bilayer are pumped out of the 
membrane by the P-gp pump and are expelled into the extracellular aqueous phase.  
 
In terms of the KF-series for renal cell carcinoma, this drug efflux proposal could 
be analysed further by means of blocking the efflux ability of the cells in a similar 
fashion as the use of Verapamil to sort the side population cells, enriched for stem-
like cells (Ch. 5). 
 
Further investigation for the methodology points towards a simplification step 
whereby perhaps differences in cell cycle chemistry could be separated from the 
different effects of particular anti-cancer drugs.  
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Chapter 7 │Discriminating Chemical Responses by 
Cell Cycle Phase 
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7.1 │ Introduction and Aims 
The previous chapter outlined the difficulties in trying to separate cellular response 
from different agents. PCA score plots of the cell spectra, displayed widely 
dispersive intra-group clustering, as observed in Chapter 6 (Fig. 6.6) and by K. 
Flower et al. [1]. It is suggested that there may be small sub-clusters where spectra 
are grouping in PC1, predominantly because of cell cycle signatures, rather than 
slight chemical changes that may occur by cellular drug response.  A collection of 
SR-FTIR spectra from a ‘typical’ population will yield a mixture of cell spectra 
displaying different quantities of biomolecular components, depending on the cell 
phase at the time of chemical fixation.  
 
It is possible to sort and collect cells in different phases of the cell cycle through the 
use of a fluorescence-activated cell sorting (FACS) which analyses the DNA 
content of the cell, by use of a fluorescent dye that quantitatively binds to it 
(Chapter 2) [2]. 
 
Cells in the resting phase are G0/ G1, the pre-DNA synthesis phase. The cells in the 
S phase are actively undergoing DNA-synthesis and contain increasing quantities of 
DNA [3]. In clinical terms, patient tumours observed to have a high S phase fraction 
are typically said to be at high risk from tumour recurrence [4-5]. The post DNA-
synthesis phase is referred to as G2/M where cells have twice the amount of DNA 
as the G0/G1 phase as they are entering into mitosis. 
 
Propidium iodide (PI) stoichiometrically binds to double-stranded DNA by 
intercalation. As a ligand, the die fits between the base pairs of DNA, causing 
inevitable conformational changes in the DNA [2]. 
 
Using this dye for cellular spectral analysis and PCA discrimination will lead to an 
obvious cluster separation of the cells from different phases, as presumably the 
higher the PI concentration the greater the extent of DNA conformational change 
(Fig 7.4b).  
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Due to the stoichiometric nature of the staining reaction mechanism, however, it 
would still be possible to evaluate a single cell line treated with different agents 
with this approach, provided that the cell spectra were analysed from one phase at a 
time. This would be viable as the PI concentration per cell cycle phase would 
generally be a constant in one cell line and therefore can be omitted as a factor of 
multivariate discrimination.  
 
The aim was to determine if cellular responses could be detected without having to 
consider cell cycle differences. It was predicted that interpretation and possible 
biomarker generation from the multivariate analysis loading plots would also be 
clearer and perhaps more accurate.  
 
7.2 │Experimental 
7.2.1 │SRB cytotoxicity assay 
The cytotoxicity assay followed the same protocol as described in Chapter 2.4.4 to 
obtain IC50 values for the A-498 cell line. 
 
7.2.2 │FACS  
The experimental procedures in Chapter 2.4.7 describe the experimental setup to 
enable cells to be stained with propidium iodide and sorted using flow cytometry.  
 
7.2.3 │Spectral sample preparation 
Following cell sorting cells were spun and re-suspended in 150 L of ddH2O. The 
aliquots were deposited with a cell cytospinner (Ch. 2.4.2.2) onto CaF2 substrates at 
800 g for 5 minutes  
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7.2.4 │ Data acquisition 
SR-FTIR transmission spectra were acquired on the SMIS beamline according to 
the protocol in Ch. 2.4.3.2. Spectra were recorded at 4 cm-1 resolution with 256 co-
scans.  
 
7.2.5 │ Data pre-processing and analysis 
The day 1 control dataset contained 73 spectra in total and the day 3 dataset 
(control, 5FU treated or KF1 treated) contained 113 spectra.  For the day 3 dataset a 
total of 40 spectra were recorded for each cell type. The raw spectra were corrected 
with a Matrigel reference spectrum and 150 iterations of the RMieS-EMSC 
algorithm.  The corrected spectra were vector normalised and mean centred prior to 
PCA, using the spectral range 1110-1825 cm-1.  
 
7.3 │Results and Discussion  
7.3.1 │Cell cytotoxicity  
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1 │ Dose response curves to determine IC50 values for the A-498 cell line from the SRB 
assay data (repeated in triplicate). Graphs were created in Graphpad Prism using mean values ± 
standard error.  
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Both cell lines used throughout the course of the drug-response research were 
closely matched, defined as primary RCC with wildtype p53 expression [6]. As in 
Chapter 6 for the Caki-2 cell line, the IC50 values had to be obtained for the A-498 
cell line. These were found to be: KF1 [2.61 M]; KF13 [2.23 M]; KF5 [3.26M]; 
5FU [2.91 M]. The IC50 values obtained from the replicate SRB assays revealed 
that the cell line A-498 was more sensitive to the gold-based agents than the Caki-2 
cell line (Fig. 7.1), whereas 5FU did not vary distinctively. This may be due to P-gp 
expression differences as P-gp does not export small hydrophilic drugs such as 
Cisplatin, 5-Fluorouracil [7]. The A-498 cell line was used in this instance to 
possibly detect a greater response within the cells, with respect to the non-treated 
control cells. 
 
7.3.2 │ FACS cell cycle sorting  
Cells were collected after 24 and 72 hours of exposure to the agents and stained 
with propidium iodide for FACS sorting. There appeared no apparent discrepancies 
between control cells and KF1 treated cells during both time periods. The only 
unique histogram profile was obtained for cells 72 hours upon treatment with 5FU, 
highlighting cell cycle arrest in the S phase as expected (Fig. 7.2).   
 
As described in further detail in Chapter 1, 5-fluorouracil belongs to the anti-
metabolite category of chemotherapy agents.  Anti-metabolites are very similar to 
normal substances within the cell affecting cells at very specific phases in the cycle.  
When the cells incorporate these substances into the cellular metabolism, they are 
unable to divide [8].   
 
Interestingly in Figure 7.2, the effect of 5FU at the IC50 concentration was not 
observed until 72 hours of exposure to the drug. This time period coincides with the 
length of time the IC50 value was determined by the 72 hours cytotoxicity SRB 
assay. It may simply be that a higher proportion of cells are affected by the 
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concentration of 5FU at the 3 day time point and this is reflected by a notable 
change in the cell numbers at each phase.  
 
5FU is said to inhibit cell cycle progression at S phase [8].; however we do not see a 
change in the FACS cell cycle profile until 72 hours after drug addition. The result 
may also suggest that 5FU did not have an immediate notable effect on the cell 
population 24 hours after drug addition. The cells were to establish onto the 
substrates in the tissue culture wells for 24 hours prior to drug addition, making a 
total of 48 hours for cells to complete their cycle. Although 48 hours seems a 
substantial time period for cell cycle competition, the cells may have remained in 
G0/1 phase longer when cultured onto a MirrIR substrate rather than the more 
preferable conditions of a tissue culture plastic alone. At the time point 72 hours 
after drug addition, the cells had been cultured for a total of 5 days in the substrate 
environment, a suitable duration for cells to settle onto the substrate and attempt to 
complete the cell cycle.  
 
 
 
 
 
Figure 7.2 │ FACS histogram plots of G1 (green), S (gold) and G2/M (blue) cell counts. The A-
498 cells were exposed to agents KF1, KF13 and 5FU at the IC50 for a period of 24 and 72 
hours.   
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7.3.3 │ Spectral and sample quality  
The control spectra for the 24 hour dataset were analysed in terms of G(1), S and 
G2/M phase. Figure 7.3 displays the mean spectra directly after RMieS-EMSC 
correction (without vector normalisation).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Overall absorbance appeared to be greater in G2/M cells than in the other cell cycle 
spectra. This result favourably compared with the research of Holman et al. [9] (Fig. 
7.4) who postulated this may due to either more material in the cell, or thickness 
differences in M phase. In the second case there could be a greater path length for 
the IR beam to traverse. The vs(CH3).peak at ~1392 cm-1 is noticeably larger in the 
G2/M phase, an observation again described by Holman et al. [9].   
 
The positive correlations suggest that the PI dye is not seriously affecting the 
associated chemistry of the cell cycle within the spectral bands of molecules other 
than those associated with DNA.  
 
 
Figure 7.3 │ Mean RMies-EMSC corrected spectra for non-drug treated control cells after 24 
hours of cell culture (not normalised). 
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The spectra (Fig. 7.5) were typically of poorer quality in the lower wavenumber 
region (1200-1000 cm-1), with low signal and increased noise, relative to other 
drug-treated (Chapter 6) or cytospun spectra (Chapter 5). 
Figure 7.4 │A figure taken from the publication of Holman et al. [9] comparing the mean 
spectra of cell cycle phase in normal human foetal lung fibroblast cells IMR-90. 
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After discussion with the SMIS beamline team at Soleil, the large absorbance below 
1100 cm-1 probably arises from a misalignment of the condenser. It has been 
observed that the condenser not remaining aligned when the lower microscope 
illumination was left on. It is probable that this is due to the warming of the mirror 
and a change in the mirror curvature or alignment due to dilatation.  
 
The fingerprint region was therefore decreased to 1110-1825 cm-1, omitting the 
poor signal to noise areas that contained nucleic that may have otherwise been 
highly informative.     
 
Figure 7.6a displays of RMieS-EMSC corrected, vector normalised mean spectra 
per cycle phase displaying their standard deviation. The amide I and II regions 
displayed notable variance, as well as the region 1200-1400 cm-1 spectral region in 
the G1 phase spectra. It may be that in the cells in G1 phase are more heterogeneous 
as DNA replication is occurring, perhaps faster in some cells than others, hence the 
larger variability in the nucleic acid region due to PI dye concentration.  
 
The PCA score plot for the control dataset is shown in Figure 7.6b. G1 phase 
spectra are anti-correlated against S and G2/M phase spectra in PC1. Distinction 
Figure 7.5 │ RMieS corrected dataset for 24 hour control. The spectral range used for analysis 
had to be reduced to 1110-1825 cm-1. 
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can also be made in PC2 where G2/M phase spectra anti-correlate with G1 and S 
data.  
 
The cell spectra in different cell cycle phases could not be compared to one another 
due to the influence of PI. Increased DNA content in the later phases of the cycle, 
just before mitosis, means that the concentration of the PI dye will be higher in 
these cells, and therefore the extent of DNA conformational change.  
 
 
 
 
 
 
  
 
199
 
 
 
 
 
Figure 7.6 │ (a) mean (RMieS-EMSC corrected; vector normalised) fingerprint spectra for G1 
(green), S (gold) and G2/M (blue) control cells  describing the difference in standard deviation 
(not to scale). Variance in the spectra can be mainly found at the amide I and II absorbance 
bands (b) PCA of the dataset and subsequent loading plots (c, d for PC1, PC2). The equivalent 
2nd derivative score plot (e) and PC2 loading (f). 
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Figure 7.7 displays optical images of the FACS-sorted control cells, cytospun onto 
calcium fluoride substrates. The S and G2/M cells appear darker, due to the extent 
of PI intercalation within the cell.  
 
Interestingly, the cells in G1 phase appear larger in diameter than the other cells. 
During the cell cycle process, typically the cells become larger as these progresses 
through each stage. G2 stage cells should technically be the largest as cells continue 
to grow through the cell cycle, prior to mitosis [3].  
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Figure 7.7 │Optical images of a selection of control cells prepared for spectroscopy 
measurements, highlighting differences between G(1), S, and G2/M cells. 
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The diameters of 50 cells were measured using a ruler tool in the Omnic software 
for each phase. The group means were 24 m, 22 m and 19m for cells in G(1), S 
and G2/M phase respectively and were found to be statistically different (P<0.001) 
using a one-way analysis of variance (ANOVA) test in Graphpad Prism (Fig. 7.8).    
 
 
 
 
 
 
 
 
 
 
It is possible that the cells collected in G2/M phase, which had undergone spectral 
acquisition, included a cell population richer in M phase cells than G2 cells. In M 
phase cell division would have occurred. The daughter cells would be smaller in 
size than cells in the rest of the cell cycle prior to mitosis [3].  
 
It would be impossible, however, to make a definitive assumption about the natural 
size of the cells prior to processing for spectroscopy measurements.  The cells were 
ethanol fixed prior to FACS sorting. The ethanol fixation may have an effect 
morphological distortion, such that dehydration may shrink the cells [10]. The 
difference in PI concentration between cell phases, however, is probably not a 
factor, as the dye is applied after ethanol fixation.   
 
Research has shown that, for a cell line of different origin, G2/M cells were said to 
be more rigid than G1 cells [11]. This may be another plausible explanation as to 
why the G1 cells appeared larger after cyto-spinning. It was possible that the G2/M 
cells, displaying more rigid properties than the G1 or S cells, remained relatively 
Figure 7.8 │ Mean diameter of cytospun cells for each cell cycle phase ± standard deviation 
(S.D). 
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spherical when the centrifugal force was applied whereas the G1/S cells flattened 
slightly more on impact. 
 
It was important to utilise the RMieS correction algorithm on this dataset, 
particularly because of the size difference. The cells from different phases may have 
all appeared similar in morphological shape; however, the difference in size would 
have an effect on the Mie scattering profile. Cells may have been discriminated 
against because of these different profiles, of which can be observed in the mean 
raw spectra (with standard deviation) in Figure 7.9. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.3.3 │Cellular response after 24 hours of drug exposure 
In Chapter 6, chemometric distinction between KF1 and 5FU treated Caki-2 cells 
after 24 hours was found. This distinction was only achieved, however, with the use 
of spectral derivatives and discriminant function analysis.   
Figure 7.9 │The mean cell phase spectra for G1 (green), S (gold) and G2/M (blue), acquired 
from the non-drug treated control at the 24 hour time point.
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As previously discussed, it was not a viable option to compare drug-treated cell 
spectra from different cell phases due to the difference in DNA conformation from 
the propidium iodide concentrations.  
 
As previously discussed, during FACS analysis whereby the cells were sorted in 
preparation for the SR-FTIR experiments, the cell count profiles showed no 
apparent difference in cell accumulation in each phase after 24 hours of agent 
addition, in all group cases (Fig 7.2)  
 
Spectral data collection focused on the 72 hour time point samples, however, G1 
phase cell spectra for the PI stained 24 hour drug exposure samples were also 
collected. PCA was performed on the stained, G1 phase SR-FTIR spectra, enabling 
a comparison of cells treated with different agents in same phase, irrespective of PI 
concentration.   
 
Cluster separation between cells treated with different agents was achieved (Fig. 
7.10). Due to the single-phase analysis where PI concentration and cell cycle 
chemistry remained a constant, the complexity of the dataset was reduced, such that 
the use of spectral derivatives and supervised LDA were not necessary to 
discriminate spectra.  The SR-FTIR and chemometric approach found differences in 
cell chemistry after 24 hours of drug exposure, a result that was not detectable by 
corresponding FACS analysis. This demonstrates the sensitivity of the infrared 
technique. 
 
Figure 7.10 │ PCA of cell spectra in G1 phase after 24 hours of drug exposure (a) with PC1 and 
PC3 loadings (b, c)  
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Drug treated cell spectra could be discriminated from the control group in PC1. The 
loading plot in PC1 predominantly highlights protein differences. KF1 also 
appeared to discriminate from the CTL/5FU groups in PC2. The loadings in PC3 
revealed a notable peak at ~1700 cm-1. This peak resides near the protein region of 
the spectral fingerprint, although according to Dovbeshko et al. [12], it may be 
associated with nucleic acid damage and repair. Stretching C=O vibrations that are 
H-bonded (in guanine, thymine) may be connected with destruction of old H-bonds 
and creation of the new ones. A full assignment [13] of loadings peaks for PC1 and 
PC3 can be found in Table 7.1, 7.2 (Ch. 9, Appendix).  
  
It may be postulated that the KF1 drug is interacting with the cellular DNA at this 
time point. Similarly when Caki-2 cells were treated with KF1 and KF13, they 
appeared to have a greater initial change in cell chemistry than the 5FU after 24 
hours (Ch. 6). In some cases the loading plots from chapter 6 displayed similar 
peaks at ~1700 cm-1 however it was difficult to deduce cell cycle contributions from 
drug effect.  
 
Proliferating cells are generally more susceptible than resting cells to toxic and 
mutagenic effects of DNA-damaging agents as DNA replication and chromosome 
segregation processes are easily disrupted by DNA damage [14]. To prevent cells 
with damaged DNA to continue to S-phase, signal transducers activate p53 and de-
activate cyclin-dependent kinases to inhibit cell cycle progression. Cell cycle arrest 
can occur, which enables extra time for repair enzymes to work on the damaged 
DNA before cell cycle continuation [14-15].  
 
As described (Ch. 1.2.2) activation and deactivation of signal transduction pathways 
are initiated by phosphorylation. In PC3, which separates the CTL and 5FU clusters 
from KF1, there is a notable contribution to the loading around the lower spectral 
fingerprint region, most notably ~1240 cm-1 which is primarily associated with 
phosphate as(PO2) stretching from phosphodiester groups of cellular nucleic acids 
[12].  
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7.3.4 │Cellular response after 72 hours of drug exposure 
The analysis of cells after 24 hours of exposure will sample cells that are most 
likely within the process of cellular damage and repair. Here, cell spectra were 
acquired for cells treated with KF1 and 5FU (and non-treated control cells) after 72 
hours after initial exposure to the drugs. At 72 hours, however, cells likely to be 
affected by the chemotherapeutic agents would no longer be viable and would not 
have been part of the cell population. Dead cells and debris would have been 
removed during the sample processing. During the flow-cytometry forward angle 
light-scatter gating would have remove small debris. Dead cells prior would also 
have been gated out due to a reduced DNA fluorescence signal because of DNA 
breakdown in dead cells prior to chemical fixation [16-17]. Therefore the cell 
populations studied in the 72 hour dataset included largely viable cells unaffected 
by the initial drug dose. Cells in the process of repair or damage would also be 
present however, though perhaps at a reduced frequency than the 24 hour dataset.   
 
The dataset, including all G1, S and G2/M phases was analysed by PCA as a whole 
dataset (Fig. 7.11). The resulting spread of data points appeared similar to previous 
experiments in chapter 6, where cell cycle chemistry appeared to inhibit or mask the 
effects of the different drugs. Similar plots were also seen by Flower et al. in drug-
treated ovarian cancer cell lines [1]. 
 
However the spectra corresponding to the individual stage were known and were 
highlighted accordingly in the sub-plots below the main figure. Without the use of 
derivatives, or further discriminant analysis, it was clear that most of the variation 
in the main dataset cluster stemmed from the differences in cell chemistry in S 
phase.  
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Figure 7.11│ PCA of total dataset (top) and the respective spectra from each phase that made up 
the total dataset are shown below where it is apparent that the greatest variance between the 
drug types occurs in S phase.   
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Analysis of the complete dataset loadings would not be viable due to the variable 
extent of DNA conformational change from PI concentration from phase to phase. 
To validate this result, PCA was repeated using S phase group spectra alone. The 
same relationship was observed (Fig. 7.12a), suggesting that the cell chemistry in 
KF1-treated cell spectra is anti-correlated with the 5FU-treated cell spectra. This is 
again in agreement with the FACS analysis which illustrated a significant change in 
the cell population profile in S phase after 72 hours of drug exposure. The use of 
5FU validates the FACS methodology and therefore it can be said that KF1 does not 
appear to cause significant cell cycle arrest in the A-498 RCC cell line.  
 
 
The peak at 1700 cm-1 found in the PC loading when G1 phase (Fig. 7.10b) was 
compared is not present in the S phase PC2 loading plot above (Fig. 7.12b).   
 
A compete assignment [13] is given in Table 7.3, (Ch.9, Appendix). Notable 
loading peaks concern protein bands, and the s(PO2) symmetric phosphodiester 
stretching band of RNA at ~1120 cm-1. The protocol for PI staining requires RNAse 
treatment [6] so that both RNA and DNA are not stained, thus evidence is given of 
a chemical difference detected that is wholly unaffected by PI staining, therefore 
validating the use of intra-phase analysis.  
 
As described previously (Ch. 1), 5FU is an analogue of uracil with a fluorine atom 
at the C-5 position in place of hydrogen. Upon cellular entry it is converted to 
Figure 7.12│ PCA using S phase data only (a) and the PC2 loading plot that highlights the 
discriminatory chemical differences between the two different drug-treated cell populations
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several active metabolites: fluorodeoxyuridine monophosphate (FdUMP), 
fluorodeoxyuridine triphosphate (FdUTP) and fluorouridine triphosphate (FUTP). 
These active metabolites disrupt RNA synthesis and the action of thymidine 
synthase (TS) [15].   
 
There is also an intra-S-phase checkpoint that can block replication. It is activated 
by damage encountered during the S phase, or previously unrepaired damage that 
has escaped the G1/S checkpoint.  The damage sensors for the intra-S checkpoint 
include a large set of checkpoint and repair proteins [15].  
 
As a final exercise, PC-LDA was performed (Fig 7.13) using 5 PCs and second 
derivative spectra, a combination used in Chapter 6. In this case, however, there are 
9 different groups (G1, S and G2/M for CTL, KF1 and 5FU) and the size of the 
dataset was too limited for any results to provide 100% confidence at this stage.   
 
It does however enhance the separation of cell-treatment groups in S phase. To a 
certain extent, it could be argued that there are cellular chemical differences in 
G2/M phase also. The G2/M checkpoint prevents cells from undergoing mitosis in 
the presence of DNA damage. It could be postulated, as the cells selected for 
spectroscopy are viable ones at this 72 hour stage, there may be an indication of 
repair mechanisms in motion.  
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Figure 7.13│ LDA of the total 2nd derivative dataset using 5PCs. The respective spectra from 
each phase that made up the total dataset are shown below where it is apparent that the greatest 
variance between the drug types occurs in S phase and possibly some difference in G2/M phase. 
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7.4 │Conclusions and Future Prospects 
The use of FACS sorting the cells enabled differences due to drug effect to be 
analysed alone, which simplified interpretation of the multivariate analysis results.  
In chapter 6 it appeared that generally, the KF compound series caused a greater 
change cellular chemistry earlier.  
 
This chemical change may pertain to the fact that the KF drugs are causing DNA 
cross-linking at this stage, as suggested. It is known that 5FU acts in a very different 
mode and disrupts progression in the S phase of the cell cycle.   
 
This evidence may help determine the timing of future experiments, depending 
upon the question to be asked. Is it an initial response that is to be observed, or is it 
the greatest extent of the response and chemical change, which will be determined 
by the length of the corresponding inhibitory concentration assay, 50% of cells will 
not be inhibited. It is these viable cells that are analysed (Ch. 7.3.4), as well as 
perhaps partially-viable cells.   
 
As seen in chapter 6 with the Caki-2 cell line, a cellular response to the anticancer 
compounds could be detected after 24 hours of exposure, unlike the other 
techniques used. This highlights an advantage of the technique, and shows promise 
that an indication of drug efficacy may be detectable in a short time frame, in the 
context of high-throughput screening of a multidrug panel. Result at this time point 
has also raised the question as to what earliest time point an initial response may be 
detected by FTIR spectroscopy. An ideal way to monitor this would be to use a live 
cell experiment. Flow cytometry is a progressive field, particularly with the use of 
synchrotron radiation sources for single cell experiments [18-20]. Water 
contributions, however, would dominate the signal unless a correction could 
account for the contributions, or a flow cytometry cell is well designed to limit the 
effects of water in the spectrum. Alternatively Raman spectroscopy has an 
advantage over infrared for liquid based experiments, however, there is an added 
risk of damaging the sample due to the heat generated, which would affect cell 
viability. Regardless of this, recent research has shown promise [21-23]. 
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Through the use of FACS analysis, sorting single cells by their progression phase in 
the cell cycle, it was possible to analyse differences largely due to drug effect by 
analysing one phase at a time. Where cluster patterns and chemical signatures could 
be interpreted by assessing same-phase spectra, a number of chemical differences 
agreed with the FACS analysis and the known mode of action of 5FU. The results 
including tentative band assignments would warrant further confirmation with 
alternative methods in order to be validated.   
 
The necessary use of propidium iodide staining, however, was not the most ideal 
situation. As chemical fixation was used prior to staining, the staining should not 
have had too much of an effect on the cellular chemistry overall. It did, however, 
affect the detection of changes in nucleic acids; a highly important feature in 
monitoring cellular response to drugs. Cells analysed across different phases would 
most likely involve difference in peaks associated with nucleic acids, due to the 
DNA conformational changes from the intercalation of different concentrations of 
PI dye.  
 
It is still desirable to separate chemistry based on cell cycle differences from 
chemistry changes from cellular drug response. Removal or isolation of cell cycle 
chemistry as a variable makes for more simple and accurate analysis of drug 
response effects. The next logical step in this line of research, therefore, would be to 
establish a method to define spectra to respective cell cycle phase without having to 
stain the cells first, thereby introducing chemical changes in a highly important 
region of spectrum.  
 
To do this a supervised training algorithm would need to be implemented; using a 
technique similar to Boydston-White et al. [24]. Cell spectra could be acquired and 
subsequently stained with 4’,6-diamidino-2-phenylindole (DAPI) which is a 
fluorescent stain that binds strongly to DNA in a stoichiometric reaction. It can be 
used to quantify cellular DNA content by measuring the integrated intensity of the 
dye in the nucleus and is used extensively in fluorescence microscopy and for the 
analysis of both live and fixed cells [25-26]. It is more advantageous to PI which 
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requires RNAse treatment so that both RNA and DNA are not stained. DAPI does 
bind to RNA but is not as strongly fluorescent and the use of RNAse is not required. 
Cell cycle could be deduced by applying the appropriate fluorescence intensity 
thresholds where intensity = G1 < S < G2/M.  
 
In order to locate individual cells before and after spectral acquisition and staining 
the use of an England finder graticule would be advantageous, held underneath a 
reflective slide such as MirrIR. Once a cell was selected for acquisition, the focus 
could be shifted to the graticule and the position co-ordinate recorded along with 
the image.  
 
An example of this is shown (Fig. 7.14) using Omnic software at the Soleil 
synchrotron. Another advantage of this approach would be that cells could be 
grown directly onto the infrared substrate, removing the need for cyto-spinning and 
preserving true cellular morphology (as true as can be for cells grown onto a flat, 
2D surface).  
 
 
 
 
 
 
 
Figure 7.14│ Optical images of the England finder graticule (left) and corresponding region on 
the sample surface (right). The cross-hair marks the co-ordinate of the cell in both images. 
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The cultured cells would then be stained for DNA content and defined in cell cycle 
phase using the fluorescent DAPI dye as illustrated in Figure 7.15. Once a 
supervised training algorithm was in place, cell spectra may be characterised 
without the use of staining in the future, which would be advantageous not only to 
the analysis of cellular response to drugs, but for many other applications.  
 
 
 
 
 
 
 
 
 
Figure 7.15│ Fluorescence microscopy: example of A-498 cells with their nuclei stained with 
DAPI (in mountant) taken with an Olympus microscope equipped with a 20× lens for an 
exposure time of 300 ms.  
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To lay the foundation work in order to investigate the feasibility of FTIR 
spectroscopy as a tool for cellular response to drugs, three levels of progression 
were involved.  
 
8.1│Validation of the RMieS-EMSC algorithm for spectral 
interpretation using cell line characterisation of renal 
carcinoma cell lines 
The novel correction RMieS-EMSC algorithm to correct FTIR spectra of biological 
material is a welcomed improvement in spectral pre-processing. The algorithm has 
been shown to correct simulated spectra with greatly improved performance over 
older algorithms, such as EMSC alone. While using simulated spectra can result in 
a definite evaluation of the algorithm’s performance, it is more difficult to comment 
on the performance with real biological spectra, as the ‘true’ corrected spectrum 
answer cannot easily be known. 
 
If the spectroscopy community is to rely heavily on such an algorithm in order to 
confidently interpret biological spectra, it was important to validate the RMieS-
EMSC corrected spectra with other scientific techniques that did not suffer from 
such optical distortions.  
  
In addition, validation with more clinically familiar -omic techniques was also 
explored in order to perhaps reach a wider audience, such as members of the 
clinical community that are unfamiliar with infrared spectroscopy.  
 
Interpretation from the multivariate analysis of the corrected FTIR spectra 
highlighted key differences in the protein composition of the RCC cell line 2247R, 
relative to the 2245R and 2246R cell line. For validation, label-free LCMS analysis 
of the cell lysates revealed that the 2247R protein chemistry was more anomalous to 
that of the other two cells lines. In particular, alpha-rich sub-units of Histone H2A 
were revealed to be highly expressed in cell line 2247R, which also appeared to be 
  
 
220
rich in alpha helical protein secondary structure in the FTIR analysis. The over-
expression of Histone H2A was in turn validated by Western blot for confirmation.  
 
8.2│Characterisation of renal carcinoma cell lines and cells 
displaying ‘stem-cell like’ properties  
In the eventual analysis of the changes in cellular chemistry to different drugs, 
spectroscopic and chemometric discrimination would involve tracking discrete 
changes in one cell line, not simply discriminating cell lines of different origin.  
 
The low proportion of cells displaying stem-cell like characteristics as a sub-
population provided yet another model of cell characterisation with increased 
difficulty. A project running parallel to the investigation looking at targeted side 
population cancer therapy meant that these cells were readily available for 
spectroscopic analysis. They were typically small and required the use of an 
infrared source of high brilliance (synchrotron radiation) and use of the RMieS-
EMSC correction algorithm in order to fully characterise.  
 
Not only could the general side population cells be characterised by a different 
spectral infrared signature to the general, non-side population but the two sub-side 
populations were also discriminated. This was an encouraging result and allows 
potential to follow up the parallel, targeted therapy experiment with FTIR and 
chemometric analysis to determine drug-side population response in the future.    
  
8.3│Exploring methods of detecting cellular response to 
chemotherapeutics 
In the model, it was recognised that 5FU is not very efficient in treating RCC in 
clinical practice; it provided a good basis as a model agents as it is an established 
drug with known mode of action, including cell cycle arrest.   
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For the gold-based KF series of novel drugs, it was not known whether they would 
perform. At the end of the initial investigation, however, it was deemed that while 
the KF drugs did have an initial effect, where signs of possible DNA damage and 
repair were observed, subsequent analysis after 3 days showed disappointing 
results. Viability assays showed that proliferation had recovered.   
 
In single point monolayer analysis using PCA, the chemical profiles of the infrared 
spectra of the cells seemed no different to control, suggesting that the cells had not 
developed resistance or perhaps the drugs were simply no longer present due to cell 
efflux, or breakdown.  
 
This also highlights the question as to which day of exposure to drugs should cell 
spectra be analysed? It may be hard to predict response from day 1 as some agents 
may take more time to act, particularly if they cause cell cycle arrest. The results 
have also sparked another question concerning dosage: as it is difficult to translate 
drug dosages in vitro to in vivo, it is better to look at a single dose at the IC50, or 
multiple doses at multiple concentrations?  
 
PCA works well enough for cell monolayers looking at general trends of a 
population of cells and is preferable over supervised chemometric techniques that 
can include levels of subjectivity.  
 
The issue of sample heterogeneity due to cell cycle differences was amplified when 
analysing single cell spectra. Efforts must be made to separate the infrared 
information of drug response from differences simply due to inherent cell cycle 
chemistry if the technique is to be further developed. It was shown in chapter 7 that 
advanced techniques of discrimination such as LDA may not be required if cell 
cycle can be omitted factor of discrimination. 
 
In the context of the experiments (Ch.6 and Ch.7.) the FTIR methodology has been 
successful in indicating a cellular response to the novel gold compounds, which 
suggests that they are certainly active and able to infiltrate into the cells, particularly 
in the first 24 hours. While the overall efficacy of the compounds against RCC is 
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poor, the result is powerful enough to suggest that the compounds may be more 
effective in other types of cancer cell. Using multivariate analysis it was also 
possible to distinguish between the gold compounds from 5FU, which has a distinct 
mode of action that affects cells in the S phase in particular.  
 
In conclusion, use of FTIR spectroscopy appears a feasible technique to monitor 
drug effects in cells. While the full extent of this method is not yet validated and 
there are many unanswered questions to account for, the conclusions gained from 
the spectral analyses were in line with complimentary methods such as the FACS 
and viability assays. Once further development of this approach to early assessment 
of drug efficacy can be achieved, it may attract pharmaceutical interest.  
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Table 4.1 │Calculating the alpha/beta ratio of protein secondary 
structure  
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Table 4.2 │ MS peptide feature abundance and best peptide 
match 
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Table 4.3 │ MSMS protein identification and secondary structure 
estimation 
 
 
  
 
227
 
Table 4.4 │ MSMS protein identification and secondary structure 
estimation 
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Table 7.1 │ PC1 Loading plot analysis of G1 phase cell spectra 
after 24 hours of exposure   
 
PC1 separates CTL against KF1, 5FU  
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Table 7.2 │PC3 Loading plot analysis of G1 phase cell spectra 
after 24 hours exposure  
 
PC3 separates KF1 against CTL, 5FU 
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Table 7.3 │PC1 Loading plot analysis of S phase cell spectra 
after 72 hours exposure  
 
PC1 separates KF1 against 5FU 
 
 
 
